Processing 00000000.tx.1: Physiological Increases in Uncoupling Protein 3 Augment Fatty Acid Oxidation and Decrease Reactive Oxygen Species Production Without Uncoupling Respiration in Muscle Cells J. 

Phrase: "Physiological Increases in Uncoupling Protein 3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0442805:increases [Functional Concept]

Phrase: "Augment"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205217:augment [Quantitative Concept]

Phrase: "Fatty Acid Oxidation"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1158366:fatty acid oxidation [Molecular Function]
   901   C0015684:Fatty acid [Lipid]
   827   C0001128:Acid [Chemical]
   827   C0030011:Oxidation [Molecular Function]
   827   C0202406:Acid [Laboratory Procedure]

Phrase: "and"

Phrase: "Decrease"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0392756:Decrease [Qualitative Concept]
  1000   C0547047:Decrease [Quantitative Concept]

Phrase: "Reactive Oxygen Species Production Without"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0033268:production [Occupational Activity]

Phrase: "Uncoupling"

Phrase: "Respiration in Muscle Cells J."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   781   C0282636:Cell Respiration [Cell Function]
           respiration
   760   C0035203:Respiration [Physiologic Function]
   760   C1160636:respiration [Biologic Function]
Processing 00000000.tx.2: Darcy MacLellan1, Martin F. 

Phrase: "Darcy MacLellan1,"

Phrase: "Martin F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.3: Gerrits1, Adrienne Gowing1, Peter J.S. 

Phrase: "Gerrits1,"

Phrase: "Adrienne Gowing1,"

Phrase: "Peter J.S."
Processing 00000000.tx.4: Smith2, Michael B. 

Phrase: "Smith2,"

Phrase: "Michael B."
Processing 00000000.tx.5: Wheeler3, and Mary-Ellen Harper1 1 Department of Biochemistry, Microbiology, and Immunology, Faculty of Medicine, University of Ottawa, Ottawa, Ontario, Canada 2 BioCurrents Research Center, Program in Molecular Physiology, Marine Biological Laboratory, Woods Hole, Massachusetts 3 Departments of Medicine and Physiology, University of Toronto, Toronto, Ontario, Canada  ABSTRACT TOP ABSTRACT RESEARCH DESIGN AND METHODS RESULTS DISCUSSION REFERENCES  Decreased uncoupling protein (UCP)3 is associated with insulin resistance in muscle of pre-diabetic and diabetic individuals, but the function of UCP3 remains unclear. 

Phrase: "Wheeler3,"

Phrase: "and"

Phrase: "Mary-Ellen Harper1 1 Department of Biochemistry,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1704729:Department [Organization]

Phrase: "Microbiology,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025952:Microbiology [Biomedical Occupation or Discipline]
  1000   C0025953:microbiology [Intellectual Product]
  1000   C0085672:Microbiology [Laboratory Procedure]

Phrase: "and"

Phrase: "Immunology,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0152036:Immunology [Biomedical Occupation or Discipline]
  1000   C1522005:immunology [Qualitative Concept]
   928 E C0205470:Immunological [Functional Concept]

Phrase: "Faculty of Medicine,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0015535:Faculty [Professional or Occupational Group]

Phrase: "University of Ottawa,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0041740:University [Manufactured Object,Organization]
   827   C1551454:Ottawa [Population Group]

Phrase: "Ottawa,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1551454:Ottawa [Population Group]

Phrase: "Ontario,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0029040:Ontario [Geographic Area]

Phrase: "Canada 2 BioCurrents"

Phrase: "Research"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0035168:research [Research Activity]
  1000   C0242481:Research [Research Activity]

Phrase: "Center,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205099:Center [Spatial Concept]

Phrase: "Program in Molecular Physiology,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C1709697:Program [Conceptual Entity]
   770   C2728259:Program [Pharmacologic Substance]
   770   C3484370:Program [Functional Concept]

Phrase: "Marine Biological Laboratory,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0022877:Laboratory [Manufactured Object,Organization]
   827   C3244292:laboratory [Functional Concept]

Phrase: "Woods Hole,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0544726:Hole [Finding]
   861   C1823381:hole [Gene or Genome]
   861   C1881060:HOLE [Event]

Phrase: "Massachusetts 3 Departments of Medicine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   726   C1704729:Department [Organization]

Phrase: "and"

Phrase: "Physiology,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0031842:Physiology [Biomedical Occupation or Discipline]
  1000   C0031843:physiology [Physiologic Function]
   928 E C0205463:Physiologic [Functional Concept]

Phrase: "University of Toronto,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0041740:University [Manufactured Object,Organization]

Phrase: "Toronto,"

Phrase: "Ontario,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0029040:Ontario [Geographic Area]

Phrase: "Canada  ABSTRACT TOP ABSTRACT RESEARCH DESIGN"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0035171:Research Design [Research Activity]
   799   C0035168:research [Research Activity]
   799   C0242481:Research [Research Activity]
   799   C1707689:Design [Activity]
   799   C2983265:DESIGN [Intellectual Product]

Phrase: "AND"

Phrase: "METHODS RESULTS DISCUSSION REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   779   C1514811:Reference [Idea or Concept]
   779   C1706462:Reference [Conceptual Entity]

Phrase: "Decreased"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0205216:Decreased [Quantitative Concept]
  1000   C0392756:Decreased [Qualitative Concept]
  1000   C0442797:decreased [Qualitative Concept]
   966 E C0547047:Decrease [Quantitative Concept]

Phrase: "uncoupling protein (UCP)3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0539733:uncoupling protein-3 [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
  1000   C1421315:UNCOUPLING PROTEIN 3 [Gene or Genome]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "is"

Phrase: "associated with insulin resistance"
Meta Candidates (Total=12; Excluded=3; Pruned=0; Remaining=9)
   833   C0021655:Insulin Resistance [Pathologic Function]
   833   C0332281:Associated with [Qualitative Concept]
           Associated
   833   C2700570:INSULIN RESISTANCE [Gene or Genome]
   770   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C0237834:Resistance [Mental Process]
   770   C1514892:Resistance [Physiologic Function]
   770   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C1579433:Insulin [Pharmacologic Substance]
   737 E C0750490:Associate [Idea or Concept]
   737 E C1706221:Associate [Professional or Occupational Group]
   715 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "in muscle"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0026845:Muscle [Tissue]
   928 E C0442025:Muscular [Spatial Concept]

Phrase: "of pre-diabetic"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0362046:pre-diabetic [Disease or Syndrome]
   861   C0241863:DIABETIC [Finding]
   861   C0332152:Pre [Temporal Concept]
   861   C0740175:Pre [Qualitative Concept]
   861   C2257086:PRE [Genetic Function]

Phrase: "and"

Phrase: "diabetic individuals,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0027361:Individual [Population Group]
   827   C0237401:Individual [Human]

Phrase: "but"

Phrase: "the function of UCP3"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   783   C0815043:function protein [Amino Acid, Peptide, or Protein]
   783   C1527118:Protein Function [Molecular Function]
   753   C0031843:function [Physiologic Function]
   753   C0542341:Function [Functional Concept]
   753   C0700205:FUNCTION [Classification]
   753   C1705273:Function [Intellectual Product]

Phrase: "remains"

Phrase: "unclear."
Processing 00000000.tx.6: Our goal was to elucidate mechanisms underlying the negative correlation between UCP3 and insulin resistance in muscle. 

Phrase: "Our goal"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0018017:Goal [Intellectual Product]
  1000   C1571704:Goal [Idea or Concept]

Phrase: "was"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "elucidate"

Phrase: "mechanisms"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0441712:Mechanisms [Functional Concept]
   966 E C1706376:Mechanism [Manufactured Object]

Phrase: "underlying"

Phrase: "the negative correlation between UCP3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1707520:Correlation [Qualitative Concept]

Phrase: "and"

Phrase: "insulin resistance in muscle."
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   833   C0021655:Insulin Resistance [Pathologic Function]
   833   C2700570:INSULIN RESISTANCE [Gene or Genome]
   770   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C0237834:Resistance [Mental Process]
   770   C1514892:Resistance [Physiologic Function]
   770   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C1579433:Insulin [Pharmacologic Substance]
   715 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
Processing 00000000.tx.7: We determined effects of physiologic UCP3 overexpression on glucose and fatty acid oxidation and on mitochondrial uncoupling and reactive oxygen species (ROS) production in L6 muscle cells. 

Phrase: "We"

Phrase: "determined"

Phrase: "effects of physiologic UCP3 overexpression"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   748   C1280500:effects [Qualitative Concept]
   724   C1372798:Physiological Effects [Physiologic Function]
   714 E C2348382:Effect [Qualitative Concept]

Phrase: "on glucose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "and"

Phrase: "fatty acid oxidation"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1158366:fatty acid oxidation [Molecular Function]
   901   C0015684:Fatty acid [Lipid]
   827   C0001128:Acid [Chemical]
   827   C0030011:Oxidation [Molecular Function]
   827   C0202406:Acid [Laboratory Procedure]

Phrase: "and on mitochondrial"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0026237:Mitochondrial [Cell Component]
   790   C0521451:Mitochondrial [Functional Concept]
   790   C1515981:And [Idea or Concept]

Phrase: "uncoupling"

Phrase: "and"

Phrase: "reactive oxygen species (ROS) production in L6 muscle cells."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0033268:production [Occupational Activity]
Processing 00000000.tx.8: An adenoviral construct caused a 2.2- to 2.5-fold increase in UCP3 protein. 

Phrase: "An adenoviral construct"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2827421:Construct [Classification]

Phrase: "caused"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0015127:cause [Functional Concept]
   966   C1524003:Cause [Conceptual Entity]

Phrase: "a 2.2-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0740116:+2 [Quantitative Concept]
   861   C2827735:2+ [Quantitative Concept]
   861   C2981700:2+ [Classification]

Phrase: "to 2.5-fold increase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0442805:Increase [Functional Concept]

Phrase: "in UCP3 protein."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   756   C0539733:uncoupling protein-3 [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   756   C1421315:UNCOUPLING PROTEIN 3 [Gene or Genome]
Processing 00000000.tx.9: Palmitate oxidation was increased in muscle cells incubated under normoglycemic or hyperglycemic conditions, whereas adenoviral green fluorescent protein infection or chronic low doses of the uncoupler dinitrophenol had no effect. 

Phrase: "Palmitate oxidation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030011:Oxidation [Molecular Function]

Phrase: "was"

Phrase: "increased in muscle cells"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   833   C0596981:Muscle Cells [Cell]
   770   C0007634:Cells [Cell]
   770   C0026845:Muscle [Tissue]
   770   C0205217:Increased [Quantitative Concept]
   770   C0442805:Increased [Functional Concept]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "incubated under normoglycemic"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0580545:Normoglycaemic [Finding]
   790   C1439852:Incubated [Laboratory Procedure]

Phrase: "or"

Phrase: "hyperglycemic conditions,"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   827   C0012634:condition [Disease or Syndrome]
   827   C0348080:Condition [Qualitative Concept]
   827   C1705253:Condition [Conceptual Entity]
   777 E C0009647:Conditioned [Mental Process]
   777 E C1701901:Conditional [Qualitative Concept]
   777 E C1963686:Conditional [Functional Concept]
   755 E C1519605:Conditionality [Conceptual Entity]

Phrase: "whereas"

Phrase: "adenoviral green fluorescent protein infection"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   897   C0851887:adenoviral infection [Disease or Syndrome]
   804   C0009450:Infection, NOS [Disease or Syndrome]
   733 E C0439663:Infected [Functional Concept]
   717   C0120285:green fluorescent protein [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]

Phrase: "or"

Phrase: "chronic low doses of the uncoupler dinitrophenol"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   762   C0445550:Low dose [Quantitative Concept]
   762   C1708745:Low-Dose [Research Activity]
   748   C0178602:Doses [Quantitative Concept]
   714 E C0869039:Dose [Quantitative Concept]
   714 E C1114758:Dose # [Clinical Attribute]
   714 E C1428722:DOS [Gene or Genome]

Phrase: "had"

Phrase: "no effect."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1280500:Effect [Qualitative Concept]
  1000   C2348382:Effect [Qualitative Concept]
Processing 00000000.tx.10: Increased UCP3 did not affect glucose oxidation, whereas dinitrophenol and insulin treatments caused increases. 

Phrase: "Increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "UCP3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0539733:uncoupling protein-3 [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
  1000   C1421315:UNCOUPLING PROTEIN 3 [Gene or Genome]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "affect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001721:Affect [Mental Process]

Phrase: "glucose oxidation,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030011:Oxidation [Molecular Function]

Phrase: "whereas"

Phrase: "dinitrophenol"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0012466:Dinitrophenol [Organic Chemical]

Phrase: "and"

Phrase: "insulin treatments"
Meta Candidates (Total=7; Excluded=5; Pruned=0; Remaining=2)
  1000   C0745343:insulin treatments [Therapeutic or Preventive Procedure]
   861   C0087111:Treatments [Therapeutic or Preventive Procedure]
   827 E C0039798:treatment [Functional Concept]
   827 E C1522326:Treatment [Functional Concept]
   827 E C1533734:Treatment [Therapeutic or Preventive Procedure]
   827 E C1705169:Treatment [Conceptual Entity]
   827 E C3538994:TREATMENT [Research Activity]

Phrase: "caused"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0015127:cause [Functional Concept]
   966   C1524003:Cause [Conceptual Entity]

Phrase: "increases."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442805:increases [Functional Concept]
Processing 00000000.tx.11: Basal oxygen consumption, assessed in situ using self-referencing microelectrodes, was not significantly affected, whereas dinitrophenol caused increases. 

Phrase: "Basal oxygen consumption,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0030055:Oxygen Consumption [Clinical Attribute]
   901   C1305742:oxygen consumption [Diagnostic Procedure]
   827   C0009830:Consumption [Activity]
   827   C0030054:Oxygen [Element, Ion, or Isotope,Pharmacologic Substance]
   827   C1947907:Consumption [Physiologic Function]

Phrase: "assessed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1516048:Assessed [Activity]

Phrase: "in situ"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0444498:In situ [Spatial Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "self-referencing microelectrodes,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0025973:Microelectrodes [Medical Device]

Phrase: "was"

Phrase: "not significantly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1518422:Not [Functional Concept]

Phrase: "affected"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0392760:Affected [Functional Concept]
  1000   C1314939:Affected [Functional Concept]
   966 E C0001721:Affect [Mental Process]

Phrase: ","

Phrase: "whereas"

Phrase: "dinitrophenol caused increases."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0442805:increases [Functional Concept]
Processing 00000000.tx.12: Mitochondrial membrane potential was decreased by dinitrophenol but was not affected by increased UCP3 expression. 

Phrase: "Mitochondrial membrane potential"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
  1000   C1720920:Membrane Potential, Mitochondrial [Cell Function]
   901   C0025251:Membrane Potential [Cell Function]
   901   C0596952:Mitochondrial membrane [Cell Component]
   827   C0025255:Membrane [Tissue]
   827   C0026237:Mitochondrial [Cell Component]
   827   C0521451:Mitochondrial [Functional Concept]
   827   C0596901:Membrane [Cell Component]
   827   C1706182:Membrane [Manufactured Object]
   827   C3245505:Potential [Qualitative Concept]
   755 E C0205287:Membranous [Qualitative Concept]

Phrase: "was"

Phrase: "decreased by dinitrophenol"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   790   C0012466:Dinitrophenol [Organic Chemical]
   790   C0205216:Decreased [Quantitative Concept]
   790   C0392756:Decreased [Qualitative Concept]
   790   C0442797:decreased [Qualitative Concept]
   756 E C0547047:Decrease [Quantitative Concept]

Phrase: "but"

Phrase: "was"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "affected by increased UCP3 expression."
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   814   C0539733:uncoupling protein-3 [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   814   C1421315:UNCOUPLING PROTEIN 3 [Gene or Genome]
   774   C1171362:expression protein [Genetic Function]
   748   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0185117:Expression [Therapeutic or Preventive Procedure]
   748   C0205217:Increased [Quantitative Concept]
   748   C0392760:Affected [Functional Concept]
   748   C0442805:Increased [Functional Concept]
   748   C1314939:Affected [Functional Concept]
   714 E C0001721:Affect [Mental Process]
Processing 00000000.tx.13: Finally, mitochondrial ROS production decreased significantly with increased UCP3 expression. 

Phrase: "Finally,"

Phrase: "mitochondrial ROS production"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0033268:production [Occupational Activity]
   717   C0162772:Reactive Oxygen Species [Biologically Active Substance,Element, Ion, or Isotope]

Phrase: "decreased"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0205216:Decreased [Quantitative Concept]
  1000   C0392756:Decreased [Qualitative Concept]
  1000   C0442797:decreased [Qualitative Concept]
   966 E C0547047:Decrease [Quantitative Concept]

Phrase: "significantly with increased UCP3 expression."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   814   C0539733:uncoupling protein-3 [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   814   C1421315:UNCOUPLING PROTEIN 3 [Gene or Genome]
   774   C1171362:expression protein [Genetic Function]
   748   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0185117:Expression [Therapeutic or Preventive Procedure]
   748   C0205217:Increased [Quantitative Concept]
   748   C0442805:Increased [Functional Concept]
Processing 00000000.tx.14: Results are consistent with UCP3 functioning to facilitate fatty acid oxidation and minimize ROS production. 

Phrase: "Results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "are"

Phrase: "consistent with UCP3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   806   C0332290:Consistent with [Idea or Concept]
           Consistent

Phrase: "functioning"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0542341:functioning [Functional Concept]
   966 E C0031843:function [Physiologic Function]
   966 E C0700205:FUNCTION [Classification]
   966 E C1705273:Function [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "facilitate"

Phrase: "fatty acid oxidation"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1158366:fatty acid oxidation [Molecular Function]
   901   C0015684:Fatty acid [Lipid]
   827   C0001128:Acid [Chemical]
   827   C0030011:Oxidation [Molecular Function]
   827   C0202406:Acid [Laboratory Procedure]

Phrase: "and"

Phrase: "minimize"

Phrase: "ROS production."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0033268:production [Occupational Activity]
   756   C0162772:Reactive Oxygen Species [Biologically Active Substance,Element, Ion, or Isotope]
Processing 00000000.tx.15: As impaired fatty acid metabolism and ROS handling are important precursors in muscular insulin resistance, UCP3 is an important therapeutic target in type 2 diabetes. 

Phrase: "As impaired fatty acid metabolism"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   923   C0596563:Fatty Acid Metabolism [Molecular Function]
   812   C0025519:Metabolism [Organism Function]
   812   C0025520:metabolism [Functional Concept]

Phrase: "and"

Phrase: "ROS"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0162772:Reactive Oxygen Species [Biologically Active Substance,Element, Ion, or Isotope]
   827   C0030054:Oxygen [Element, Ion, or Isotope,Pharmacologic Substance]
   827   C0205332:Reactive [Qualitative Concept]
   827   C1705920:Species [Conceptual Entity]

Phrase: "handling"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0018578:Handling [Behavior]
  1000   C1832073:Handling [Finding]
   966 E C1708320:Handle [Conceptual Entity]

Phrase: "are"

Phrase: "important precursors in muscular insulin resistance,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   719   C1709634:Precursor [Idea or Concept]

Phrase: "UCP3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0539733:uncoupling protein-3 [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
  1000   C1421315:UNCOUPLING PROTEIN 3 [Gene or Genome]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "is"

Phrase: "an important therapeutic target in type 2 diabetes."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C1521840:Target [Functional Concept]
   744   C2986546:TARGET [Diagnostic Procedure]
Processing 00000000.tx.16: Insulin resistance in muscle is a primary component of type 2 diabetes, a disease with a prevalence that is increasing at an alarming rate in modern society. 

Phrase: "Insulin resistance in muscle"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   833   C0021655:Insulin Resistance [Pathologic Function]
   833   C2700570:INSULIN RESISTANCE [Gene or Genome]
   770   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C0237834:Resistance [Mental Process]
   770   C1514892:Resistance [Physiologic Function]
   770   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C1579433:Insulin [Pharmacologic Substance]
   715 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "is"

Phrase: "a primary component of type 2 diabetes,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   774   C3645606:Component type [Intellectual Product]
   748   C0449432:Component [Manufactured Object]
   748   C1705248:Component [Conceptual Entity]

Phrase: "a disease with a prevalence"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   760   C0012634:Disease [Disease or Syndrome]
   704 E C1836721:MALS [Finding]
   704 E C3538764:MALS [Gene or Genome]
   704 E C3540595:MAL [Gene or Genome]

Phrase: "that"

Phrase: "is"

Phrase: "increasing at an alarming rate"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   760   C0336648:alarming [Medical Device]
   760   C0442808:Increasing [Functional Concept]
   760   C0871208:Rate [Activity]
   760   C1521828:Rate [Quantitative Concept]
   760   C2945761:alarming [Phenomenon or Process]
   726 E C0442805:Increase [Functional Concept]
   726 E C0542180:ALARM [Mental Process]
   726 E C1706451:Alarm [Medical Device]

Phrase: "in modern society."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0680319:modern society [Population Group]
   861   C0037455:society [Organization]
Processing 00000000.tx.17: The importance of mitochondrial oxidative phosphorylation in the development of type 2 diabetes has recently been demonstrated through gene expression profiling studies in muscle of pre-diabetic, diabetic, and nondiabetic populations. 

Phrase: "The importance of mitochondrial oxidative phosphorylation"

Phrase: "in the development"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0243107:development [Physiologic Function]
  1000   C0678723:Development [Organism Function]
  1000   C1527148:Development [Functional Concept]
   928 E C0458003:Developmental [Qualitative Concept]

Phrase: "of type 2 diabetes"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0011860:Type 2 Diabetes [Disease or Syndrome]
   913   C1320657:type diabetes [Finding]
   901   C0441730:Type 2 [Classification]
   827   C0011847:Diabetes [Disease or Syndrome]
   827   C0011849:Diabetes [Disease or Syndrome]
   827   C0332307:Type [Qualitative Concept]
   827   C1547052:*Type [Quantitative Concept]

Phrase: "has"

Phrase: "recently"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332185:Recently [Temporal Concept]

Phrase: "been"

Phrase: "demonstrated through gene expression profiling studies"
Meta Candidates (Total=13; Excluded=3; Pruned=0; Remaining=10)
   833   C0752248:Gene Expression Profiling [Laboratory Procedure,Molecular Biology Research Technique]
   833   C1449575:Gene Expression Profiling [Laboratory Procedure]
   816 E C1956267:Profile, Gene Expression [Quantitative Concept]
   790   C0017262:Gene Expression [Genetic Function]
   790   C1513400:Expression Profiling [Molecular Biology Research Technique]
   783   C1273305:Gene studies [Laboratory Procedure]
   753   C0017337:Gene [Gene or Genome]
   753   C0185117:Expression [Therapeutic or Preventive Procedure]
   753   C0947630:studies [Laboratory Procedure]
   719 E C0557651:Study [Manufactured Object]
   719   C1979963:Profile [Laboratory Procedure]
   719   C2003903:Profile [Functional Concept]
   719 E C2603343:Study [Research Activity]

Phrase: "in muscle"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0026845:Muscle [Tissue]
   928 E C0442025:Muscular [Spatial Concept]

Phrase: "of pre-diabetic, diabetic,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C0362046:pre-diabetic [Disease or Syndrome]

Phrase: "and"

Phrase: "nondiabetic populations."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0032659:Population [Quantitative Concept]
   861   C1257890:Population [Population Group]
Processing 00000000.tx.18: Individuals with type 2 diabetes were shown to have reduced expression of genes for key proteins in oxidative metabolism and mitochondrial function in muscle (1). 

Phrase: "Individuals with type 2 diabetes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   726   C0027361:Individual [Population Group]
   726   C0237401:Individual [Human]

Phrase: "were"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "have"

Phrase: "reduced expression of genes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   802   C0017262:Gene Expression [Genetic Function]
   770   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "for key proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "in oxidative metabolism"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0282636:oxidative metabolism [Cell Function]
   861   C0025519:Metabolism [Organism Function]
   861   C0025520:metabolism [Functional Concept]

Phrase: "and"

Phrase: "mitochondrial function in muscle"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   819   C0231484:Muscle function [Organ or Tissue Function]
   819   C0517929:function muscle [Finding]
   770   C0031843:function [Physiologic Function]
   770   C0542341:Function [Functional Concept]
   770   C0700205:FUNCTION [Classification]
   770   C1705273:Function [Intellectual Product]

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ")."
Processing 00000000.tx.19: Furthermore, pre-diabetic individuals with insulin resistance but normal glucose tolerance display the same pattern of decreased expression of genes related to mitochondrial oxidative metabolism, consistent with the possibility that such characteristics are directly relevant to the origins and development of type 2 diabetes (2). 

Phrase: "Furthermore,"

Phrase: "pre-diabetic individuals with insulin resistance"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   719   C0027361:Individual [Population Group]
   719   C0237401:Individual [Human]

Phrase: "but"

Phrase: "normal glucose tolerance"
Meta Candidates (Total=13; Excluded=2; Pruned=0; Remaining=11)
   901   C0178665:Glucose tolerance [Physiologic Function]
   901   C0860800:normal glucose [Finding]
   827   C0013220:Tolerance [Finding]
   827   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   827   C0020963:Tolerance [Pathologic Function]
   827   C0205307:Normal [Qualitative Concept]
   827   C0220929:tolerance [Mental Process]
   827   C0231197:Tolerance [Physiologic Function]
   827   C0439166:% normal [Quantitative Concept]
   827   C1704410:Tolerance [Qualitative Concept]
   827   C2347086:% Normal [Quantitative Concept]
   771 E C0680282:toleration [Social Behavior]
   755 E C0231198:Tolerant [Functional Concept]

Phrase: "display"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705417:Display [Manufactured Object]

Phrase: "the same pattern of decreased expression of genes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0449774:Pattern [Spatial Concept]

Phrase: "related to mitochondrial oxidative metabolism,"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   806   C0282636:oxidative metabolism [Cell Function]
   760   C0025519:Metabolism [Organism Function]
   760   C0025520:metabolism [Functional Concept]
   760   C0026237:Mitochondrial [Cell Component]
   760   C0311404:Oxidative [Functional Concept]
   760   C0439849:Related [Qualitative Concept]
   760   C0445223:Related [Finding]
   760   C0521451:Mitochondrial [Functional Concept]
   726 E C0163712:Relate [Organic Chemical]

Phrase: "consistent with the possibility"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0332290:Consistent with [Idea or Concept]
           Consistent

Phrase: "that"

Phrase: "such characteristics"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1521970:Characteristics [Qualitative Concept]

Phrase: "are"

Phrase: "directly relevant to the origins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C2347946:Relevant [Qualitative Concept]

Phrase: "and"

Phrase: "development of type 2 diabetes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0243107:development [Physiologic Function]
   760   C0678723:Development [Organism Function]
   760   C1527148:Development [Functional Concept]

Phrase: "(2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: ")."
Processing 00000000.tx.20: One of the mitochondrial proteins having decreased mRNA expression in pre-diabetic and diabetic subjects is uncoupling protein (UCP)3 (2). 

Phrase: "One of the mitochondrial proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0205447:One [Quantitative Concept]

Phrase: "having"

Phrase: "decreased mRNA expression in pre-diabetic"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1515670:mRNA Expression [Genetic Function]
   753   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "diabetic subjects"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0681850:Subject [Group]
   827   C1550501:{Subject} [Idea or Concept]
   827   C1706203:Subject [Idea or Concept]
   827   C2349001:Subject [Human]
   827   C2697811:Subject [Functional Concept]

Phrase: "is"

Phrase: "uncoupling protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(UCP)3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0539733:uncoupling protein-3 [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
  1000   C1421315:UNCOUPLING PROTEIN 3 [Gene or Genome]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: ")."
Processing 00000000.tx.21: Not only are the levels of mRNA for UCP3 decreased but also are the levels of UCP3 protein. 

Phrase: "Not only"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205171:Only [Quantitative Concept]
   861   C1518422:Not [Functional Concept]
   861   C1720467:Only [Intellectual Product]

Phrase: "are"

Phrase: "the levels of mRNA"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   770   C0441889:Levels [Qualitative Concept]
   737 E C0456079:Level [Classification]
   737 E C1547707:Level [Geographic Area]
   737 E C2946261:Level [Pharmacologic Substance]

Phrase: "for UCP3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0539733:uncoupling protein-3 [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
  1000   C1421315:UNCOUPLING PROTEIN 3 [Gene or Genome]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "decreased"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0205216:Decreased [Quantitative Concept]
  1000   C0392756:Decreased [Qualitative Concept]
  1000   C0442797:decreased [Qualitative Concept]
   966 E C0547047:Decrease [Quantitative Concept]

Phrase: "but"

Phrase: "also"

Phrase: "are"

Phrase: "the levels of UCP3 protein."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   757   C0428479:Protein level [Laboratory or Test Result]
   757   C0456949:Level 3 [Intellectual Product]
   748   C0441889:Levels [Qualitative Concept]
   714 E C0456079:Level [Classification]
   714 E C1547707:Level [Geographic Area]
   714 E C2946261:Level [Pharmacologic Substance]
Processing 00000000.tx.22: Schrauwen et al. 

Phrase: "Schrauwen et al."
Processing 00000000.tx.23: (3) demonstrated decreased UCP3 protein in vastus lateralis of type 2 diabetic patients and no significant association between UCP3 protein and BMI of patients. 

Phrase: "(3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: ")"

Phrase: "demonstrated"

Phrase: "decreased"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0205216:Decreased [Quantitative Concept]
  1000   C0392756:Decreased [Qualitative Concept]
  1000   C0442797:decreased [Qualitative Concept]
   966 E C0547047:Decrease [Quantitative Concept]

Phrase: "UCP3 protein in vastus lateralis of type 2 diabetic patients"

Phrase: "and"

Phrase: "no significant association between UCP3 protein"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   744   C0004083:Association [Mental Process]
   744   C0439849:Association [Qualitative Concept]
   744   C0596306:Association [Phenomenon or Process]
   744   C0699792:association [Social Behavior]

Phrase: "and"

Phrase: "BMI of patients."
Processing 00000000.tx.24: Mitochondrial UCPs belong to a large family of anion carrier proteins that facilitate the exchange of substrates across the mitochondrial inner membrane. 

Phrase: "Mitochondrial UCPs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1421313:UCP [Gene or Genome]

Phrase: "belong to a large family of anion carrier proteins"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   764   C0007292:Carrier Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   764   C0424972:Large family [Family Group]
   745   C0038164:Protein A [Amino Acid, Peptide, or Protein,Immunologic Factor,Indicator, Reagent, or Diagnostic Aid]
   745   C1335532:Protein Family [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0003075:Anion [Element, Ion, or Isotope]
   742   C0007294:Carrier [Finding]
   742   C0015576:Family [Family Group]
   742   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0549177:Large [Quantitative Concept]
   742   C0560175:Carrier [Finding]
   742   C1704727:Family [Conceptual Entity]
   742   C1706209:Carrier [Medical Device]
   742   C3273162:Carrier [Intellectual Product]

Phrase: "that"

Phrase: "facilitate"

Phrase: "the exchange of substrates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0678640:exchange [Social Behavior]

Phrase: "across the mitochondrial inner membrane."
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C0230840:Mitochondrial Inner Membrane [Cell Component]
   913   C0596952:Mitochondrial membrane [Cell Component]
   827   C0025255:Membrane [Tissue]
   827   C0205102:Inner [Spatial Concept]
   827   C0596901:Membrane [Cell Component]
   827   C1706182:Membrane [Manufactured Object]
   755 E C0205287:Membranous [Qualitative Concept]
Processing 00000000.tx.25: Members of this family play essential roles in the trafficking of intermediary metabolites into and out of the mitochondrial matrix. 

Phrase: "Members of this family"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   819   C0086282:Family Members [Family Group]
   802 E C1611821:Family Member [Intellectual Product]
   770   C0680022:members [Population Group]
   737 E C2698041:Member [Professional or Occupational Group]

Phrase: "play"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:play [Finding]

Phrase: "essential roles in the"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0035820:Roles [Social Behavior]
   737 E C1705810:Role [Conceptual Entity]

Phrase: "trafficking of intermediary metabolites"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0599896:trafficking [Cell Function]
   770   C0870883:Metabolites [Biologically Active Substance]
   770   C2698672:METABOLITES [Regulation or Law]

Phrase: "into"

Phrase: "and out of the mitochondrial matrix."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   790   C1510421:Mitochondrial matrix [Cell Component]
   753   C0026237:Mitochondrial [Cell Component]
   753   C0439787:Out [Spatial Concept]
   753   C0521451:Mitochondrial [Functional Concept]
   753   C0849355:Out [Qualitative Concept]
   753   C1515981:And [Idea or Concept]
   753   C1704640:Matrix [Spatial Concept]
   753   C1706515:Matrix [Body Substance]
Processing 00000000.tx.26: The archetypal UCP, UCP1, is abundantly expressed in brown adipose tissue, where it dissipates the energy potential generated by respiration to serve both thermoregulatory and metaboregulatory roles (46). 

Phrase: "The archetypal UCP,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "UCP1,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1421313:UCP1 [Gene or Genome]

Phrase: "is"

Phrase: "abundantly"

Phrase: "expressed in brown adipose tissue,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   862   C0006298:Adipose Tissue, Brown [Tissue]
   806   C0001527:Adipose tissue [Tissue]
   760   C0040300:Tissue [Tissue]
   760   C0678579:Brown [Natural Phenomenon or Process]
   760   C1547928:Tissue [Intellectual Product]

Phrase: "where"

Phrase: "it"

Phrase: "dissipates"

Phrase: "the energy potential"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3245505:Potential [Qualitative Concept]

Phrase: "generated by respiration to"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0035203:Respiration [Physiologic Function]
   770   C0282636:respiration [Cell Function]
   770   C1160636:respiration [Biologic Function]
   770   C3146294:Generated [Activity]

Phrase: "serve"

Phrase: "both thermoregulatory"

Phrase: "and"

Phrase: "metaboregulatory roles"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0035820:Roles [Social Behavior]
   827 E C1705810:Role [Conceptual Entity]

Phrase: "(46"

Phrase: ")."
Processing 00000000.tx.27: However, UCP1 knockout mice, although cold intolerant, are no more susceptible to obesity than their wild-type littermates (7) and in fact demonstrate some resistance to diet-induced obesity (8). 

Phrase: "However,"

Phrase: "UCP1 knockout mice,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0206745:Knock-out Mice [Mammal]
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]

Phrase: "although"

Phrase: "cold intolerant,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0231200:Intolerant [Functional Concept]

Phrase: "are"

Phrase: "no more susceptible to obesity"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0231204:Susceptible [Functional Concept]
   760   C2827758:SUSCEPTIBLE [Laboratory or Test Result]

Phrase: "than their wild-type littermates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C1883559:Wild Type [Organism Attribute]

Phrase: "(7"

Phrase: ")"

Phrase: "and in fact"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1515981:And [Idea or Concept]

Phrase: "demonstrate"

Phrase: "some resistance to diet-induced obesity"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   754   C0332325:Resistant to [Functional Concept]
   753   C0237834:Resistance [Mental Process]
   753   C1514892:Resistance [Physiologic Function]

Phrase: "(8"

Phrase: ")."
Processing 00000000.tx.28: The latter suggests that the compensatory mechanisms are energetically more costly than UCP1-mediated thermogenesis (8). 

Phrase: "The latter"

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the compensatory mechanisms"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0441712:Mechanisms [Functional Concept]
   827 E C1706376:Mechanism [Manufactured Object]

Phrase: "are"

Phrase: "energetically more costly than UCP1-mediated thermogenesis"

Phrase: "(8"

Phrase: ")."
Processing 00000000.tx.29: In 1997, genes for two additional anion carrier proteins having 56% sequence homology to UCP1 were identified and named UCP2 (9,10) and UCP3 (11,12). 

Phrase: "In 1997,"

Phrase: "genes for two additional anion carrier proteins"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   774   C0751455:genes proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0017337:Genes [Gene or Genome]

Phrase: "having"

Phrase: "56% sequence homology to UCP1"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   806   C0162775:Sequence Homology [Quantitative Concept]
   760   C0004793:Sequence [Nucleotide Sequence]
   760   C0162326:Sequence [Nucleotide Sequence]
   760   C0162327:Sequence [Nucleotide Sequence]
   760   C1334043:Homology [Gene or Genome]
   760   C1519249:Sequence [Functional Concept]
   760   C2697616:Homology [Qualitative Concept]
   756 E C0162774:Sequence Homolog [Molecular Sequence]

Phrase: "were"

Phrase: "identified"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205396:Identified [Qualitative Concept]
  1000   C1550043:Identified [Finding]
  1000   C1551388:Identified [Functional Concept]

Phrase: "and"

Phrase: "named UCP2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1421314:UCP2 [Gene or Genome]

Phrase: "(9,"

Phrase: "10"

Phrase: ")"

Phrase: "and"

Phrase: "UCP3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0539733:uncoupling protein-3 [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
  1000   C1421315:UNCOUPLING PROTEIN 3 [Gene or Genome]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(11,"

Phrase: "12"

Phrase: ")."
Processing 00000000.tx.30: The corresponding proteins are both expressed in brown adipocytes, albeit at levels far less than that of UCP1. 

Phrase: "The corresponding proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "are"

Phrase: "both"

Phrase: "expressed in brown adipocytes,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C1720857:Adipocytes, Brown [Cell]
   770   C0206131:Adipocytes [Cell]
   770   C0678579:Brown [Natural Phenomenon or Process]

Phrase: "albeit at levels far less"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   760   C0205108:far [Spatial Concept]
   760   C0441889:Levels [Qualitative Concept]
   726 E C0456079:Level [Classification]
   726 E C1547707:Level [Geographic Area]
   726 E C2946261:Level [Pharmacologic Substance]

Phrase: "than that"

Phrase: "of UCP1."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1421313:UCP1 [Gene or Genome]
Processing 00000000.tx.31: In other tissues, UCP2 protein is localized to areas of the pancreas, immune system, white adipose tissue, and the brain (13) and has been linked to insulin secretion and protection from reactive oxygen species (ROS) (1416). 

Phrase: "In other tissues,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0040300:Tissues [Tissue]
   966 E C1547928:Tissue [Intellectual Product]

Phrase: "UCP2 protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "is"

Phrase: "localized to areas of the pancreas,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   753   C0030274:Pancreas [Body Part, Organ, or Organ Component]
   753   C0205146:areas [Spatial Concept]
   753   C0392752:Localized [Spatial Concept]
   753   C1278931:Pancreas [Body Part, Organ, or Organ Component]
   719 E C0017446:Area [Geographic Area]

Phrase: "immune system,"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C0020962:Immune system [Body System]
  1000   C1291764:IMMUNE SYSTEM [Finding]
   861   C0439662:Immune [Functional Concept]
   861   C0449913:System [Functional Concept]
   861   C1553451:System [Manufactured Object]
   861   C1704459:System [Medical Device]
   789 E C0205373:Systemic [Functional Concept]

Phrase: "white adipose tissue,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C1704223:White Adipose Tissue [Tissue]
   901   C0001527:Adipose tissue [Tissue]
   827   C0007457:White [Population Group]
   827   C0040300:Tissue [Tissue]
   827   C0043157:White [Population Group]
   827   C0220938:White [Qualitative Concept]
   827   C1547928:Tissue [Intellectual Product]
   755   C0028754:Adiposity [Disease or Syndrome]
   755   C1563743:adiposity [Organism Attribute]

Phrase: "and"

Phrase: "the brain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0006104:Brain [Body Part, Organ, or Organ Component]
  1000   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "(13"

Phrase: ")"

Phrase: "and"

Phrase: "has"

Phrase: "been"

Phrase: "linked to insulin secretion"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   833   C1256369:insulin secretion [Cell Function]
   770   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C0036536:secretion [Biologic Function]
   770   C0036537:Secretion [Body Substance]
   770   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C1579433:Insulin [Pharmacologic Substance]
   737   C1517892:Link [Intellectual Product]
   737   C1704666:Link [Intellectual Product]
   715 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "and"

Phrase: "protection from reactive oxygen species"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1545588:Protection [Finding]

Phrase: "(ROS"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0162772:Reactive Oxygen Species [Biologically Active Substance,Element, Ion, or Isotope]
   827   C0030054:Oxygen [Element, Ion, or Isotope,Pharmacologic Substance]
   827   C0205332:Reactive [Qualitative Concept]
   827   C1705920:Species [Conceptual Entity]

Phrase: ")"

Phrase: "(1416"

Phrase: ")."
Processing 00000000.tx.32: Although UCP3 is expressed predominantly in skeletal muscle, it is also found in brown adipose tissue, cardiac muscle, and in certain areas of the brain (11,12,17). 

Phrase: "Although"

Phrase: "UCP3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0539733:uncoupling protein-3 [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
  1000   C1421315:UNCOUPLING PROTEIN 3 [Gene or Genome]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "is"

Phrase: "expressed"

Phrase: "predominantly in skeletal muscle,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0242692:Muscle, Skeletal [Tissue]
   833   C1280260:Skeletal muscle [Body Part, Organ, or Organ Component]
   770   C0026845:Muscle [Tissue]
   770   C0037253:skeletal [Body System]
   770   C0521324:Skeletal [Spatial Concept]

Phrase: "it"

Phrase: "is"

Phrase: "also"

Phrase: "found in brown adipose tissue,"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   862   C0006298:Adipose Tissue, Brown [Tissue]
   806   C0001527:Adipose tissue [Tissue]
   760   C0040300:Tissue [Tissue]
   760   C0150312:Found [Quantitative Concept]
   760   C0678579:Brown [Natural Phenomenon or Process]
   760   C1547928:Tissue [Intellectual Product]
   726 E C0243095:Find [Finding]

Phrase: "cardiac muscle,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0027061:Muscle, Cardiac [Tissue]
   861   C0018787:Cardiac [Body Part, Organ, or Organ Component]
   861   C0026845:Muscle [Tissue]
   861   C1522601:Cardiac [Spatial Concept]
   789 E C0442025:Muscular [Spatial Concept]

Phrase: "and in certain areas of the brain"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   748   C0006104:Brain [Body Part, Organ, or Organ Component]
   748   C0205146:areas [Spatial Concept]
   748   C1269537:Brain [Body Part, Organ, or Organ Component]
   748   C1515981:And [Idea or Concept]
   714 E C0017446:Area [Geographic Area]

Phrase: "(11,"

Phrase: "12,"

Phrase: "17"

Phrase: ")."
Processing 00000000.tx.33: Originally it was thought that these additional UCPs functioned in a thermoregulatory manner similar to UCP1. 

Phrase: "Originally"

Phrase: "it"

Phrase: "was"

Phrase: "thought"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0039869:Thought [Mental Process]

Phrase: "that"

Phrase: "these additional UCPs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1421313:UCP [Gene or Genome]

Phrase: "functioned in a thermoregulatory manner"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   726   C0031843:function [Physiologic Function]
   726   C0542341:Function [Functional Concept]
   726   C0700205:FUNCTION [Classification]
   726   C1705273:Function [Intellectual Product]

Phrase: "similar to UCP1."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C2348205:Similar [Qualitative Concept]
Processing 00000000.tx.34: However, expression patterns of UCP2 and UCP3 are not always consistent with changes in thermogenesis (18) or mitochondrial uncoupling (19,20). 

Phrase: "However,"

Phrase: "expression patterns of UCP2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0449774:Patterns [Spatial Concept]

Phrase: "and"

Phrase: "UCP3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0539733:uncoupling protein-3 [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
  1000   C1421315:UNCOUPLING PROTEIN 3 [Gene or Genome]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "are"

Phrase: "not always consistent with changes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   806   C0332290:Consistent with [Idea or Concept]
           Consistent

Phrase: "in thermogenesis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0018841:Thermogenesis [Organism Function]

Phrase: "(18"

Phrase: ")"

Phrase: "or"

Phrase: "mitochondrial"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0026237:Mitochondrial [Cell Component]
  1000   C0521451:Mitochondrial [Functional Concept]

Phrase: "uncoupling"

Phrase: "(19,"

Phrase: "20"

Phrase: ")."
Processing 00000000.tx.35: Moreover, in overexpression studies in which uncoupling has been observed, there is concern that uncoupling is an artifact of supraphysiological levels of the protein in the mitochondrial inner membrane (21,22). 

Phrase: "Moreover,"

Phrase: "in overexpression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1514559:Overexpression [Genetic Function]

Phrase: "studies in which"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0557651:Study [Manufactured Object]
   790   C0947630:studies [Laboratory Procedure]
   790   C2603343:Study [Research Activity]

Phrase: "uncoupling"

Phrase: "has"

Phrase: "been"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: ","

Phrase: "there"

Phrase: "is"

Phrase: "concern"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2699424:Concern [Idea or Concept]

Phrase: "that"

Phrase: "uncoupling"

Phrase: "is"

Phrase: "an artifact of supraphysiological levels of the protein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0085089:Artefact [Human-caused Phenomenon or Process]
   744   C1879740:ARTIFACT [Phenomenon or Process]

Phrase: "in the mitochondrial inner membrane"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C0230840:Mitochondrial Inner Membrane [Cell Component]
   913   C0596952:Mitochondrial membrane [Cell Component]
   827   C0025255:Membrane [Tissue]
   827   C0205102:Inner [Spatial Concept]
   827   C0596901:Membrane [Cell Component]
   827   C1706182:Membrane [Manufactured Object]
   755 E C0205287:Membranous [Qualitative Concept]

Phrase: "(21,"

Phrase: "22"

Phrase: ")."
Processing 00000000.tx.36: It has also been proposed that UCP3 protects against ROS damage. 

Phrase: "It"

Phrase: "has"

Phrase: "also"

Phrase: "been"

Phrase: "proposed"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1441414:PROPOSED [Idea or Concept]
  1000   C1553874:Proposed [Qualitative Concept]
  1000   C1578820:Proposed [Idea or Concept]

Phrase: "that UCP3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0539733:uncoupling protein-3 [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
  1000   C1421315:UNCOUPLING PROTEIN 3 [Gene or Genome]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "protects against ROS damage."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   833   C0162772:Reactive Oxygen Species [Biologically Active Substance,Element, Ion, or Isotope]
   753   C0010957:Damage [Injury or Poisoning]
   753   C0030054:Oxygen [Element, Ion, or Isotope,Pharmacologic Substance]
   753   C0205332:Reactive [Qualitative Concept]
   753   C1705920:Species [Conceptual Entity]
   753   C1883709:Damage [Functional Concept]
Processing 00000000.tx.37: This is supported both in vivo (increased ROS damage in muscle of UCP3 knockout mice) and in vitro (mitochondria from knockout versus control mice treated with superoxide or hydroxynonenal). 

Phrase: "This"

Phrase: "is"

Phrase: "supported"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1521721:Supported [Conceptual Entity]
   966 E C0183683:Support [Medical Device]

Phrase: "both in vivo"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo

Phrase: "(increased ROS"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   923   C0162772:Reactive Oxygen Species [Biologically Active Substance,Element, Ion, or Isotope]
   812   C0030054:Oxygen [Element, Ion, or Isotope,Pharmacologic Substance]
   812   C0205332:Reactive [Qualitative Concept]
   812   C1705920:Species [Conceptual Entity]

Phrase: "damage in muscle of UCP3 knockout mice"
Meta Candidates (Total=16; Excluded=0; Pruned=0; Remaining=16)
   790   C0539733:uncoupling protein-3 [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   790   C1421315:UNCOUPLING PROTEIN 3 [Gene or Genome]
   764   C0206745:Knock-out Mice [Mammal]
   762   C0026832:Muscle Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   762   C0410158:Muscle damage [Acquired Abnormality]
   745   C1334805:Mouse Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   745   C1513763:Mouse Muscle [Tissue]
   742   C0010957:Damage [Injury or Poisoning]
   742   C0025914:Mice [Mammal]
   742   C0025929:mice [Mammal]
   742   C0026809:Mice [Mammal]
   742   C0026845:Muscle [Tissue]
   742   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0560617:knock out [Injury or Poisoning]
   742   C1522225:Knock-out [Experimental Model of Disease]
   742   C1883709:Damage [Functional Concept]

Phrase: ")"

Phrase: "and"

Phrase: "in vitro"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021135:In Vitro [Intellectual Product]
  1000   C1533691:in vitro [Qualitative Concept]
           vitro
  1000   C2827718:In Vitro [Functional Concept]

Phrase: "(mitochondria from knockout"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0026237:Mitochondria [Cell Component]

Phrase: "versus"

Phrase: "control mice"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   861   C0025914:Mice [Mammal]
   861   C0025929:mice [Mammal]
   861   C0026809:Mice [Mammal]
   861   C0243148:control [Qualitative Concept]
   861   C1550141:Control [Substance]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]

Phrase: "treated with superoxide"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   882   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   790   C0038836:Superoxide [Element, Ion, or Isotope]
   790   C1522326:Treated [Functional Concept]
   756 E C1292734:TREAT [Functional Concept]

Phrase: "or"

Phrase: "hydroxynonenal"

Phrase: ")."
Processing 00000000.tx.38: ROS are normal by-products of mitochondrial respiration. 

Phrase: "ROS"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0162772:Reactive Oxygen Species [Biologically Active Substance,Element, Ion, or Isotope]
   827   C0030054:Oxygen [Element, Ion, or Isotope,Pharmacologic Substance]
   827   C0205332:Reactive [Qualitative Concept]
   827   C1705920:Species [Conceptual Entity]

Phrase: "are"

Phrase: "normal by-products of mitochondrial respiration."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C1514468:Products [Entity]
   719 E C1704444:Product [Quantitative Concept]
Processing 00000000.tx.39: However, ROS produced in excess of scavenging systems can mediate cellular damage, which is known to contribute to hyperglycemia-induced diabetes complications (23,24). 

Phrase: "However,"

Phrase: "ROS"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0162772:Reactive Oxygen Species [Biologically Active Substance,Element, Ion, or Isotope]
   827   C0030054:Oxygen [Element, Ion, or Isotope,Pharmacologic Substance]
   827   C0205332:Reactive [Qualitative Concept]
   827   C1705920:Species [Conceptual Entity]

Phrase: "produced in excess of scavenging systems"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C1979886:Excess [Qualitative Concept]
   719   C0449913:System [Functional Concept]
   719   C1553451:System [Manufactured Object]
   719   C1704459:System [Medical Device]

Phrase: "can"

Phrase: "mediate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086597:Mediate [Social Behavior]

Phrase: "cellular damage,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0010957:Damage [Injury or Poisoning]
   861   C1883709:Damage [Functional Concept]

Phrase: "which"

Phrase: "is"

Phrase: "known"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205309:Known [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "contribute to hyperglycemia-induced diabetes complications"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   790   C0342257:Diabetes Complications [Pathologic Function]
   753   C0009566:Complications [Pathologic Function]
   753   C0011847:Diabetes [Disease or Syndrome]
   753   C0011849:Diabetes [Disease or Syndrome]
   753   C0020456:Hyperglycaemia [Disease or Syndrome]
   753   C0205263:Induced [Functional Concept]
   753   C1171258:complications [Pathologic Function]
   753   C1880177:Contribute [Activity]
   719 E C2362589:Complication [Idea or Concept]

Phrase: "(23,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]

Phrase: "24"

Phrase: ")."
Processing 00000000.tx.40: Elevated mitochondrial membrane potential can be a direct cause of accelerated cellular ROS production, so one way to mitigate ROS-mediated damage is to increase the proton "leakiness" of the mitochondrial inner membrane (25). 

Phrase: "Elevated mitochondrial membrane potential"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   923   C1720920:Membrane Potential, Mitochondrial [Cell Function]
   861   C0025251:Membrane Potential [Cell Function]
   861   C0596952:Mitochondrial membrane [Cell Component]
   812   C0025255:Membrane [Tissue]
   812   C0026237:Mitochondrial [Cell Component]
   812   C0521451:Mitochondrial [Functional Concept]
   812   C0596901:Membrane [Cell Component]
   812   C1706182:Membrane [Manufactured Object]
   812   C3245505:Potential [Qualitative Concept]
   741 E C0205287:Membranous [Qualitative Concept]

Phrase: "can"

Phrase: "be"

Phrase: "a direct cause of accelerated cellular ROS production,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   739   C0015127:cause [Functional Concept]
   739   C1524003:Cause [Conceptual Entity]

Phrase: "so"

Phrase: "one way to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0205447:One [Quantitative Concept]

Phrase: "mitigate"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C1553901:Mitigate [Idea or Concept]
   944 E C0205081:Moderate [Qualitative Concept]
   944 E C1881878:Moderate [Qualitative Concept]

Phrase: "ROS-mediated damage"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0010957:Damage [Injury or Poisoning]
   804   C1883709:Damage [Functional Concept]
   717   C0162772:Reactive Oxygen Species [Biologically Active Substance,Element, Ion, or Isotope]

Phrase: "is"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "increase"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "the proton ""leakiness"""

Phrase: "of the mitochondrial inner membrane"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C0230840:Mitochondrial Inner Membrane [Cell Component]
   913   C0596952:Mitochondrial membrane [Cell Component]
   827   C0025255:Membrane [Tissue]
   827   C0205102:Inner [Spatial Concept]
   827   C0596901:Membrane [Cell Component]
   827   C1706182:Membrane [Manufactured Object]
   755 E C0205287:Membranous [Qualitative Concept]

Phrase: "(25"

Phrase: ")."
Processing 00000000.tx.41: Because mitochondrial ROS production is exquisitely sensitive to membrane potential, even mild uncoupling is thought to be highly effective for reducing ROS at this source. 

Phrase: "Because"

Phrase: "mitochondrial ROS production"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0033268:production [Occupational Activity]
   717   C0162772:Reactive Oxygen Species [Biologically Active Substance,Element, Ion, or Isotope]

Phrase: "is"

Phrase: "exquisitely sensitive to membrane potential,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C0332324:Sensitive to [Functional Concept]
           Sensitive
   760   C1550474:sensitive [Idea or Concept]

Phrase: "even mild"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2945599:Mild [Qualitative Concept]

Phrase: "uncoupling"

Phrase: "is"

Phrase: "thought"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0039869:Thought [Mental Process]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "highly effective for reducing ROS"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1280519:effective [Qualitative Concept]
   748   C1704419:Effective [Qualitative Concept]

Phrase: "at this source."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0449416:Source [Finding]
  1000   C1705919:Source [Idea or Concept]
Processing 00000000.tx.42: Thus, an alternative explanation for UCP3-dependent protection against hyperglycemia-induced damage in muscle may be a reduction in ROS production through mild uncoupling of oxidative phosphorylation. 

Phrase: "Thus,"

Phrase: "an alternative explanation for UCP3-dependent protection"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0681841:Explanation [Intellectual Product]

Phrase: "against hyperglycemia-induced damage"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0010957:Damage [Injury or Poisoning]
   827   C1883709:Damage [Functional Concept]

Phrase: "in muscle"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0026845:Muscle [Tissue]
   928 E C0442025:Muscular [Spatial Concept]

Phrase: "may"

Phrase: "be"

Phrase: "a reduction in ROS production"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0301630:Reduction [Natural Phenomenon or Process]
   748   C0392756:Reduction [Qualitative Concept]
   748   C0441610:Reduction [Therapeutic or Preventive Procedure]

Phrase: "through mild"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2945599:Mild [Qualitative Concept]

Phrase: "uncoupling of oxidative phosphorylation."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0030013:Oxidative Phosphorylation [Molecular Function]
   770   C0031715:Phosphorylation [Molecular Function]
   770   C0311404:Oxidative [Functional Concept]
   770   C1158886:Phosphorylation [Molecular Function]
Processing 00000000.tx.43: The goal of the research described herein was to study the mechanisms underlying the negative correlation between UCP3 expression and insulin resistance in muscle. 

Phrase: "The goal of the research"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0018017:Goal [Intellectual Product]
   760   C1571704:Goal [Idea or Concept]

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "herein"

Phrase: "was"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "the mechanisms"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0441712:Mechanisms [Functional Concept]
   966 E C1706376:Mechanism [Manufactured Object]

Phrase: "underlying"

Phrase: "the negative correlation between UCP3 expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1707520:Correlation [Qualitative Concept]

Phrase: "and"

Phrase: "insulin resistance in muscle."
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   833   C0021655:Insulin Resistance [Pathologic Function]
   833   C2700570:INSULIN RESISTANCE [Gene or Genome]
   770   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C0237834:Resistance [Mental Process]
   770   C1514892:Resistance [Physiologic Function]
   770   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C1579433:Insulin [Pharmacologic Substance]
   715 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
Processing 00000000.tx.44: Specifically the aim was to determine, in intact L6 muscle cells, the effects of physiological increases in UCP3 expression on glucose and fatty acid oxidation and on the interrelationship between ROS production and mitochondrial uncoupling. 

Phrase: "Specifically"

Phrase: "the aim"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1947946:Aim [Idea or Concept]
  1000   C2948600:Aim [Pharmacologic Substance]
  1000   C3540471:AIM [Gene or Genome]
  1000   C3540472:AIM [Functional Concept]

Phrase: "was"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "determine"

Phrase: ","

Phrase: "in intact L6 muscle cells,"
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   886   C0682538:intact cell [Cell]
   861   C0596981:Muscle Cells [Cell]
   812   C0007634:Cells [Cell]
   812   C0026845:Muscle [Tissue]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]
   741 E C0442025:Muscular [Spatial Concept]

Phrase: "the effects of physiological increases"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   797   C1372798:Physiological Effects [Physiologic Function]
   760   C1280500:effects [Qualitative Concept]
   726 E C2348382:Effect [Qualitative Concept]

Phrase: "in UCP3 expression"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   875   C1171362:protein expression [Genetic Function]
   812   C0185117:Expression [Therapeutic or Preventive Procedure]
   756   C0539733:uncoupling protein-3 [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   756   C1421315:UNCOUPLING PROTEIN 3 [Gene or Genome]

Phrase: "on glucose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "and"

Phrase: "fatty acid oxidation"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1158366:fatty acid oxidation [Molecular Function]
   901   C0015684:Fatty acid [Lipid]
   827   C0001128:Acid [Chemical]
   827   C0030011:Oxidation [Molecular Function]
   827   C0202406:Acid [Laboratory Procedure]

Phrase: "and on the interrelationship"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1515981:And [Idea or Concept]

Phrase: "between ROS production"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0033268:production [Occupational Activity]
   756   C0162772:Reactive Oxygen Species [Biologically Active Substance,Element, Ion, or Isotope]

Phrase: "and"

Phrase: "mitochondrial"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0026237:Mitochondrial [Cell Component]
  1000   C0521451:Mitochondrial [Functional Concept]

Phrase: "uncoupling."
Processing 00000000.tx.45: We demonstrate that moderate (2.2- to 2.5-fold) overexpression of UCP3 protein in L6 myotubes specifically increases fatty acid oxidation but is without effect on glucose oxidation. 

Phrase: "We"

Phrase: "demonstrate"

Phrase: "that moderate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205081:Moderate [Qualitative Concept]
  1000   C1881878:Moderate [Qualitative Concept]

Phrase: "(2.2-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0740116:+2 [Quantitative Concept]
   861   C2827735:2+ [Quantitative Concept]
   861   C2981700:2+ [Classification]

Phrase: "to 2.5-fold"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0332462:Fold [Spatial Concept]
   827   C1880834:FOLD [Phenomenon or Process]
   734   C0450346:2 5 [Quantitative Concept]

Phrase: ")"

Phrase: "overexpression of UCP3 protein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   783   C1514559:Protein Overexpression [Genetic Function]
           Overexpression

Phrase: "in L6 myotubes specifically"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0242697:myotubes [Cell]
   827   C1704336:Myotubes [Cell]

Phrase: "increases"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "fatty acid oxidation"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1158366:fatty acid oxidation [Molecular Function]
   901   C0015684:Fatty acid [Lipid]
   827   C0001128:Acid [Chemical]
   827   C0030011:Oxidation [Molecular Function]
   827   C0202406:Acid [Laboratory Procedure]

Phrase: "but"

Phrase: "is without effect"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1280500:Effect [Qualitative Concept]
   790   C2348382:Effect [Qualitative Concept]

Phrase: "on glucose oxidation."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030011:Oxidation [Molecular Function]
Processing 00000000.tx.46: Furthermore, we demonstrate for the first time that UCP3 overexpression mitigates the production of ROS in a manner that is independent of mitochondrial uncoupling. 

Phrase: "Furthermore,"

Phrase: "we"

Phrase: "demonstrate for the first time"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   760   C0040223:Time [Temporal Concept]
   760   C0205435:First [Quantitative Concept]
   760   C1279901:First [Qualitative Concept]
   760   C3541383:Time [Temporal Concept]
   704 E C0442043:Temporal [Spatial Concept]
   704 E C2362314:Temporal [Temporal Concept]

Phrase: "that UCP3 overexpression"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   875   C1514559:Protein Overexpression [Genetic Function]
           Overexpression
   756   C0539733:uncoupling protein-3 [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   756   C1421315:UNCOUPLING PROTEIN 3 [Gene or Genome]

Phrase: "mitigates"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C1553901:Mitigate [Idea or Concept]
   944 E C0205081:Moderate [Qualitative Concept]
   944 E C1881878:Moderate [Qualitative Concept]

Phrase: "the production of ROS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0033268:production [Occupational Activity]

Phrase: "in a manner"

Phrase: "that"

Phrase: "is independent of mitochondrial"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0332291:Independent of [Functional Concept]
   770   C0026237:Mitochondrial [Cell Component]
   770   C0085862:Independent [Idea or Concept]
   770   C0521451:Mitochondrial [Functional Concept]
   770   C1299583:Independent [Finding]

Phrase: "uncoupling."
Processing 00000000.tx.47: The findings thus imply that the decreased expression of UCP3 in muscle of pre-diabetic and diabetic individuals may be specifically mediated through some impairment in fatty acid metabolism and/or by increasing ROS-mediated cellular damage.  

Phrase: "The findings thus"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   861   C2607943:findings [Functional Concept]
   861   C2926606:Findings [Clinical Attribute]
   861   C3539655:Findings [Intellectual Product]
   827 E C0037088:Finding [Sign or Symptom]
   827 E C0243095:Finding [Finding]
   827 E C2825141:Finding [Finding]

Phrase: "imply"

Phrase: "that"

Phrase: "the decreased expression of UCP3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   774   C1171362:expression protein [Genetic Function]
   748   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "in muscle"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0026845:Muscle [Tissue]
   928 E C0442025:Muscular [Spatial Concept]

Phrase: "of pre-diabetic"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0362046:pre-diabetic [Disease or Syndrome]
   861   C0241863:DIABETIC [Finding]
   861   C0332152:Pre [Temporal Concept]
   861   C0740175:Pre [Qualitative Concept]
   861   C2257086:PRE [Genetic Function]

Phrase: "and"

Phrase: "diabetic individuals"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0027361:Individual [Population Group]
   827   C0237401:Individual [Human]

Phrase: "may"

Phrase: "be"

Phrase: "specifically"

Phrase: "mediated through some impairment"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0086597:mediated [Social Behavior]
   770   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]
   770   C0684336:Impairment [Pathologic Function]

Phrase: "in fatty acid metabolism"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0596563:Fatty Acid Metabolism [Molecular Function]
   827   C0025519:Metabolism [Organism Function]
   827   C0025520:metabolism [Functional Concept]
   734   C0015684:Fatty acid [Lipid]

Phrase: "and/or by increasing ROS-mediated cellular damage."
Meta Candidates (Total=14; Excluded=1; Pruned=0; Remaining=13)
   782   C0162772:Reactive Oxygen Species [Biologically Active Substance,Element, Ion, or Isotope]
   760   C1706528:And/Or [Conceptual Entity]
   739   C0007634:Cellular [Cell]
   739   C0010957:Damage [Injury or Poisoning]
   739   C0030054:Oxygen [Element, Ion, or Isotope,Pharmacologic Substance]
   739   C0086597:mediated [Social Behavior]
   739   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]
   739   C0178539:Cellular [Functional Concept]
   739   C0205332:Reactive [Qualitative Concept]
   739   C0442808:Increasing [Functional Concept]
   739   C1515981:And [Idea or Concept]
   739   C1705920:Species [Conceptual Entity]
   739   C1883709:Damage [Functional Concept]
   706 E C0442805:Increase [Functional Concept]
Processing 00000000.tx.48: RESEARCH DESIGN AND METHODS TOP ABSTRACT RESEARCH DESIGN AND METHODS RESULTS DISCUSSION REFERENCES  Cell culture reagents, including -minimum essential medium, fetal bovine serum, and antibiotics/antimycotics were purchased from Invitrogen-Gibco (Burlington, ON). 

Phrase: "RESEARCH DESIGN"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0035171:Research Design [Research Activity]
   861   C0035168:research [Research Activity]
   861   C0242481:Research [Research Activity]
   861   C1707689:Design [Activity]
   861   C2983265:DESIGN [Intellectual Product]

Phrase: "AND"

Phrase: "METHODS TOP ABSTRACT RESEARCH DESIGN"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   875   C0086912:methods research [Research Activity]
   840   C0035171:Research Design [Research Activity]
   804   C0035168:research [Research Activity]
   804   C0242481:Research [Research Activity]
   804   C1707689:Design [Activity]
   804   C2983265:DESIGN [Intellectual Product]

Phrase: "AND"

Phrase: "METHODS RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Cell culture reagents,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0034760:Reagents [Indicator, Reagent, or Diagnostic Aid]
   734   C0007585:Cell Culture [Laboratory Procedure]

Phrase: "including -"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "minimum essential medium,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0009458:Medium [Intellectual Product]
   827   C0439536:Medium [Quantitative Concept]
   827   C1705217:Medium [Substance]
   827   C3244283:medium [Intellectual Product]

Phrase: "fetal bovine serum,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   827   C0007452:Bovine [Mammal]
   827   C0015965:Fetal [Embryonic Structure]
   827   C0229671:Serum [Body Substance]
   827   C0521457:Fetal [Functional Concept]
   827   C1140701:bovine [Mammal]
   827   C1546774:Serum [Intellectual Product]
   827   C1550100:Serum [Body Substance]

Phrase: "and"

Phrase: "antibiotics/antimycotics"

Phrase: "were"

Phrase: "purchased from Invitrogen-Gibco"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0869011:purchased [Activity]

Phrase: "(Burlington,"

Phrase: "ON"

Phrase: ")."
Processing 00000000.tx.49: Fluorescent probes were obtained from Molecular Probes (Eugene, OR). 

Phrase: "Fluorescent probes"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0016321:Fluorescent Probes [Indicator, Reagent, or Diagnostic Aid]
   861   C0182400:Probes [Medical Device]
   861   C0303920:Fluorescent [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   827 E C1704681:Probe [Gene or Genome]
   827 E C2347609:Probe [Chemical Viewed Functionally]
   827 E C3536729:Probe [Manufactured Object]

Phrase: "were"

Phrase: "obtained from Molecular Probes"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   833   C0026381:Molecular Probes [Indicator, Reagent, or Diagnostic Aid]
   770   C0182400:Probes [Medical Device]
   770   C1301820:Obtained [Functional Concept]
   770   C1521991:Molecular [Qualitative Concept]
   737 E C1704681:Probe [Gene or Genome]
   737 E C1706701:Obtain [Activity]
   737 E C2347609:Probe [Chemical Viewed Functionally]
   737 E C3536729:Probe [Manufactured Object]

Phrase: "(Eugene,"

Phrase: "OR"

Phrase: ")."
Processing 00000000.tx.50: Radioactive [U-14C]glucose and [1-14C]palmitate were from New England Nuclear (Boston, MA). 

Phrase: "Radioactive"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0034553:radioactive [Natural Phenomenon or Process]

Phrase: "[U-14C"

Phrase: "]glucose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "and ["

Phrase: "1-14C"

Phrase: "]palmitate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0030233:palmitate [Lipid]
  1000   C3503116:palmitate [Biomedical or Dental Material,Lipid]

Phrase: "were from New England"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C0027965:New England [Geographic Area]
   770   C0014282:England [Geographic Area]
   770   C0205314:New [Temporal Concept]

Phrase: "Nuclear"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0521447:Nuclear [Spatial Concept]

Phrase: "(Boston,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0006037:Boston [Geographic Area]

Phrase: "MA"

Phrase: ")."
Processing 00000000.tx.51: Affinity-purified polyclonal rabbit anti-UCP3, directed against a 19amino acid sequence in the COOH-terminus was purchased from Chemicon (Temecula, CA). 

Phrase: "Affinity-purified polyclonal rabbit anti-UCP3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   835   C0539733:uncoupling protein-3 [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   835   C1421315:UNCOUPLING PROTEIN 3 [Gene or Genome]
   793   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "directed against a 19amino acid sequence"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   753   C0001128:Acid [Chemical]
   753   C0004793:Sequence [Nucleotide Sequence]
   753   C0162326:Sequence [Nucleotide Sequence]
   753   C0162327:Sequence [Nucleotide Sequence]
   753   C0202406:Acid [Laboratory Procedure]
   753   C1519249:Sequence [Functional Concept]
   719   C0439851:Direct [Qualitative Concept]
   719   C1947931:Direct [Qualitative Concept]

Phrase: "in the COOH-terminus"

Phrase: "was"

Phrase: "purchased from Chemicon"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0869011:purchased [Activity]

Phrase: "(Temecula,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1555271:Temecula [Population Group]

Phrase: "CA)."
Processing 00000000.tx.52: All other chemicals were purchased from Sigma (Oakville, ON). 

Phrase: "All"

Phrase: "other chemicals"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0220806:Chemicals [Chemical]
   966 E C3272558:Chemical [Intellectual Product]

Phrase: "were"

Phrase: "purchased from Sigma"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0869011:purchased [Activity]
   790   C1719918:Sigma [Intellectual Product]

Phrase: "(Oakville,"

Phrase: "ON"

Phrase: ")."
Processing 00000000.tx.53: Cell culture and treatment. 

Phrase: "Cell culture"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0007585:Cell Culture [Laboratory Procedure]
   861   C0007634:Cell [Cell]
   861   C0010453:Culture [Idea or Concept]
   861   C0220814:culture [Functional Concept]
   861   C0430400:Culture [Laboratory Procedure]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]
   861   C2242979:Culture [Laboratory Procedure]

Phrase: "and"

Phrase: "treatment."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0039798:treatment [Functional Concept]
  1000   C0087111:Treatment [Therapeutic or Preventive Procedure]
  1000   C1522326:Treatment [Functional Concept]
  1000   C1533734:Treatment [Therapeutic or Preventive Procedure]
  1000   C1705169:Treatment [Conceptual Entity]
  1000   C3538994:TREATMENT [Research Activity]
Processing 00000000.tx.54: L6 rat myoblasts were maintained in -minimum Eagles medium containing 10% (vol/vol) fetal bovine serum, 100 units/ml penicillin G, 100 g/ml streptomycin, and 0.25 g/ml amphotericin B (growth medium). 

Phrase: "L6 rat myoblasts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0596995:Myoblasts [Cell]

Phrase: "were"

Phrase: "maintained"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1314677:Maintained [Functional Concept]
   966 E C0024501:Maintain [Activity]

Phrase: "in -minimum Eagles medium"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0009458:Medium [Intellectual Product]
   812   C0439536:Medium [Quantitative Concept]
   812   C1705217:Medium [Substance]
   812   C3244283:medium [Intellectual Product]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "10%"

Phrase: "(vol/vol) fetal bovine serum,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   804   C0007452:Bovine [Mammal]
   804   C0015965:Fetal [Embryonic Structure]
   804   C0229671:Serum [Body Substance]
   804   C0521457:Fetal [Functional Concept]
   804   C1140701:bovine [Mammal]
   804   C1546774:Serum [Intellectual Product]
   804   C1550100:Serum [Body Substance]

Phrase: "100 units/ml penicillin G,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   853   C1637390:mL/g [Quantitative Concept]
   840   C0030827:Penicillin G [Antibiotic,Organic Chemical]
   804   C0030842:Penicillin [Antibiotic,Organic Chemical]
   804   C0220892:Penicillin [Antibiotic,Organic Chemical]
   804   C0439267:g% [Quantitative Concept]

Phrase: "100 g/ml streptomycin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0038425:Streptomycin [Antibiotic,Carbohydrate]

Phrase: "and"

Phrase: "0.25 g/ml amphotericin B"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0002679:Amphotericin B [Antibiotic,Organic Chemical]
   799   C0085795:Amphotericin [Antibiotic,Carbohydrate,Pharmacologic Substance]
   771 E C0812405:Fungizone [Antibiotic,Organic Chemical]

Phrase: "(growth medium"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0010454:Growth Medium [Indicator, Reagent, or Diagnostic Aid]
   861   C0009458:Medium [Intellectual Product]
   861   C0018270:'growth' NOS [Organism Function]
   861   C0220844:growth [Physiologic Function]
   861   C0439536:Medium [Quantitative Concept]
   861   C1621966:Growth [Organ or Tissue Function]
   861   C1705217:Medium [Substance]
   861   C2911660:Growth [Activity]
   861   C3244283:medium [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.55: For experiments, myoblasts were reseeded into 6-cm2 cell culture dishes, 10-cm2 cell culture dishes, opaque 96-well plates, or 25-cm2 flasks, depending on the experiment to be performed. 

Phrase: "For experiments,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0681814:Experiments [Research Activity]
   966 E C1706386:Experiment [Conceptual Entity]
   916 E C1517586:Experimental [Qualitative Concept]

Phrase: "myoblasts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596995:Myoblasts [Cell]

Phrase: "were"

Phrase: "reseeded into 6-cm2 cell culture dishes,"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   778   C0007585:Cell Culture [Laboratory Procedure]
   748   C0007634:Cell [Cell]
   748   C0010453:Culture [Idea or Concept]
   748   C0220814:culture [Functional Concept]
   748   C0430400:Culture [Laboratory Procedure]
   748   C0439479:cm2 [Quantitative Concept]
   748   C0555206:CM2 [Congenital Abnormality]
   748   C1269647:Cell [Cell]
   748   C1704653:Cell [Medical Device]
   748   C1948049:Cell [Spatial Concept]
   748   C2242979:Culture [Laboratory Procedure]
   714   C0020498:DISH [Disease or Syndrome]

Phrase: "10-cm2 cell culture dishes,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   771   C0020498:DISH [Disease or Syndrome]

Phrase: "opaque 96-well"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0029053:opaque [Finding]
   827   C0205170:Well [Qualitative Concept]
   827   C1261286:Opaque [Qualitative Concept]
   827   C1882150:OPAQUE [Phenomenon or Process]
   827   C3146287:Well [Manufactured Object]

Phrase: "plates"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0005971:Plate [Medical Device]
  1000   C1139930:plate [Medical Device]
  1000   C3537155:Plate [Manufactured Object]

Phrase: ","

Phrase: "or"

Phrase: "25-cm2 flasks,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0872171:flasks [Medical Device]

Phrase: "depending on the experiment to"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0681814:Experiment [Research Activity]
   760   C1706386:Experiment [Conceptual Entity]
   726   C0725813:depend [Medical Device]

Phrase: "be"

Phrase: "performed."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]
Processing 00000000.tx.56: Once cells reached confluency, differentiation was induced by lowering the serum concentration to 2% (differentiation medium). 

Phrase: "Once cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "reached"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2584321:Reach [Organism Function]

Phrase: "confluency,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   928   C0205200:Confluent [Qualitative Concept]

Phrase: "differentiation"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0007589:Differentiation [Cell Function]
  1000   C1511938:Differentiation [Clinical Attribute]
  1000   C2945687:Differentiation [Functional Concept]
   928 E C0205615:Differentiated [Qualitative Concept]

Phrase: "was"

Phrase: "induced by lowering"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0205263:Induced [Functional Concept]
   790   C0441994:lowering [Spatial Concept]
   790   C2003888:Lowering [Activity]
   756 E C1548802:Lower [Body Location or Region]

Phrase: "the serum concentration to 2%"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C0683149:serum concentration [Quantitative Concept]
   760   C0086045:Concentration [Mental Process]
   760   C1446561:Concentration [Quantitative Concept]

Phrase: "(differentiation medium"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0009458:Medium [Intellectual Product]
   861   C0439536:Medium [Quantitative Concept]
   861   C1705217:Medium [Substance]
   861   C3244283:medium [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.57: Differentiation medium was replaced every 48 h for 5 days, unless otherwise stated, allowing sufficient time for myotubes formation. 

Phrase: "Differentiation medium"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0009458:Medium [Intellectual Product]
   861   C0439536:Medium [Quantitative Concept]
   861   C1705217:Medium [Substance]
   861   C3244283:medium [Intellectual Product]

Phrase: "was"

Phrase: "replaced"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0559956:Replaced [Functional Concept]
  1000   C1299987:replaced [Functional Concept]
   966 E C1554078:Replace [Idea or Concept]

Phrase: "every 48 h for 5 days,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0033727:H+ [Element, Ion, or Isotope]
   753   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   753   C0441932:H+ [Classification]
   753   C0564385:/h [Quantitative Concept]

Phrase: "unless"

Phrase: "otherwise"

Phrase: "stated"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1301808:stated [Geographic Area]
  1000   C1442792:Stated [Functional Concept]
   966 E C3148680:State [Geographic Area]

Phrase: ","

Phrase: "allowing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0683607:allowing [Social Behavior]

Phrase: "sufficient time for myotubes formation."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   760   C0040223:Time [Temporal Concept]
   760   C3541383:Time [Temporal Concept]
   704 E C0442043:Temporal [Spatial Concept]
   704 E C2362314:Temporal [Temporal Concept]
Processing 00000000.tx.58: All experiments were initiated 5 days postdifferentiation. 

Phrase: "All experiments"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0681814:Experiments [Research Activity]
   966 E C1706386:Experiment [Conceptual Entity]
   916 E C1517586:Experimental [Qualitative Concept]

Phrase: "were"

Phrase: "initiated"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1548602:Initiate [Idea or Concept]
   966   C1704686:Initiate [Functional Concept]

Phrase: "5 days"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C1442466:5 Days [Temporal Concept]
   861   C0439228:days [Temporal Concept]
   827 E C0332173:/day [Temporal Concept]
   827 E C0439505:/day [Temporal Concept]

Phrase: "postdifferentiation."
Processing 00000000.tx.59: Adenoviral transfection. 

Phrase: "Adenoviral transfection."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0040669:Transfection [Genetic Function,Molecular Biology Research Technique]
Processing 00000000.tx.60: Transfection of L6 cells with an adenoviral vector (1 x 107 pfu/ml) containing recombinant UCP3 was performed 2 days postdifferentiation. 

Phrase: "Transfection of L6 cells"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0040669:Transfection [Genetic Function,Molecular Biology Research Technique]

Phrase: "with an adenoviral vector"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1510800:Adenoviral Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0442335:Vector [Spatial Concept]
   861   C1705099:Vector [Idea or Concept]

Phrase: "(1 x 107 pfu/"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1882406:PFU [Quantitative Concept]

Phrase: "ml)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439526:/mL [Quantitative Concept]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "recombinant UCP3"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   923   C0539733:uncoupling protein-3 [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   923   C1421315:UNCOUPLING PROTEIN 3 [Gene or Genome]
   875   C0034861:Recombinant protein [Amino Acid, Peptide, or Protein]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "was"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "2 days"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C1442455:2 Days [Temporal Concept]
   861   C0439228:days [Temporal Concept]
   827 E C0332173:/day [Temporal Concept]
   827 E C0439505:/day [Temporal Concept]

Phrase: "postdifferentiation."
Processing 00000000.tx.61: The virus was removed after a 48-h incubation period, and fresh differentiation medium was added. 

Phrase: "The virus"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042776:Virus [Virus]
  1000   C0319157:virus [Virus]

Phrase: "was"

Phrase: "removed after a 48-h incubation period,"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   778   C1320226:Incubation period [Finding]
   748   C0033727:H+ [Element, Ion, or Isotope]
   748   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   748   C0439531:/period [Temporal Concept]
   748   C0441932:H+ [Classification]
   748   C0564385:/h [Quantitative Concept]
   748   C0849355:Removed [Qualitative Concept]
   748   C1948053:Period [Temporal Concept]
   714 E C1883720:Remove [Activity]
   714 E C3244314:remove [Functional Concept]

Phrase: "and"

Phrase: "fresh differentiation medium"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0009458:Medium [Intellectual Product]
   827   C0439536:Medium [Quantitative Concept]
   827   C1705217:Medium [Substance]
   827   C3244283:medium [Intellectual Product]

Phrase: "was"

Phrase: "added."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1524062:Added [Functional Concept]
   966 E C1883712:Add [Functional Concept]
Processing 00000000.tx.62: The efficacy of infection was determined by transfecting parallel plates with an equivalent titer of green fluorescent protein (GFP). 

Phrase: "The efficacy of infection"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1280519:Efficacy [Qualitative Concept]
   770   C1707887:EFFICACY [Research Activity]

Phrase: "was"

Phrase: "determined by transfecting parallel plates"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   760   C1139930:plates [Medical Device]
   760   C2348042:Parallel [Qualitative Concept]
   760   C2826345:PARALLEL [Research Activity]
   726 E C0005971:Plate [Medical Device]
   726 E C3537155:Plate [Manufactured Object]

Phrase: "with an equivalent titer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0475208:Titer [Quantitative Concept]

Phrase: "of green fluorescent protein (GFP)."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0120285:green fluorescent protein [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0303920:Fluorescent [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   827   C0332583:Green [Qualitative Concept]
Processing 00000000.tx.63: GFP-transfected myotubes were also used to verify that experimental outcomes were not adenoviral mediated. 

Phrase: "GFP-transfected myotubes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0242697:myotubes [Cell]
   804   C1704336:Myotubes [Cell]
   717   C0120285:green fluorescent protein [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]

Phrase: "were"

Phrase: "also"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "verify"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1711411:Verify [Functional Concept]

Phrase: "that experimental outcomes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1274040:Outcome [Functional Concept]

Phrase: "were"

Phrase: "not adenoviral mediated."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0086597:mediated [Social Behavior]
   827   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.64: To simultaneously study the effects of chemical uncoupling, separate plates were treated with 50 mol/l 2,4-dinitrophenol starting 2 days postdifferentiation for 72 h with the dinitrophenol being replaced every 24 h. 

Phrase: "To simultaneously"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0521115:simultaneously [Temporal Concept]
   861   C1883351:To [Qualitative Concept]

Phrase: "study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "the effects of chemical"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C1280500:effects [Qualitative Concept]
   737 E C2348382:Effect [Qualitative Concept]

Phrase: "uncoupling"

Phrase: ","

Phrase: "separate plates"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C1139930:plates [Medical Device]
   827 E C0005971:Plate [Medical Device]
   827 E C3537155:Plate [Manufactured Object]

Phrase: "were"

Phrase: "treated with 50 mol/l 2,"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   790   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   790   C0347982:mol/L [Quantitative Concept]
   753   C0027960:Mole [Neoplastic Process]
   753   C0324740:Mole [Mammal]
   753   C0439189:Mole [Quantitative Concept]
   753   C1456781:mole [Neoplastic Process]
   753   C1522326:Treated [Functional Concept]
   753   C1824986:mol [Gene or Genome]
   719 E C1292734:TREAT [Functional Concept]

Phrase: "4-dinitrophenol"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0012466:Dinitrophenol [Organic Chemical]

Phrase: "starting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0439659:Start [Temporal Concept]

Phrase: "2 days"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C1442455:2 Days [Temporal Concept]
   861   C0439228:days [Temporal Concept]
   827 E C0332173:/day [Temporal Concept]
   827 E C0439505:/day [Temporal Concept]

Phrase: "postdifferentiation for 72 h"

Phrase: "with the dinitrophenol"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0012466:Dinitrophenol [Organic Chemical]

Phrase: "being"

Phrase: "replaced"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0559956:Replaced [Functional Concept]
  1000   C1299987:replaced [Functional Concept]
   966 E C1554078:Replace [Idea or Concept]

Phrase: "every 24 h."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.65: This concentration was used based on the results of our preliminary studies and on the concentrations used chronically with the same cell line by others (26). 

Phrase: "This concentration"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0086045:Concentration [Mental Process]
  1000   C1446561:Concentration [Quantitative Concept]
   928 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "was"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "based on the results of our preliminary studies"
Meta Candidates (Total=14; Excluded=5; Pruned=0; Remaining=9)
   767   C0683954:results studies [Finding]
   767   C1548161:Preliminary results [Idea or Concept]
   744   C0439611:Preliminary [Temporal Concept]
   744   C0947630:studies [Laboratory Procedure]
   744   C1527178:Based [Functional Concept]
   744   C1705938:Based [Idea or Concept]
   711 E C0002055:base [Inorganic Chemical]
   711 E C0178499:Base [Chemical Viewed Functionally]
   711 E C0557651:Study [Manufactured Object]
   711   C1274040:Result [Functional Concept]
   711   C1546471:Result [Idea or Concept]
   711 E C1880279:Base [Biomedical or Dental Material]
   711 E C2603343:Study [Research Activity]
   711   C2825142:Result [Finding]

Phrase: "and on the concentrations"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0086045:Concentrations [Mental Process]
   770   C1515981:And [Idea or Concept]
   737 E C1446561:Concentration [Quantitative Concept]

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "chronically with the same cell line"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   790   C0007600:Cell Line [Cell]
   753   C0007634:Cell [Cell]
   753   C0205132:Line [Spatial Concept]
   753   C0445247:Same [Qualitative Concept]
   753   C1269647:Cell [Cell]
   753   C1550648:Line [Substance]
   753   C1552960:Line [Quantitative Concept]
   753   C1704653:Cell [Medical Device]
   753   C1948049:Cell [Spatial Concept]

Phrase: "by others"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1955473:Others [Finding]
   966 E C0205394:Other [Qualitative Concept]

Phrase: "(26"

Phrase: ")."
Processing 00000000.tx.66: For acute uncoupling, higher concentrations ranging from 0.5 to 5 mmol/l can be used and effects observed within minutes. 

Phrase: "For acute"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205178:acute [Temporal Concept]

Phrase: "uncoupling"

Phrase: ","

Phrase: "higher concentrations"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0086045:Concentrations [Mental Process]
   827 E C1446561:Concentration [Quantitative Concept]
   777 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "ranging from 0.5"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0444499:0/5 [Quantitative Concept]
   737   C1514721:Range [Quantitative Concept]
   737   C2348147:Range [Quantitative Concept]
   737   C3542016:Range [Intellectual Product]

Phrase: "to 5 mmol/l"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   913   C2348935:.5 L [Quantitative Concept]
   901   C1532563:mmol/L [Quantitative Concept]

Phrase: "can"

Phrase: "be"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "and"

Phrase: "effects"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1280500:effects [Qualitative Concept]
   966 E C2348382:Effect [Qualitative Concept]

Phrase: "observed within minutes."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0439232:minute [Temporal Concept]
   790   C0700321:minute [Quantitative Concept]
   790   C0702093:/minute [Temporal Concept]
   790   C1282918:Minute [Quantitative Concept]
   790   C1441672:Observed [Functional Concept]
   790   C2347166:Minute [Quantitative Concept]
Processing 00000000.tx.67: However, the use of such higher concentrations for longer periods of time will cause cell death. 

Phrase: "However,"

Phrase: "the use of such higher concentrations"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C1524063:Use of [Functional Concept]
   753   C0042153:use [Functional Concept]
   753   C0457083:Use [Functional Concept]
   753   C1947944:Use [Intellectual Product]

Phrase: "for longer periods"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0439531:/period [Temporal Concept]
   827   C1948053:Period [Temporal Concept]
   777 E C0332182:Periodic [Temporal Concept]
   777 E C1706381:PERIODIC [Intellectual Product]
   755 E C0031084:Periodicities [Temporal Concept]

Phrase: "of time"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0040223:Time [Temporal Concept]
  1000   C3541383:Time [Temporal Concept]
   944 E C0442043:Temporal [Spatial Concept]
   944 E C2362314:Temporal [Temporal Concept]
   916 E C1632851:Times [Quantitative Concept]

Phrase: "will"

Phrase: "cause"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0015127:cause [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "cell death."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0007587:Cell Death [Cell Function]
   861   C0007634:Cell [Cell]
   861   C0011065:Death [Organism Function]
   861   C1269647:Cell [Cell]
   861   C1306577:Death, NOS [Finding]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.68: Control myotubes were left untreated. 

Phrase: "Control myotubes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0242697:myotubes [Cell]
   861   C1704336:Myotubes [Cell]

Phrase: "were"

Phrase: "left"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205091:Left [Spatial Concept]
  1000   C1552822:left [Functional Concept]

Phrase: "untreated."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332155:untreated [Finding]
Processing 00000000.tx.69: Western blotting. 

Phrase: "Western blotting."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0005863:Western Blotting [Laboratory Procedure,Molecular Biology Research Technique]
   983 E C0949466:Western Blot [Laboratory Procedure]
   861   C1705493:Western [Spatial Concept]
Processing 00000000.tx.70: Cells were removed from flasks following incubation with 0.25% trypsin, washed, and then total protein was isolated using Trizol. 

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "removed from flasks"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C0849355:Removed [Qualitative Concept]
   790   C0872171:flasks [Medical Device]
   756 E C1883720:Remove [Activity]
   756 E C3244314:remove [Functional Concept]

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "incubation with 0.25% trypsin,"

Phrase: "washed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1548982:Washed [Idea or Concept]
   966 E C0441648:Wash [Activity]

Phrase: ","

Phrase: "and"

Phrase: "then total protein"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0555903:Total protein [Laboratory Procedure]
   901   C1261360:total protein [Laboratory or Test Result]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0439175:% total [Quantitative Concept]
   827   C0439810:Total [Qualitative Concept]

Phrase: "was"

Phrase: "isolated"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0205409:Isolated [Functional Concept]
  1000   C1548221:Isolated [Idea or Concept]
   966 E C0370215:Isolate [Substance]
   966 E C1875400:ISOLATE [Pharmacologic Substance]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "Trizol."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0916178:trizol [Organic Chemical]
Processing 00000000.tx.71: To increase the concentration of protein before Western blotting, cell extracts were passed through Microcon YM-10 centrifugal filters (Millipore, Etobicoke, ON, Canada) following manufacturers guidelines. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "increase"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "the concentration of protein"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   819   C0427716:Protein concentration [Laboratory Procedure]
   819   C1304757:Protein concentration [Laboratory or Test Result]
   770   C0086045:Concentration [Mental Process]
   770   C1446561:Concentration [Quantitative Concept]

Phrase: "before Western blotting,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0005863:Western Blotting [Laboratory Procedure,Molecular Biology Research Technique]
   983 E C0949466:Western Blot [Laboratory Procedure]
   861   C1705493:Western [Spatial Concept]

Phrase: "cell extracts"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0007592:Cell Extracts [Cell Component]
   827   C2828366:Extract [Substance]

Phrase: "were"

Phrase: "passed through Microcon YM-10 centrifugal filters"
Meta Candidates (Total=9; Excluded=5; Pruned=0; Remaining=4)
   748   C0180860:Filters [Manufactured Object]
   748   C1301962:Centrifugal [Qualitative Concept]
   748   C2349168:ym [Quantitative Concept]
   748   C2828386:Passed [Finding]
   714 E C0581406:Filter [Medical Device]
   714 E C1522664:Filter [Intellectual Product]
   714 E C1704449:Filter [Conceptual Entity]
   714 E C1704684:Filter [Medical Device]
   714 E C1875155:FILTER [Medical Device]

Phrase: "(Millipore,"

Phrase: "Etobicoke,"

Phrase: "ON,"

Phrase: "Canada"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0006823:Canada [Geographic Area]

Phrase: ")"

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "manufacturers guidelines."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0162791:Guidelines [Intellectual Product]
   861   C0220845:guidelines [Intellectual Product]
   861   C0282423:guidelines [Intellectual Product]
Processing 00000000.tx.72: The filters were spun at 14,000g to exclude proteins having molecular weights <10 kDa and to concentrate protein for Western blotting. 

Phrase: "The filters"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0180860:Filters [Manufactured Object]
   966 E C0581406:Filter [Medical Device]
   966 E C1522664:Filter [Intellectual Product]
   966 E C1704449:Filter [Conceptual Entity]
   966 E C1704684:Filter [Medical Device]
   966 E C1875155:FILTER [Medical Device]

Phrase: "were"

Phrase: "spun at 14,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   790   C1446863:Spun [Laboratory Procedure]
   756 E C1415347:SPIN [Gene or Genome]
   756 E C1823107:SPIN [Gene or Genome]

Phrase: "000g to"

Phrase: "exclude"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332196:Exclude [Functional Concept]
  1000   C2828389:Exclude [Activity]

Phrase: "proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "having"

Phrase: "molecular weights"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
  1000   C0026385:Molecular weights [Quantitative Concept]
   861   C0043100:Weights [Quantitative Concept]
   861   C1521991:Molecular [Qualitative Concept]
   827 E C0005910:weight [Organism Attribute]
   827 E C1305866:weight [Diagnostic Procedure]
   827 E C1705104:Weight [Idea or Concept]
   789 E C0567416:Molecule [Substance]

Phrase: "<10 kDa"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1532717:kDa [Quantitative Concept]

Phrase: "and"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "concentrate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1880310:Concentrate [Manufactured Object]
  1000   C2003864:Concentrate [Substance]

Phrase: "protein for Western blotting."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   819   C0005863:protein blotting [Laboratory Procedure,Molecular Biology Research Technique]
   770   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.73: To prevent increases in the concentration of SDS during these procedures, concentrated protein was diluted in PBS and respun twice at 14,000g. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "prevent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0309872:PREVENT [Pharmacologic Substance]

Phrase: "increases in the concentration of SDS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0442805:increases [Functional Concept]

Phrase: "during these procedures,"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
  1000   C0025664:procedures [Intellectual Product]
  1000   C0184661:Procedures [Diagnostic Procedure,Therapeutic or Preventive Procedure]
  1000   C2700391:procedures [Activity]
   966 E C1948041:Procedure [Therapeutic or Preventive Procedure]
   966 E C3274430:PROCEDURE [Health Care Activity]
   966 E C3538935:Procedure [Idea or Concept]
   966 E C3539779:Procedure [Intellectual Product]

Phrase: "concentrated protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "was"

Phrase: "diluted in PBS"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C1720830:PBS [Disease or Syndrome]
   790   C1823521:PBS [Gene or Genome]
   756   C1720119:Dilute [Functional Concept]
   756   C1948037:Dilute [Functional Concept]

Phrase: "and"

Phrase: "respun twice at 14,"

Phrase: "000g."
Processing 00000000.tx.74: Equal amounts of cellular protein (80 g) were loaded into each lane of a BioRad Minigel (12% polyacrylamide) system. 

Phrase: "Equal amounts of cellular protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1265611:amounts [Quantitative Concept]

Phrase: "(80 g)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "were"

Phrase: "loaded into each lane of a BioRad Minigel"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   744   C1708639:Lane [Spatial Concept]
   744   C1708715:Loaded [Activity]
   711 E C1550025:Load [Idea or Concept]
   711 E C1704782:Load [Manufactured Object]

Phrase: "(12% polyacrylamide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0071499:polyacrylamide [Biomedical or Dental Material,Organic Chemical]

Phrase: ")"

Phrase: "system."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0449913:System [Functional Concept]
  1000   C1553451:System [Manufactured Object]
  1000   C1704459:System [Medical Device]
   928 E C0205373:Systemic [Functional Concept]
Processing 00000000.tx.75: After transfer to nitrocellulose membranes, primary antibody (UCP3, AB-3046; Chemicon) was incubated at a 1:1,000 dilution overnight at 4C. 

Phrase: "After"

Phrase: "transfer to nitrocellulose membranes,"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   812   C0025255:Membranes [Tissue]
   779 E C0596901:Membrane [Cell Component]
   779 E C1706182:Membrane [Manufactured Object]
   729 E C0205287:Membranous [Qualitative Concept]

Phrase: "primary antibody"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   861   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(UCP3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0539733:uncoupling protein-3 [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
  1000   C1421315:UNCOUPLING PROTEIN 3 [Gene or Genome]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "AB-3046"

Phrase: "; Chemicon"

Phrase: ")"

Phrase: "was"

Phrase: "incubated at a 1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1439852:Incubated [Laboratory Procedure]

Phrase: ":"

Phrase: "1,000 dilution overnight at 4C."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0079240:Dilution [Laboratory Procedure]
   753   C1948037:Dilution [Functional Concept]
Processing 00000000.tx.76: The secondary antibody was a peroxidase-conjugated goat anti-rabbit IgG (Santa Cruz, Santa Cruz, CA) and was incubated at a 1:500 dilution for 1 h at room temperature. 

Phrase: "The secondary antibody"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   861   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "was"

Phrase: "a peroxidase-conjugated goat anti-rabbit IgG"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   839   C0051979:anti-IgG [Amino Acid, Peptide, or Protein,Immunologic Factor]
   799   C0034493:Rabbit [Mammal]

Phrase: "(Santa Cruz,"

Phrase: "Santa Cruz,"

Phrase: "CA)"

Phrase: "and"

Phrase: "was"

Phrase: "incubated at a 1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1439852:Incubated [Laboratory Procedure]

Phrase: ":"

Phrase: "500 dilution for 1 h"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0079240:Dilution [Laboratory Procedure]
   760   C1948037:Dilution [Functional Concept]

Phrase: "at room temperature."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C2348236:ROOM TEMPERATURE [Qualitative Concept]
   861   C0005903:temperature [Organism Attribute]
   861   C0039476:*Temperature [Quantitative Concept]
   861   C1547703:Room [Spatial Concept]
Processing 00000000.tx.77: As a negative control, muscle mitochondrial proteins (75 g) from UCP3/ mice were used. 

Phrase: "As a negative control,"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
  1000   C1639518:% negative control [Quantitative Concept]
  1000   C1947986:Negative Control [Conceptual Entity]
   861   C0205160:Negative [Qualitative Concept]
   861   C0243148:control [Qualitative Concept]
   861   C1513916:Negative [Finding]
   861   C1550141:Control [Substance]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C2825415:Negative [Conceptual Entity]
   861   C2825491:Negative [Qualitative Concept]
   861   C3274648:Control [Qualitative Concept]

Phrase: "muscle mitochondrial proteins"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   913   C0026832:Muscle Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C0949610:Mitochondrial Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(75 g) from UCP3/ mice"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   778   C1979839:75 g [Quantitative Concept]
   774   C0060916:protein g [Amino Acid, Peptide, or Protein]
   774   C0086376:G-Protein [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0439267:g% [Quantitative Concept]

Phrase: "were"

Phrase: "used."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]
Processing 00000000.tx.78: As a positive control, recombinant murine UCP3 (prepared in our laboratory) was used. 

Phrase: "As a positive control,"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
  1000   C1883676:Positive Control [Conceptual Entity]
   861   C0243148:control [Qualitative Concept]
   861   C0439178:% Positive [Quantitative Concept]
   861   C1446409:Positive [Qualitative Concept]
   861   C1514241:Positive [Finding]
   861   C1550141:Control [Substance]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C2825490:Positive [Qualitative Concept]
   861   C3274648:Control [Qualitative Concept]

Phrase: "recombinant murine UCP3"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   884   C0539733:uncoupling protein-3 [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   884   C1421315:UNCOUPLING PROTEIN 3 [Gene or Genome]
   875   C0034861:Recombinant protein [Amino Acid, Peptide, or Protein]
   804   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "("

Phrase: "prepared in our laboratory"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0022877:Laboratory [Manufactured Object,Organization]
   770   C3244292:laboratory [Functional Concept]
   737   C1521827:Prepare [Functional Concept]

Phrase: ")"

Phrase: "was"

Phrase: "used."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]
Processing 00000000.tx.79: For detection, blots were processed using enhanced chemiluminescence kits (Amersham Pharmacia; Baie dUrfe, Quebec, Canada). 

Phrase: "For detection,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1511790:Detection [Therapeutic or Preventive Procedure]

Phrase: "blots"

Phrase: "were"

Phrase: "processed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1522240:Processed [Phenomenon or Process]
   966 E C1184743:Process [Body Part, Organ, or Organ Component]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "enhanced chemiluminescence kits"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   827   C1690540:Kits [Qualitative Concept]
   793 E C0812225:KIT [Medical Device]
   793 E C1150635:KIT [Molecular Function]
   793 E C1705212:Kit [Medical Device]
   793 E C1705213:KIT [Medical Device]
   793 E C3273202:Kit [Manufactured Object]

Phrase: "(Amersham Pharmacia"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0331955:Pharmacia [Health Care Related Organization]

Phrase: "; Baie dUrfe,"

Phrase: "Quebec,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0034390:Quebec [Geographic Area]

Phrase: "Canada"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0006823:Canada [Geographic Area]

Phrase: ")."
Processing 00000000.tx.80: Substrate oxidation. 

Phrase: "Substrate oxidation."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030011:Oxidation [Molecular Function]
Processing 00000000.tx.81: Rates of palmitate and glucose oxidation were measured in L6 myotubes cultured in 25-cm2 flasks using a method similar to that described by Roduit et al. 

Phrase: "Rates of palmitate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   756   C0871208:Rate [Activity]
   756   C1521828:Rate [Quantitative Concept]

Phrase: "and"

Phrase: "glucose oxidation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030011:Oxidation [Molecular Function]

Phrase: "were"

Phrase: "measured in L6 myotubes"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   770   C0242697:myotubes [Cell]
   770   C0444706:Measured [Qualitative Concept]
   770   C1704336:Myotubes [Cell]
   770   C3541902:MEASURED [Diagnostic Procedure]
   737 E C0079809:Measure [Quantitative Concept]
   737 E C0242485:Measure [Functional Concept]

Phrase: "cultured in 25-cm2 flasks"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   760   C0439479:cm2 [Quantitative Concept]
   760   C0555206:CM2 [Congenital Abnormality]
   760   C0872171:flasks [Medical Device]
   726   C0010453:Culture [Idea or Concept]
   726   C0220814:culture [Functional Concept]
   726   C0430400:Culture [Laboratory Procedure]
   726   C2242979:Culture [Laboratory Procedure]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a method"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025663:Method [Intellectual Product]
  1000   C0449851:Method [Functional Concept]
  1000   C0871511:METHOD [Intellectual Product]

Phrase: "similar to that"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C2348205:Similar [Qualitative Concept]

Phrase: "described by Roduit et al."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1552738:described [Idea or Concept]
Processing 00000000.tx.82: (27). 

Phrase: "(27"

Phrase: ")."
Processing 00000000.tx.83: Briefly, myotubes were washed once and incubated for 30 min at 37C in Krebs-Ringer bicarbonate buffer containing 10 mmol/l HEPES (pH 7.4), 0.5% (wt/vol) defatted BSA, and 5 mmol/l glucose. 

Phrase: "Briefly,"

Phrase: "myotubes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0242697:myotubes [Cell]
  1000   C1704336:Myotubes [Cell]

Phrase: "were"

Phrase: "washed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1548982:Washed [Idea or Concept]
   966 E C0441648:Wash [Activity]

Phrase: "once"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1720092:Once [Intellectual Product]
  1000   C1948045:Once [Temporal Concept]

Phrase: "and"

Phrase: "incubated for 30 min"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0456693:/30 min [Temporal Concept]
   833   C1442458:30 min [Temporal Concept]
   770   C0702093:/min [Temporal Concept]
   770   C1439852:Incubated [Laboratory Procedure]

Phrase: "at 37C"

Phrase: "in Krebs-Ringer bicarbonate buffer"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   812   C0005367:Bicarbonate [Inorganic Chemical,Pharmacologic Substance]
   812   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   812   C0973231:Bicarbonate [Inorganic Chemical]
   812   C1875730:RINGER'S [Organic Chemical,Pharmacologic Substance]
   812   C2722820:BICARBONATE [Organic Chemical,Pharmacologic Substance]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "10 mmol/l HEPES"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0019215:HEPES [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "(pH 7.4"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   913   C2678549:PH-4 [Gene or Genome]
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: ")"

Phrase: ","

Phrase: "0.5%"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0444499:0/5 [Quantitative Concept]

Phrase: "(wt/vol) defatted BSA,"

Phrase: "and"

Phrase: "5 mmol/l glucose."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   708   C2348935:.5 L [Quantitative Concept]
Processing 00000000.tx.84: For palmitate oxidation, myotubes were incubated for 1 h at 37C in Krebs-Ringer bicarbonate HEPES buffer containing 0.2 mmol/l palmitate (bound to BSA at 0.5% [wt/vol]), 0.2 Ci/ml [1-14C]palmitate, 1 mmol/l carnitine, and either 5.0 or 16.0 mmol/l glucose (oxidation medium). 

Phrase: "For palmitate oxidation,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030011:Oxidation [Molecular Function]

Phrase: "myotubes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0242697:myotubes [Cell]
  1000   C1704336:Myotubes [Cell]

Phrase: "were"

Phrase: "incubated for 1 h"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   819   C0700308:h 1 [Element, Ion, or Isotope]
   770   C0033727:H+ [Element, Ion, or Isotope]
   770   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0441932:H+ [Classification]
   770   C0564385:/h [Quantitative Concept]
   770   C1439852:Incubated [Laboratory Procedure]

Phrase: "at 37C"

Phrase: "in Krebs-Ringer bicarbonate HEPES buffer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "0.2 mmol/l palmitate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0030233:palmitate [Lipid]
   804   C3503116:palmitate [Biomedical or Dental Material,Lipid]

Phrase: "("

Phrase: "bound to BSA"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0332297:bound [Spatial Concept]
   790   C1145667:Bound [Activity]
   790   C1167622:Bound [Molecular Function]
   790   C1689898:% bound [Quantitative Concept]
   790   C2349209:Bound [Conceptual Entity]

Phrase: "at 0.5%"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0444499:0/5 [Quantitative Concept]

Phrase: "[wt/vol]"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0449468:VOL [Quantitative Concept]
   861   C0560268:vol% [Quantitative Concept]
   861   C1690016:% vol [Qualitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "0.2 Ci/ml [1-14C"

Phrase: "]palmitate,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0030233:palmitate [Lipid]
  1000   C3503116:palmitate [Biomedical or Dental Material,Lipid]

Phrase: "1 mmol/l carnitine,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1532563:mmol/L [Quantitative Concept]
   812   C0007258:Carnitine [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   812   C0087163:Carnitine [Organic Chemical,Pharmacologic Substance,Vitamin]

Phrase: "and"

Phrase: "either 5.0"

Phrase: "or"

Phrase: "16.0 mmol/l glucose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "(oxidation medium"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0009458:Medium [Intellectual Product]
   861   C0439536:Medium [Quantitative Concept]
   861   C1705217:Medium [Substance]
   861   C3244283:medium [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.85: Glucose oxidation was measured under identical conditions but in the presence of 16 mmol/l glucose and 0.2 Ci/ml [U-14C]glucose, 1 mmol/l carnitine, and either 0.05 or 0.2 mmol/l palmitate. 

Phrase: "Glucose oxidation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030011:Oxidation [Molecular Function]

Phrase: "was"

Phrase: "measured under identical conditions"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   770   C0205280:Identical [Qualitative Concept]
   770   C0444706:Measured [Qualitative Concept]
   770   C3541902:MEASURED [Diagnostic Procedure]
   737   C0012634:condition [Disease or Syndrome]
   737 E C0079809:Measure [Quantitative Concept]
   737 E C0242485:Measure [Functional Concept]
   737   C0348080:Condition [Qualitative Concept]
   737   C1705253:Condition [Conceptual Entity]

Phrase: "but in the presence of 16 mmol/l glucose"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   764   C1532563:mmol/L [Quantitative Concept]
   742   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   742   C0233535:but [Mental or Behavioral Dysfunction]
   742   C0392148:Presence [Therapeutic or Preventive Procedure]
   742   C0439190:MMOLE [Quantitative Concept]

Phrase: "and"

Phrase: "0.2 Ci/ml [U-14C"

Phrase: "]glucose,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "1 mmol/l carnitine,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1532563:mmol/L [Quantitative Concept]
   812   C0007258:Carnitine [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   812   C0087163:Carnitine [Organic Chemical,Pharmacologic Substance,Vitamin]

Phrase: "and"

Phrase: "either 0.05"

Phrase: "or"

Phrase: "0.2 mmol/l palmitate."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0030233:palmitate [Lipid]
   804   C3503116:palmitate [Biomedical or Dental Material,Lipid]
Processing 00000000.tx.86: To collect liberated 14CO2, Whatman GF/B paper (one-third of a 25-mm circle) was soaked in 150 l of 5% KOH and placed in the lumen of a 3-cm piece of polyvinyl chloride tubing (internal diameter 4.7 mm). 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "collect"

Phrase: "liberated 14CO2,"

Phrase: "Whatman GF/B paper"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0030351:Paper [Manufactured Object]
   812   C1547566:Paper [Idea or Concept]

Phrase: "(one-third of a 25-mm circle"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0205437:Third [Quantitative Concept]
   748   C0205447:One [Quantitative Concept]
   748   C1282913:Circle [Spatial Concept]
   748   C1551714:Circle [Population Group]

Phrase: ")"

Phrase: "was"

Phrase: "soaked in 150 l of 5% KOH"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   748   C0071767:KOH [Inorganic Chemical,Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   748   C0204774:soaked [Therapeutic or Preventive Procedure]
   714 E C1549544:Soak [Functional Concept]

Phrase: "and"

Phrase: "placed in the lumen of a 3-cm piece of polyvinyl chloride tubing"
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   750   C0032624:Polyvinyl Chloride [Biomedical or Dental Material,Organic Chemical]
   735   C0008203:Chloride, NOS [Inorganic Chemical]
   735   C0032629:Polyvinyl [Biomedical or Dental Material,Organic Chemical]
   735   C0184165:tubing [Medical Device]
   735   C0524461:Lumen [Body Space or Junction]
   735   C0596019:Chloride [Element, Ion, or Isotope]
   735   C1282864:Lumen [Body Space or Junction]
   735   C1301906:Lumen [Qualitative Concept]
   735   C1551056:Lumen [Quantitative Concept]
   735   C2982836:Piece [Quantitative Concept]
   702   C0442504:Place [Spatial Concept]
   702   C1704765:Place [Functional Concept]
   702   C1882509:Place [Activity]
   702   C3496241:place [Disease or Syndrome]

Phrase: "(internal diameter 4.7 mm"

Phrase: ")."
Processing 00000000.tx.87: The tube was then inserted into a rubber stopper, and the stopper was used to seal the flask with the tube facing inward. 

Phrase: "The tube"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0175730:Tube [Medical Device]
  1000   C1547937:Tube NOS [Intellectual Product]
  1000   C1561954:tube [Conceptual Entity]
  1000   C1704730:TUBE [Medical Device]

Phrase: "was"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "inserted into a rubber stopper,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   760   C0035918:Rubber [Organic Chemical]
   760   C0441587:Inserted [Health Care Activity]
   760   C3272593:Stopper [Manufactured Object]
   726 E C1743766:Insert [Medical Device]
   726 E C1883719:Insert [Functional Concept]

Phrase: "and"

Phrase: "the stopper"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3272593:Stopper [Manufactured Object]

Phrase: "was"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "seal"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0036492:Seal [Mammal]
  1000   C0325125:seal [Mammal]
  1000   C1704637:Seal [Manufactured Object]

Phrase: "the flask with the tube"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0872171:Flask [Medical Device]

Phrase: "facing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0015450:Face [Body Location or Region]
   966   C1281591:Face [Body Part, Organ, or Organ Component]

Phrase: "inward."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439786:Inward [Spatial Concept]
Processing 00000000.tx.88: At the end of the incubation period, 200 l of 40% (vol/vol) perchloric acid was injected into the flasks through the rubber stopper. 

Phrase: "At the end"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0444930:End [Spatial Concept]
  1000   C2746065:End [Temporal Concept]
   944 E C0205088:Terminal [Temporal Concept]
   944 E C1705314:Terminal [Manufactured Object]
   944 E C1705315:Terminal [Spatial Concept]

Phrase: "of the incubation period,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C1320226:Incubation period [Finding]
   861   C0439531:/period [Temporal Concept]
   861   C1948053:Period [Temporal Concept]
   789 E C0332182:Periodic [Temporal Concept]
   789 E C1706381:PERIODIC [Intellectual Product]
   761 E C0031084:Periodicities [Temporal Concept]

Phrase: "200 l of 40%"

Phrase: "(vol/vol) perchloric acid"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0030981:Perchloric acid [Inorganic Chemical,Indicator, Reagent, or Diagnostic Aid]
   812   C0001128:Acid [Chemical]
   812   C0202406:Acid [Laboratory Procedure]

Phrase: "was"

Phrase: "injected into the flasks"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0872171:flasks [Medical Device]
   737   C1720154:Inject [Functional Concept]

Phrase: "through the rubber stopper."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3272593:Stopper [Manufactured Object]
Processing 00000000.tx.89: The following day, the filter paper and 100 l oxidation medium from each flask were collected and placed in scintillation vials containing 4 ml scintillation fluid. 

Phrase: "The following day,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0332173:/day [Temporal Concept]
   861   C0439228:day [Temporal Concept]
   861   C0439505:/day [Temporal Concept]

Phrase: "the filter paper"
Meta Candidates (Total=14; Excluded=5; Pruned=0; Remaining=9)
  1000   C0180859:filter paper [Medical Device]
   861   C0030351:Paper [Manufactured Object]
   861   C0180860:Filter [Manufactured Object]
   861   C0581406:Filter [Medical Device]
   861   C1522664:Filter [Intellectual Product]
   861   C1547566:Paper [Idea or Concept]
   861   C1704449:Filter [Conceptual Entity]
   861   C1704684:Filter [Medical Device]
   861   C1875155:FILTER [Medical Device]
   805 E C0080194:Strain [Injury or Poisoning]
   805 E C0442694:Straining [Physiologic Function]
   805 E C0456178:strain [Intellectual Product]
   805 E C1518614:Strain [Organism]
   805 E C2987481:Strain [Mental Process]

Phrase: "and"

Phrase: "100 l oxidation medium from each flask"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0009458:Medium [Intellectual Product]
   748   C0439536:Medium [Quantitative Concept]
   748   C1705217:Medium [Substance]
   748   C3244283:medium [Intellectual Product]

Phrase: "were"

Phrase: "collected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1516695:Collected [Idea or Concept]
  1000   C1516698:Collected [Functional Concept]

Phrase: "and"

Phrase: "placed in scintillation vials"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   770   C0184301:vials [Medical Device]
   770   C0678573:scintillation [Natural Phenomenon or Process]
   770   C1533199:Vials [Quantitative Concept]
   737   C0442504:Place [Spatial Concept]
   737   C1704765:Place [Functional Concept]
   737 E C1706497:VIAL [Medical Device]
   737   C1882509:Place [Activity]
   737   C3496241:place [Disease or Syndrome]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "4 ml scintillation fluid."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0005889:FLUID [Body Substance]
   812   C0302908:fluid [Substance]
   812   C0444611:Fluid [Qualitative Concept]
   812   C1704353:Fluid [Substance]
Processing 00000000.tx.90: The vials were then left overnight before the radioactivity was measured by scintillation counting. 

Phrase: "The vials"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0184301:vials [Medical Device]
  1000   C1533199:Vials [Quantitative Concept]
   966 E C1706497:VIAL [Medical Device]

Phrase: "were"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "left"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205091:Left [Spatial Concept]
  1000   C1552822:left [Functional Concept]

Phrase: "overnight before the radioactivity"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0034553:Radioactivity [Natural Phenomenon or Process]
   770   C0439583:Overnight [Temporal Concept]

Phrase: "was"

Phrase: "measured by scintillation counting."
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   833   C0036406:Scintillation Counting [Laboratory Procedure]
   770   C0444706:Measured [Qualitative Concept]
   770   C0678573:scintillation [Natural Phenomenon or Process]
   770   C3541902:MEASURED [Diagnostic Procedure]
   737 E C0079809:Measure [Quantitative Concept]
   737 E C0242485:Measure [Functional Concept]
   737   C0750480:Count [Activity]
   737   C1705566:Count [Quantitative Concept]
Processing 00000000.tx.91: As a positive control to verify that the assay was measuring glucose and palmitate oxidation, 100 nmol/l insulin was added into separate flasks during the 15-min preincubation period to influence their respective oxidation rates. 

Phrase: "As a positive control to"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   901   C1883676:Positive Control [Conceptual Entity]
   827   C0243148:control [Qualitative Concept]
   827   C0439178:% Positive [Quantitative Concept]
   827   C1446409:Positive [Qualitative Concept]
   827   C1514241:Positive [Finding]
   827   C1550141:Control [Substance]
   827   C1882979:Control [Conceptual Entity]
   827   C2587213:Control [Functional Concept]
   827   C2825490:Positive [Qualitative Concept]
   827   C3274648:Control [Qualitative Concept]

Phrase: "verify"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1711411:Verify [Functional Concept]

Phrase: "that"

Phrase: "the assay"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0005507:Assay [Laboratory Procedure]
  1000   C0243073:assay [Qualitative Concept]
  1000   C1510438:Assay [Laboratory Procedure]

Phrase: "was"

Phrase: "measuring glucose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "and"

Phrase: "palmitate oxidation,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030011:Oxidation [Molecular Function]

Phrase: "100 nmol/l insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "was"

Phrase: "added into separate flasks"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0443299:Separate [Spatial Concept]
   770   C0872171:flasks [Medical Device]
   770   C1524062:Added [Functional Concept]
   737 E C1883712:Add [Functional Concept]

Phrase: "during the 15-min preincubation period to"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   804   C0439531:/period [Temporal Concept]
   804   C1948053:Period [Temporal Concept]
   733 E C0332182:Periodic [Temporal Concept]
   733 E C1706381:PERIODIC [Intellectual Product]
   704 E C0031084:Periodicities [Temporal Concept]

Phrase: "influence"

Phrase: "their respective oxidation rates."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0030011:Oxidation [Molecular Function]
   793   C0871208:Rate [Activity]
   793   C1521828:Rate [Quantitative Concept]
Processing 00000000.tx.92: Oxygen uptake. 

Phrase: "Oxygen uptake."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0429627:Oxygen uptake [Finding]
   861   C0030054:Oxygen [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C0243144:Uptake [Physiologic Function]
   861   C0347980:% uptake [Quantitative Concept]
Processing 00000000.tx.93: Rates of oxygen consumption from individual L6 myotubes were determined using a self-referencing microelectrode system (28) and methods described by Porterfield et al. 

Phrase: "Rates of oxygen consumption"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   737   C0871208:Rate [Activity]
   737   C1521828:Rate [Quantitative Concept]

Phrase: "from individual L6 myotubes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0242697:myotubes [Cell]
   827   C1704336:Myotubes [Cell]

Phrase: "were"

Phrase: "determined"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a self-referencing microelectrode system"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   812   C0449913:System [Functional Concept]
   812   C1553451:System [Manufactured Object]
   812   C1704459:System [Medical Device]
   741 E C0205373:Systemic [Functional Concept]

Phrase: "(28"

Phrase: ")"

Phrase: "and"

Phrase: "methods"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]

Phrase: "described by Porterfield et al."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1552738:described [Idea or Concept]
Processing 00000000.tx.94: (29). 

Phrase: "(29"

Phrase: ")."
Processing 00000000.tx.95: Oxygen microelectrodes were manufactured using the methods of Jung et al. 

Phrase: "Oxygen microelectrodes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   983   C0597155:oxygen microelectrode [Medical Device]
   861   C0025973:Microelectrodes [Medical Device]

Phrase: "were"

Phrase: "manufactured"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0870840:manufactured [Occupational Activity]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the methods of Jung et al."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   753   C0025663:Methods [Intellectual Product]
   753   C0025664:methods [Intellectual Product]
   753   C0449851:Methods [Functional Concept]
   719 E C0871511:METHOD [Intellectual Product]
Processing 00000000.tx.96: (30). 

Phrase: "(30"

Phrase: ")."
Processing 00000000.tx.97: Myotubes, cultured in a 6-cm2 dish, were placed in an Earles basic salt solution containing 117 mmol/l NaCl, 5.4 KCl, 1.5 CaCl2, 0.8 MgSO4, 0.9 mmol/l NaH2PO4, 10 mmol/l HEPES, and 5.6 mmol/l glucose. 

Phrase: "Myotubes,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0242697:myotubes [Cell]
  1000   C1704336:Myotubes [Cell]

Phrase: "cultured in a 6-cm2 dish,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   753   C0020498:DISH [Disease or Syndrome]
   753   C0439479:cm2 [Quantitative Concept]
   753   C0555206:CM2 [Congenital Abnormality]
   719   C0010453:Culture [Idea or Concept]
   719   C0220814:culture [Functional Concept]
   719   C0430400:Culture [Laboratory Procedure]
   719   C2242979:Culture [Laboratory Procedure]

Phrase: "were"

Phrase: "placed in an Earles basic salt solution"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   748   C0036140:Salt [Chemical Viewed Structurally]
   748   C0037494:Salt [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   748   C0037633:Solution [Substance]
   748   C0206136:Salt [Food,Inorganic Chemical]
   748   C0525069:Solution [Biomedical or Dental Material]
   748   C1527178:Basic [Functional Concept]
   714   C0442504:Place [Spatial Concept]
   714   C1704765:Place [Functional Concept]
   714   C1882509:Place [Activity]
   714   C3496241:place [Disease or Syndrome]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "117 mmol/l NaCl,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0037494:NaCl [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   812   C1959973:% NaCl [Quantitative Concept]

Phrase: "5.4 KCl,"

Phrase: "1.5 CaCl2,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C0450316:1/5 [Quantitative Concept]

Phrase: "0.8 MgSO4,"

Phrase: "0.9 mmol/l NaH2PO4,"

Phrase: "10 mmol/l HEPES,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0019215:HEPES [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "and"

Phrase: "5.6 mmol/l glucose."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   708   C2348935:.5 L [Quantitative Concept]
Processing 00000000.tx.98: The dish was then placed under an Axiovert 200 (Zeiss) inverted microscope that is housed within an insulated Faraday box equipped with temperature control equipment that allowed the internal environment to be maintained at 37C. 

Phrase: "The dish"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0020498:DISH [Disease or Syndrome]

Phrase: "was"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "placed under an Axiovert 200"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   726   C0442504:Place [Spatial Concept]
   726   C1704765:Place [Functional Concept]
   726   C1882509:Place [Activity]
   726   C3496241:place [Disease or Syndrome]

Phrase: "(Zeiss"

Phrase: ")"

Phrase: "inverted microscope"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0181839:Microscope [Medical Device]
   861   C1706379:Microscope [Medical Device]

Phrase: "that"

Phrase: "is"

Phrase: "housed within an insulated Faraday box"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   753   C0020056:Housed [Manufactured Object]
   753   C0179400:Box [Manufactured Object]
   753   C1533124:Box [Medical Device]
   753   C2348508:Faraday [Quantitative Concept]
   719 E C0442519:house [Conceptual Entity]
   719 E C2003847:House [Manufactured Object]

Phrase: "equipped with temperature control equipment"
Meta Candidates (Total=14; Excluded=2; Pruned=0; Remaining=12)
   797   C0428748:Equipment temperature [Finding]
   760   C0005903:temperature [Organism Attribute]
   760   C0014672:Equipment [Manufactured Object]
   760   C0039476:*Temperature [Quantitative Concept]
   760   C0220824:equipment [Manufactured Object]
   760   C0243148:control [Qualitative Concept]
   760   C1523994:Equipment [Manufactured Object]
   760   C1550141:Control [Substance]
   760   C1882979:Control [Conceptual Entity]
   760   C2587213:Control [Functional Concept]
   760   C2827396:Equipment [Manufactured Object]
   760   C3274648:Control [Qualitative Concept]
   704 E C1706469:Gear [Qualitative Concept]
   704 E C1706470:GEARS [Manufactured Object]

Phrase: "that"

Phrase: "allowed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0683607:allowed [Social Behavior]

Phrase: "the internal environment to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0014406:Environment [Spatial Concept]

Phrase: "be"

Phrase: "maintained at 37C."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C1314677:Maintained [Functional Concept]
   756 E C0024501:Maintain [Activity]
Processing 00000000.tx.99: The tip of an oxygen microelectrode was placed 2 m from the surface of a myotube and was oscillated at a frequency of 0.3 Hz to collect alternating oxygen flux and reference measurements. 

Phrase: "The tip of an oxygen microelectrode"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1710425:Tip [Medical Device]
   753   C3282898:Tip [Qualitative Concept]

Phrase: "was"

Phrase: "placed"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   966   C0442504:Place [Spatial Concept]
   966   C1704765:Place [Functional Concept]
   966   C1882509:Place [Activity]
   966   C3496241:place [Disease or Syndrome]

Phrase: "2 m from the surface of a myotube"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   744   C0441923:M+ [Intellectual Product]

Phrase: "and"

Phrase: "was"

Phrase: "oscillated at a frequency of 0.3 Hz to"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   742   C0376249:frequency [Quantitative Concept]
   742   C0439482:Hz [Quantitative Concept]
   742   C0439603:Frequency [Temporal Concept]
   742   C0871396:Frequency [Quantitative Concept]
   742   C1561548:Frequency [Qualitative Concept]
   742   C1705502:Frequency [Quantitative Concept]

Phrase: "collect"

Phrase: "alternating oxygen flux"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0429622:Oxygen flux [Clinical Attribute]
   827   C2348693:Flux [Natural Phenomenon or Process]

Phrase: "and"

Phrase: "reference measurements."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0242485:measurements [Functional Concept]
Processing 00000000.tx.100: Translational movement of the microelectrode was accomplished with a translational motion control system mounted onto the head stage of the microscope. 

Phrase: "Translational movement of the microelectrode"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0026649:Movement [Organism Function]

Phrase: "was"

Phrase: "accomplished with a translational motion control system"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   778   C0680582:control system [Regulation or Law]
   748   C0026597:Motion [Natural Phenomenon or Process]
   748   C0243148:control [Qualitative Concept]
   748   C0449913:System [Functional Concept]
   748   C1519614:Translational [Genetic Function]
   748   C1550141:Control [Substance]
   748   C1553451:System [Manufactured Object]
   748   C1704459:System [Medical Device]
   748   C1882979:Control [Conceptual Entity]
   748   C2587213:Control [Functional Concept]
   748   C3274648:Control [Qualitative Concept]

Phrase: "mounted onto the head stage of the microscope."
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   744   C0018670:Head [Body Location or Region]
   744   C0181839:Microscope [Medical Device]
   744   C0205390:Stage [Temporal Concept]
   744   C0449878:mounted [Finding]
   744   C1281590:Head [Body Part, Organ, or Organ Component]
   744   C1300072:Stage [Clinical Attribute]
   744   C1306673:Stage [Qualitative Concept]
   744   C1706305:Head [Manufactured Object]
   744   C1706379:Microscope [Medical Device]
   711 E C0181909:Mount [Medical Device]
Processing 00000000.tx.101: Movement was driven by IonView software developed, along with motion controllers and amplifiers, at the Biocurrents Research Center (MBL, Woods Hole, MA). 

Phrase: "Movement"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0026649:Movement [Organism Function]

Phrase: "was"

Phrase: "driven by IonView software"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0037585:Software [Intellectual Product,Manufactured Object]
   737   C0013126:Drive [Mental Process]

Phrase: "developed"

Phrase: ","

Phrase: "along with motion controllers"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0180112:Controllers [Medical Device]

Phrase: "and"

Phrase: "amplifiers,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0002684:Amplifiers [Manufactured Object]
   966 E C1706099:Amplifier [Manufactured Object]

Phrase: "at the Biocurrents"

Phrase: "Research"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0035168:research [Research Activity]
  1000   C0242481:Research [Research Activity]

Phrase: "Center"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205099:Center [Spatial Concept]

Phrase: "(MBL,"

Phrase: "Woods Hole,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0544726:Hole [Finding]
   861   C1823381:hole [Gene or Genome]
   861   C1881060:HOLE [Event]

Phrase: "MA"

Phrase: ")."
Processing 00000000.tx.102: The differential current outputs (in fA) obtained from three separate myotubes per plate were averaged and converted to oxygen flux using the Fick equation: J = D (C/r), where J is the flux rate, D is the diffusion coefficient of oxygen in water, C is the oxygen concentration difference between the flux and reference positions, and r is the distance of measurement. 

Phrase: "The differential current outputs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C1709366:Output [Conceptual Entity]

Phrase: "("

Phrase: "in fA)"

Phrase: "obtained from three separate myotubes"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   760   C0205449:Three [Quantitative Concept]
   760   C0242697:myotubes [Cell]
   760   C0443299:Separate [Spatial Concept]
   760   C1301820:Obtained [Functional Concept]
   760   C1704336:Myotubes [Cell]
   726 E C1706701:Obtain [Activity]

Phrase: "per plate"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0005971:Plate [Medical Device]
  1000   C1139930:plate [Medical Device]
  1000   C3537155:Plate [Manufactured Object]

Phrase: "were"

Phrase: "averaged"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1510992:Average [Quantitative Concept]
   966   C2825518:AVERAGE [Quantitative Concept]

Phrase: "and"

Phrase: "converted to oxygen flux"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C0429622:Oxygen flux [Clinical Attribute]
   770   C0030054:Oxygen [Element, Ion, or Isotope,Pharmacologic Substance]
   770   C2348693:Flux [Natural Phenomenon or Process]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the Fick equation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0552449:Equation [Conceptual Entity]

Phrase: ":"

Phrase: "J = D (C/r"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0205090:R- [Spatial Concept]
   812   C0684010:R. [Professional or Occupational Group]
   812   C2603358:R' [Clinical Attribute]

Phrase: ")"

Phrase: ","

Phrase: "where J"

Phrase: "is"

Phrase: "the flux rate,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0871208:Rate [Activity]
   861   C1521828:Rate [Quantitative Concept]

Phrase: "D"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "is"

Phrase: "the diffusion coefficient of oxygen"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0012222:Diffusion [Natural Phenomenon or Process]
   760   C1696141:Diffusion [Functional Concept]
   760   C1707429:*Coefficient [Quantitative Concept]

Phrase: "in water,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0043047:Water [Inorganic Chemical,Pharmacologic Substance]
  1000   C0599638:WATER [Substance]
  1000   C1550678:Water [Inorganic Chemical]
   928 E C0443350:Watery [Qualitative Concept]

Phrase: "C"

Phrase: "is"

Phrase: "the oxygen concentration difference between the flux"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1705241:*Difference [Quantitative Concept]
   748   C1705242:Difference [Qualitative Concept]

Phrase: "and"

Phrase: "reference positions,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0733755:positions [Spatial Concept]
   777 E C0240795:POSITIONAL [Finding]

Phrase: "and"

Phrase: "r"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "is"

Phrase: "the distance of measurement."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0012751:Distance [Quantitative Concept]
Processing 00000000.tx.103: C was determined by multiplying the differential current obtained with the slope of an independently determined electrode calibration curve. 

Phrase: "C"

Phrase: "was"

Phrase: "determined by multiplying"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   756   C1719797:Multiply [Functional Concept]
   756   C2911648:Multiply [Quantitative Concept]

Phrase: "the differential current"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0521116:Current [Temporal Concept]
   861   C1705970:Current [Natural Phenomenon or Process]

Phrase: "obtained with the slope of an independently determined electrode calibration curve."
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   738   C0006751:Calibration [Quantitative Concept]
   738   C0013812:electrode [Medical Device]
   738   C0205134:Curve [Spatial Concept]
   738   C0807955:Slope [Quantitative Concept]
   738   C1301820:Obtained [Functional Concept]
   738   C1705652:Electrode [Medical Device]
   704 E C1706701:Obtain [Activity]
Processing 00000000.tx.104: Mitochondrial membrane potential. 

Phrase: "Mitochondrial membrane potential."
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
  1000   C1720920:Membrane Potential, Mitochondrial [Cell Function]
   901   C0025251:Membrane Potential [Cell Function]
   901   C0596952:Mitochondrial membrane [Cell Component]
   827   C0025255:Membrane [Tissue]
   827   C0026237:Mitochondrial [Cell Component]
   827   C0521451:Mitochondrial [Functional Concept]
   827   C0596901:Membrane [Cell Component]
   827   C1706182:Membrane [Manufactured Object]
   827   C3245505:Potential [Qualitative Concept]
   755 E C0205287:Membranous [Qualitative Concept]
Processing 00000000.tx.105: The mitochondrial membrane potential of myotubes cultured in opaque 96-well plates was determined using tetramethylrhodamine ethyl ester (TMRE). 

Phrase: "The mitochondrial membrane potential of myotubes"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   833   C1720920:Membrane Potential, Mitochondrial [Cell Function]
   790   C0025251:Membrane Potential [Cell Function]
   790   C0596952:Mitochondrial membrane [Cell Component]
   753   C0025255:Membrane [Tissue]
   753   C0026237:Mitochondrial [Cell Component]
   753   C0521451:Mitochondrial [Functional Concept]
   753   C0596901:Membrane [Cell Component]
   753   C1706182:Membrane [Manufactured Object]
   753   C3245505:Potential [Qualitative Concept]

Phrase: "cultured in opaque 96-well"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   760   C0029053:opaque [Finding]
   760   C0205170:Well [Qualitative Concept]
   760   C1261286:Opaque [Qualitative Concept]
   760   C1882150:OPAQUE [Phenomenon or Process]
   760   C3146287:Well [Manufactured Object]
   726   C0010453:Culture [Idea or Concept]
   726   C0220814:culture [Functional Concept]
   726   C0430400:Culture [Laboratory Procedure]
   726   C2242979:Culture [Laboratory Procedure]

Phrase: "plates"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0005971:Plate [Medical Device]
  1000   C1139930:plate [Medical Device]
  1000   C3537155:Plate [Manufactured Object]

Phrase: "was"

Phrase: "determined"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "tetramethylrhodamine ethyl ester (TMRE)."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0672030:tetramethyl rhodamine ethyl ester [Organic Chemical,Pharmacologic Substance]
   827   C0014898:Ester [Organic Chemical]
Processing 00000000.tx.106: Myotubes were incubated in differentiation medium containing 100 mol/l TMRE for 15 min in the dark at 37C. 

Phrase: "Myotubes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0242697:myotubes [Cell]
  1000   C1704336:Myotubes [Cell]

Phrase: "were"

Phrase: "incubated in differentiation medium"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   770   C0007589:Differentiation [Cell Function]
   770   C0009458:Medium [Intellectual Product]
   770   C0439536:Medium [Quantitative Concept]
   770   C1439852:Incubated [Laboratory Procedure]
   770   C1511938:Differentiation [Clinical Attribute]
   770   C1705217:Medium [Substance]
   770   C2945687:Differentiation [Functional Concept]
   770   C3244283:medium [Intellectual Product]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "100 mol/l TMRE for 15 min"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0672030:tetramethyl rhodamine ethyl ester [Organic Chemical,Pharmacologic Substance]
   742   C0014898:Ester [Organic Chemical]

Phrase: "in the dark"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332582:Dark [Qualitative Concept]

Phrase: "at 37C."
Processing 00000000.tx.107: Fresh differentiation medium was then added after washing the myotubes twice with PBS to remove extracellular TMRE. 

Phrase: "Fresh differentiation medium"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0009458:Medium [Intellectual Product]
   827   C0439536:Medium [Quantitative Concept]
   827   C1705217:Medium [Substance]
   827   C3244283:medium [Intellectual Product]

Phrase: "was"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "added after washing"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0441648:Washing [Activity]
   790   C1524062:Added [Functional Concept]
   756 E C1883712:Add [Functional Concept]

Phrase: "the myotubes twice with PBS to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0242697:myotubes [Cell]
   753   C1704336:Myotubes [Cell]

Phrase: "remove"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0849355:remove [Qualitative Concept]
  1000   C1883720:Remove [Activity]
  1000   C3244314:remove [Functional Concept]

Phrase: "extracellular TMRE."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   923   C0672030:tetramethyl rhodamine ethyl ester [Organic Chemical,Pharmacologic Substance]
   812   C0014898:Ester [Organic Chemical]
Processing 00000000.tx.108: Fluorescence intensity was detected with excitation and emission wavelengths of 544 and 590 nm, respectively. 

Phrase: "Fluorescence intensity"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0016315:Fluorescence [Natural Phenomenon or Process]
   861   C0522510:Intensity [Qualitative Concept]
   789 E C0303920:Fluorescent [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "was"

Phrase: "detected with excitation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0442726:Detected [Finding]
   790   C0549255:Excitation [Activity]
   790   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "emission wavelengths of 544"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0449819:wavelengths [Quantitative Concept]

Phrase: "and"

Phrase: "590 nm,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0312860:NM [Cell Function]

Phrase: "respectively."
Processing 00000000.tx.109: ROS production. 

Phrase: "ROS production."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0033268:production [Occupational Activity]
   756   C0162772:Reactive Oxygen Species [Biologically Active Substance,Element, Ion, or Isotope]
Processing 00000000.tx.110: Myotubes cultured in opaque 96-well plates were incubated in PBS containing 1 mol/l carboxy-H2[5-(and-6)-carboxy-2',7'-dichlorohydofluorescein diacetate] (DCFDA) for 10 min in the dark. 

Phrase: "Myotubes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0242697:myotubes [Cell]
  1000   C1704336:Myotubes [Cell]

Phrase: "cultured in opaque 96-well"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   760   C0029053:opaque [Finding]
   760   C0205170:Well [Qualitative Concept]
   760   C1261286:Opaque [Qualitative Concept]
   760   C1882150:OPAQUE [Phenomenon or Process]
   760   C3146287:Well [Manufactured Object]
   726   C0010453:Culture [Idea or Concept]
   726   C0220814:culture [Functional Concept]
   726   C0430400:Culture [Laboratory Procedure]
   726   C2242979:Culture [Laboratory Procedure]

Phrase: "plates"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0005971:Plate [Medical Device]
  1000   C1139930:plate [Medical Device]
  1000   C3537155:Plate [Manufactured Object]

Phrase: "were"

Phrase: "incubated in PBS"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C1439852:Incubated [Laboratory Procedure]
   790   C1720830:PBS [Disease or Syndrome]
   790   C1823521:PBS [Gene or Genome]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "1 mol/l carboxy-H2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0919509:H2 [Gene or Genome]
   804   C1419394:H2 [Gene or Genome]

Phrase: "[5-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "("

Phrase: "and-"

Phrase: "6"

Phrase: ")-"

Phrase: "carboxy-2',"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0596260:Carboxy [Organic Chemical]

Phrase: "7'-dichlorohydofluorescein diacetate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0369114:Diacetate [Organic Chemical]

Phrase: "]"

Phrase: "(DCFDA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0057672:DCFDA [Organic Chemical]

Phrase: ")"

Phrase: "for 10 min"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0456692:/10 min [Temporal Concept]
   861   C0702093:/min [Temporal Concept]

Phrase: "in the dark."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332582:Dark [Qualitative Concept]
Processing 00000000.tx.111: After addition of 16.0 mmol/l glucose, fluorescence emission was followed for 1 h with measurements collected every 2 min (excitation = 490 nm; emission = 516 nm). 

Phrase: "After addition"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "of 16.0 mmol/l glucose,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "fluorescence emission"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0233929:Emission [Body Substance]
   861   C2349995:Emission [Substance]

Phrase: "was"

Phrase: "followed for 1 h"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   819   C0700308:h 1 [Element, Ion, or Isotope]
   770   C0033727:H+ [Element, Ion, or Isotope]
   770   C0332283:followed [Temporal Concept]
   770   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0441932:H+ [Classification]
   770   C0564385:/h [Quantitative Concept]
   737 E C1719822:Follow [Intellectual Product]

Phrase: "with measurements"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0242485:measurements [Functional Concept]

Phrase: "collected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1516695:Collected [Idea or Concept]
  1000   C1516698:Collected [Functional Concept]

Phrase: "every 2 min (excitation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0549255:Excitation [Activity]

Phrase: "= 490 nm"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0312860:NM [Cell Function]

Phrase: "; emission"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0233929:Emission [Body Substance]
  1000   C2349995:Emission [Substance]

Phrase: "= 516 nm)."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0312860:NM [Cell Function]
Processing 00000000.tx.112: Statistical analysis. 

Phrase: "Statistical analysis."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0871424:statistical analysis [Research Activity]
   861   C0002778:Analysis [Laboratory Procedure]
   861   C0936012:Analysis [Research Activity]
   861   C1524024:analysis [Functional Concept]
Processing 00000000.tx.113: Statistical analysis was performed using ANOVA and Bonferroni post hoc tests. 

Phrase: "Statistical analysis"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0871424:statistical analysis [Research Activity]
   861   C0002778:Analysis [Laboratory Procedure]
   861   C0936012:Analysis [Research Activity]
   861   C1524024:analysis [Functional Concept]

Phrase: "was"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "ANOVA"

Phrase: "and"

Phrase: "Bonferroni post hoc tests."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   812   C0022885:Tests [Laboratory Procedure]
   812   C0392366:Tests [Intellectual Product]
   779 E C0039593:Test [Functional Concept]
Processing 00000000.tx.114: Results are presented as means  SE, unless otherwise stated. 

Phrase: "Results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "are"

Phrase: "presented as means  SE,"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
   770   C0449450:Presented [Idea or Concept]
   770   C1704970:Means [Conceptual Entity]
   737 E C0150312:Present [Quantitative Concept]
   737 E C0444504:Mean [Quantitative Concept]
   737 E C2347634:Mean [Quantitative Concept]
   737 E C2348143:Mean [Quantitative Concept]

Phrase: "unless"

Phrase: "otherwise"

Phrase: "stated."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1301808:stated [Geographic Area]
  1000   C1442792:Stated [Functional Concept]
   966 E C3148680:State [Geographic Area]
Processing 00000000.tx.115: Analyses were conducted using GraphPad Prism 4 (San Diego, CA) software.  

Phrase: "Analyses"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0002778:Analysis [Laboratory Procedure]
   966   C0936012:Analysis [Research Activity]
   966   C1524024:analysis [Functional Concept]

Phrase: "were"

Phrase: "conducted"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0004927:Conduct [Individual Behavior]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "GraphPad Prism 4"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0814195:PRISM [Intellectual Product]
   771 E C0138404:prisma [Organic Chemical,Pharmacologic Substance]

Phrase: "(San Diego,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1826357:San [Gene or Genome]

Phrase: "CA) software."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0037585:Software [Intellectual Product,Manufactured Object]
Processing 00000000.tx.116: RESULTS TOP ABSTRACT RESEARCH DESIGN AND METHODS RESULTS DISCUSSION REFERENCES  Induction of UCP3 protein expression through adenoviral infection. 

Phrase: "RESULTS TOP ABSTRACT RESEARCH DESIGN"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   840   C0035171:Research Design [Research Activity]
   804   C0035168:research [Research Activity]
   804   C0242481:Research [Research Activity]
   804   C1707689:Design [Activity]
   804   C2983265:DESIGN [Intellectual Product]

Phrase: "AND"

Phrase: "METHODS RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Induction of UCP3 protein expression"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0205263:Induction [Functional Concept]
   748   C0857127:induction [Therapeutic or Preventive Procedure]

Phrase: "through adenoviral infection."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0851887:adenoviral infection [Disease or Syndrome]
   861   C0009450:Infection, NOS [Disease or Syndrome]
   789 E C0439663:Infected [Functional Concept]
   750 E C0030657:infectivity [Qualitative Concept]
Processing 00000000.tx.117: Western blots of cellular homogenates indicated that the level of UCP3 protein expression in UCP3-infected L6 myotubes was 2.2- to 2.5-fold higher than that in uninfected control cells, cells that were infected with GFP, or cells that were treated with the chemical uncoupler dinitrophenol (Fig. 1). 

Phrase: "Western blots of cellular homogenates"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   806   C0949466:Western Blots [Laboratory Procedure]
   773 E C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
   760   C1705493:Western [Spatial Concept]

Phrase: "indicated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1444656:Indicated [Finding]

Phrase: "that"

Phrase: "the level of UCP3 protein expression"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   767   C0428479:Protein level [Laboratory or Test Result]
   767   C0456949:Level 3 [Intellectual Product]
   767   C3244092:expression level [Idea or Concept]
   744   C0441889:Level [Qualitative Concept]
   744   C0456079:Level [Classification]
   744   C1547707:Level [Geographic Area]
   744   C2946261:Level [Pharmacologic Substance]

Phrase: "in UCP3-infected L6 myotubes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   799   C0242697:myotubes [Cell]
   799   C1704336:Myotubes [Cell]

Phrase: "was"

Phrase: "2.2-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0740116:+2 [Quantitative Concept]
   861   C2827735:2+ [Quantitative Concept]
   861   C2981700:2+ [Classification]

Phrase: "to 2.5-fold"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0332462:Fold [Spatial Concept]
   827   C1880834:FOLD [Phenomenon or Process]
   734   C0450346:2 5 [Quantitative Concept]

Phrase: "higher than that"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   756   C0205250:High [Qualitative Concept]
   756   C1299351:High [Qualitative Concept]
   756   C2700149:HIGH [Intellectual Product]
   706 E C0489786:Height [Organism Attribute]

Phrase: "in uninfected control cells,"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   827   C0007634:Cells [Cell]
   827   C0243148:control [Qualitative Concept]
   827   C1550141:Control [Substance]
   827   C1882979:Control [Conceptual Entity]
   827   C2587213:Control [Functional Concept]
   827   C3274648:Control [Qualitative Concept]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "that"

Phrase: "were"

Phrase: "infected with GFP,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   862   C0120285:green fluorescent protein [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]
   760   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0303920:Fluorescent [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   760   C0332583:Green [Qualitative Concept]
   760   C0439663:Infected [Functional Concept]

Phrase: "or"

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "that"

Phrase: "were"

Phrase: "treated with the chemical uncoupler dinitrophenol"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   790   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   753   C0012466:Dinitrophenol [Organic Chemical]
   753   C0220806:Chemical [Chemical]
   753   C1522326:Treated [Functional Concept]
   753   C3272558:Chemical [Intellectual Product]
   719 E C1292734:TREAT [Functional Concept]

Phrase: "(Fig. 1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.118: As cross-reactivity is a common (although not widely appreciated) problem with the polyclonal UCP3 antibodies that are currently available, we used mouse recombinant UCP3 fusion protein as a positive control. 

Phrase: "As cross-reactivity"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0010357:Cross Reactivity [Molecular Function]
  1000   C0872139:cross reactivity [Molecular Function]
  1000   C1880190:CROSS REACTIVITY [Event]
   861   C2828360:Cross [Conceptual Entity]
   789   C0205332:Reactive [Qualitative Concept]

Phrase: "is"

Phrase: "a common"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205214:Common [Quantitative Concept]
  1000   C1522138:Common [Functional Concept]
  1000   C3245511:common [Intellectual Product]

Phrase: "("

Phrase: "although"

Phrase: "not widely"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1518422:Not [Functional Concept]

Phrase: "appreciated"

Phrase: ")"

Phrase: "problem with the polyclonal UCP3 antibodies"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0033213:Problem [Finding]

Phrase: "that"

Phrase: "are"

Phrase: "currently available,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0470187:Available [Functional Concept]

Phrase: "we"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "mouse recombinant UCP3 fusion protein as a positive control."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   756   C0162768:Fusion protein [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   738   C0332466:Fusion [Functional Concept]
   738   C1293131:Fusion [Therapeutic or Preventive Procedure]
Processing 00000000.tx.119: It migrates at a molecular weight of 39 kDa due to a 5-kDa fusion peptide. 

Phrase: "It"

Phrase: "migrates at a molecular weight of 39 kDa"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   770   C0026385:Molecular Weight [Quantitative Concept]
   744   C0005910:weight [Organism Attribute]
   744   C0043100:Weight [Quantitative Concept]
   744   C0232902:migrate [Functional Concept]
   744   C1305866:weight [Diagnostic Procedure]
   744   C1521991:Molecular [Qualitative Concept]
   744   C1532717:kDa [Quantitative Concept]
   744   C1705104:Weight [Idea or Concept]

Phrase: "due to a 5-kDa fusion peptide."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0030956:Peptide [Amino Acid, Peptide, or Protein]
Processing 00000000.tx.120: As a negative control, protein isolated from purified mitochondria of muscle from UCP3 knockout mice was used. 

Phrase: "As a negative control,"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
  1000   C1639518:% negative control [Quantitative Concept]
  1000   C1947986:Negative Control [Conceptual Entity]
   861   C0205160:Negative [Qualitative Concept]
   861   C0243148:control [Qualitative Concept]
   861   C1513916:Negative [Finding]
   861   C1550141:Control [Substance]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C2825415:Negative [Conceptual Entity]
   861   C2825491:Negative [Qualitative Concept]
   861   C3274648:Control [Qualitative Concept]

Phrase: "protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "isolated from purified mitochondria of muscle"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   783   C0026240:Mitochondria, Muscle [Cell Component]
   753   C0026237:Mitochondria [Cell Component]
   753   C0026845:Muscle [Tissue]
   753   C0205409:Isolated [Functional Concept]
   753   C1548221:Isolated [Idea or Concept]
   753   C1998793:Purified [Functional Concept]
   719 E C0370215:Isolate [Substance]
   719 E C1875400:ISOLATE [Pharmacologic Substance]

Phrase: "from UCP3 knockout mice"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   840   C0206745:Knock-out Mice [Mammal]
   804   C0025914:Mice [Mammal]
   804   C0025929:mice [Mammal]
   804   C0026809:Mice [Mammal]
   717   C0539733:uncoupling protein-3 [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   717   C1421315:UNCOUPLING PROTEIN 3 [Gene or Genome]

Phrase: "was"

Phrase: "used."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]
Processing 00000000.tx.121: The immunoblotted proteins from muscle mitochondria of UCP3 knockout mice consistently showed that the middle band of three bands was absent, indicating that this band was indeed UCP3. 

Phrase: "The immunoblotted proteins from muscle mitochondria of UCP3 knockout mice consistently"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   749   C0026832:Muscle Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   735   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   715   C1334805:Mouse Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that"

Phrase: "the middle band of three bands"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0175723:Band [Medical Device]
   753   C0439645:Band [Spatial Concept]
   753   C1521913:band [Cell Component]

Phrase: "was"

Phrase: "absent,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0332197:Absent [Quantitative Concept]
  1000   C2699517:ABSENT [Finding]
   928 E C0424530:Absences [Finding]
   928 E C1689985:Absence [Anatomical Abnormality]

Phrase: "indicating"

Phrase: "that"

Phrase: "this band"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0175723:Band [Medical Device]
  1000   C0439645:Band [Spatial Concept]
  1000   C1521913:band [Cell Component]

Phrase: "was"

Phrase: "indeed UCP3."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   923   C0539733:uncoupling protein-3 [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   923   C1421315:UNCOUPLING PROTEIN 3 [Gene or Genome]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.122: This band is increased in the cells infected with UCP3. 

Phrase: "This band"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0175723:Band [Medical Device]
  1000   C0439645:Band [Spatial Concept]
  1000   C1521913:band [Cell Component]

Phrase: "is"

Phrase: "increased in the cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   770   C0007634:Cells [Cell]
   770   C0205217:Increased [Quantitative Concept]
   770   C0442805:Increased [Functional Concept]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "infected with UCP3."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   862   C0539733:uncoupling protein-3 [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   862   C1421315:UNCOUPLING PROTEIN 3 [Gene or Genome]
   760   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0439663:Infected [Functional Concept]
Processing 00000000.tx.123: The identities of the two other bands are unknown but both appeared in the immunoblots of cellular and muscle mitochondrial proteins. 

Phrase: "The identities of the two"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0424215:identities [Mental Process]
   726 E C2003939:Identity [Finding]

Phrase: "other bands"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0175723:Bands [Medical Device]
   966 E C0439645:Band [Spatial Concept]
   966 E C1521913:band [Cell Component]

Phrase: "are"

Phrase: "unknown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439673:Unknown [Qualitative Concept]

Phrase: "but"

Phrase: "both"

Phrase: "appeared in the immunoblots of cellular"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0007634:Cellular [Cell]
   753   C0178539:Cellular [Functional Concept]
   719   C0020985:Immunoblot [Laboratory Procedure]
   719   C0700364:APPEAR [Qualitative Concept]

Phrase: "and"

Phrase: "muscle mitochondrial proteins."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   913   C0026832:Muscle Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C0949610:Mitochondrial Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.124: View larger version (42K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(42K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.125: 1. 

Phrase: "1."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]
Processing 00000000.tx.126: Adenoviral-mediated increases in UCP3 protein expression. 

Phrase: "Adenoviral-mediated increases in UCP3 protein expression."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0442805:increases [Functional Concept]
Processing 00000000.tx.127: Representative Western blot for UCP3 expressed in infected and noninfected L6 myotubes. 

Phrase: "Representative Western blot for UCP3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   778   C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
   778   C0949466:Western Blot [Laboratory Procedure]
   748   C1705493:Western [Spatial Concept]

Phrase: "expressed in infected"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0439663:Infected [Functional Concept]

Phrase: "and"

Phrase: "noninfected L6 myotubes."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0242697:myotubes [Cell]
   827   C1704336:Myotubes [Cell]
Processing 00000000.tx.128: Lane 1: Molecular weight markers (MWM). 

Phrase: "Lane 1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: ":"

Phrase: "Molecular weight markers (MWM)."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   913   C0005516:molecular markers [Clinical Attribute]
           Marker
   734   C0026385:Molecular Weight [Quantitative Concept]
Processing 00000000.tx.129: The 34-kDa marker is the prominent band. 

Phrase: "The 34-kDa marker"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0005516:Marker [Clinical Attribute]

Phrase: "is"

Phrase: "the prominent band."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0175723:Band [Medical Device]
   861   C0439645:Band [Spatial Concept]
   861   C1521913:band [Cell Component]
Processing 00000000.tx.130: Lane 2: Recombinant mouse UCP3 (Rec) migrates at a corresponding molecular weight of 39 kDa rather than 34 kDa, due to a 5-kDa fusion peptide. 

Phrase: "Lane 2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: ":"

Phrase: "Recombinant mouse UCP3"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   884   C0539733:uncoupling protein-3 [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   884   C1421315:UNCOUPLING PROTEIN 3 [Gene or Genome]
   875   C0034861:Recombinant protein [Amino Acid, Peptide, or Protein]
   853   C1334805:Mouse Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(Rec)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1424025:REC [Gene or Genome]

Phrase: "migrates at a corresponding molecular weight of 39 kDa"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   764   C0026385:Molecular Weight [Quantitative Concept]
   742   C0005910:weight [Organism Attribute]
   742   C0043100:Weight [Quantitative Concept]
   742   C0232902:migrate [Functional Concept]
   742   C1305866:weight [Diagnostic Procedure]
   742   C1521991:Molecular [Qualitative Concept]
   742   C1532717:kDa [Quantitative Concept]
   742   C1705104:Weight [Idea or Concept]

Phrase: "rather than"

Phrase: "34 kDa,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1532717:kDa [Quantitative Concept]

Phrase: "due to a 5-kDa fusion peptide."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0030956:Peptide [Amino Acid, Peptide, or Protein]
Processing 00000000.tx.131: Lane 3: UCP3-infected L6 myotubes. 

Phrase: "Lane 3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: ":"

Phrase: "UCP3-infected L6 myotubes."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   799   C0242697:myotubes [Cell]
   799   C1704336:Myotubes [Cell]
Processing 00000000.tx.132: Lane 4: Dinitrophenol (DNP)-treated cells. 

Phrase: "Lane 4"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: ":"

Phrase: "Dinitrophenol (DNP)-treated cells."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.133: Lane 5: GFP-infected cells. 

Phrase: "Lane 5"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: ":"

Phrase: "GFP-infected cells."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   804   C0007634:Cells [Cell]
   804   C3282337:Cells [Cell]
   771 E C1269647:Cell [Cell]
   771 E C1704653:Cell [Medical Device]
   771 E C1948049:Cell [Spatial Concept]
   717   C0120285:green fluorescent protein [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]
Processing 00000000.tx.134: Lane 6: Control (CON) (untreated) cells. 

Phrase: "Lane 6"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: ":"

Phrase: "Control (CON)"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "(untreated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332155:untreated [Finding]

Phrase: ")"

Phrase: "cells."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.135: Lane 7: Mitochondria (mito) (75 g protein) isolated from hindlimb skeletal muscle of UCP3/ mice. 

Phrase: "Lane 7"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: ":"

Phrase: "Mitochondria (mito)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0026237:Mitochondria [Cell Component]

Phrase: "(75 g protein"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0086376:G-Protein [Amino Acid, Peptide, or Protein,Enzyme]
   901   C1979839:75 g [Quantitative Concept]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0439267:g% [Quantitative Concept]

Phrase: ")"

Phrase: "isolated from hindlimb skeletal muscle of UCP3/ mice."
Meta Candidates (Total=22; Excluded=2; Pruned=0; Remaining=20)
   782   C0539733:uncoupling protein-3 [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   782   C1421315:UNCOUPLING PROTEIN 3 [Gene or Genome]
   760   C0242692:Muscle, Skeletal [Tissue]
   760   C1280260:Skeletal muscle [Body Part, Organ, or Organ Component]
   757   C0026832:Muscle Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   741   C1334805:Mouse Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   741   C1513763:Mouse Muscle [Tissue]
   739   C0023216:Hindlimb, NOS [Body Location or Region]
   739   C0025914:Mice [Mammal]
   739   C0025929:mice [Mammal]
   739   C0026809:Mice [Mammal]
   739   C0026845:Muscle [Tissue]
   739   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C0037253:skeletal [Body System]
   739   C0205409:Isolated [Functional Concept]
   739   C0521324:Skeletal [Spatial Concept]
   739   C1269079:Hind limb [Body Part, Organ, or Organ Component]
   739   C1456800:Hindlimb [Body Part, Organ, or Organ Component]
   739   C1522391:Hindlimb [Body Part, Organ, or Organ Component]
   739   C1548221:Isolated [Idea or Concept]
   706 E C0370215:Isolate [Substance]
   706 E C1875400:ISOLATE [Pharmacologic Substance]
Processing 00000000.tx.136: For lanes 37, 80-g cellular proteins were loaded per lane. 

Phrase: "For lanes 37,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1708639:Lane [Spatial Concept]

Phrase: "80-g cellular proteins"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   875   C0086376:G-Proteins [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "were"

Phrase: "loaded per lane."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C1708639:Lane [Spatial Concept]
   790   C1708715:Loaded [Activity]
   756 E C1550025:Load [Idea or Concept]
   756 E C1704782:Load [Manufactured Object]
Processing 00000000.tx.137: Densitometric analyses indicated that UCP3-infected cells expressed 2.2- to 2.5-fold higher levels of UCP3 than cells infected with GFP or uninfected control cells. 

Phrase: "Densitometric analyses"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0002778:Analysis [Laboratory Procedure]
   827   C0936012:Analysis [Research Activity]
   827   C1524024:analysis [Functional Concept]

Phrase: "indicated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1444656:Indicated [Finding]

Phrase: "that UCP3-infected cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   804   C0007634:Cells [Cell]
   804   C3282337:Cells [Cell]
   771 E C1269647:Cell [Cell]
   771 E C1704653:Cell [Medical Device]
   771 E C1948049:Cell [Spatial Concept]
   717   C0539733:uncoupling protein-3 [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   717   C1421315:UNCOUPLING PROTEIN 3 [Gene or Genome]

Phrase: "expressed"

Phrase: "2.2-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0740116:+2 [Quantitative Concept]
   861   C2827735:2+ [Quantitative Concept]
   861   C2981700:2+ [Classification]

Phrase: "to 2.5-fold higher levels"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   897   C0456948:2 levels [Intellectual Product]
   804   C0441889:Levels [Qualitative Concept]
   771 E C0456079:Level [Classification]
   771 E C1547707:Level [Geographic Area]
   771 E C2946261:Level [Pharmacologic Substance]

Phrase: "of UCP3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0539733:uncoupling protein-3 [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
  1000   C1421315:UNCOUPLING PROTEIN 3 [Gene or Genome]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "than cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "infected with GFP"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   862   C0120285:green fluorescent protein [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]
   760   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0303920:Fluorescent [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   760   C0332583:Green [Qualitative Concept]
   760   C0439663:Infected [Functional Concept]

Phrase: "or"

Phrase: "uninfected control cells."
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   827   C0007634:Cells [Cell]
   827   C0243148:control [Qualitative Concept]
   827   C1550141:Control [Substance]
   827   C1882979:Control [Conceptual Entity]
   827   C2587213:Control [Functional Concept]
   827   C3274648:Control [Qualitative Concept]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.138: Note that the antibody reacts with two unknown proteins having slightly higher and lower molecular weights than UCP3; 

Phrase: "Note"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1316572:Note [Clinical Attribute]
  1000   C1317574:Note [Intellectual Product]
  1000   C1369612:Note [Clinical Attribute]

Phrase: "that"

Phrase: "the antibody"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
  1000   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "reacts with two unknown proteins"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0205448:Two [Quantitative Concept]
   760   C0439673:Unknown [Qualitative Concept]

Phrase: "having"

Phrase: "slightly higher"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C0205250:High [Qualitative Concept]
   827   C1299351:High [Qualitative Concept]
   827   C2700149:HIGH [Intellectual Product]
   777 E C0489786:Height [Organism Attribute]

Phrase: "and"

Phrase: "lower"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0441994:Lower [Spatial Concept]
  1000   C1548802:Lower [Body Location or Region]
  1000   C2003888:Lower [Activity]

Phrase: "molecular weights than UCP3"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   790   C0026385:Molecular weights [Quantitative Concept]
   753   C0043100:Weights [Quantitative Concept]
   753   C1521991:Molecular [Qualitative Concept]
   719 E C0005910:weight [Organism Attribute]
   719 E C1305866:weight [Diagnostic Procedure]
   719 E C1705104:Weight [Idea or Concept]

Phrase: ";"
Processing 00000000.tx.139: these nonspecific bands are present in mitochondria from UCP3/ mice.  

Phrase: "these nonspecific bands"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0175723:Bands [Medical Device]
   827 E C0439645:Band [Spatial Concept]
   827 E C1521913:band [Cell Component]

Phrase: "are"

Phrase: "present in mitochondria"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0150312:Present [Quantitative Concept]
   790   C0449450:Present [Idea or Concept]

Phrase: "from UCP3/ mice."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   812   C0025914:Mice [Mammal]
   812   C0025929:mice [Mammal]
   812   C0026809:Mice [Mammal]
   756   C0539733:uncoupling protein-3 [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   756   C1421315:UNCOUPLING PROTEIN 3 [Gene or Genome]
Processing 00000000.tx.140: Moderate overexpression of UCP3 increases palmitate oxidation. 

Phrase: "Moderate overexpression of UCP3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   783   C1514559:Protein Overexpression [Genetic Function]
           Overexpression

Phrase: "increases"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "palmitate oxidation."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030011:Oxidation [Molecular Function]
Processing 00000000.tx.141: Myotubes that were left untreated (i.e., uninfected control) and GFP-infected myotubes showed similar rates of palmitate oxidation at normal (5.0 mmol/l) and high (16.0 mmol/l) glucose concentrations (Fig. 2). 

Phrase: "Myotubes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0242697:myotubes [Cell]
  1000   C1704336:Myotubes [Cell]

Phrase: "that"

Phrase: "were"

Phrase: "left"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205091:Left [Spatial Concept]
  1000   C1552822:left [Functional Concept]

Phrase: "untreated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332155:untreated [Finding]

Phrase: "(i.e., uninfected control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   812   C0243148:control [Qualitative Concept]
   812   C1550141:Control [Substance]
   812   C1882979:Control [Conceptual Entity]
   812   C2587213:Control [Functional Concept]
   812   C3274648:Control [Qualitative Concept]

Phrase: ")"

Phrase: "and"

Phrase: "GFP-infected myotubes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0242697:myotubes [Cell]
   804   C1704336:Myotubes [Cell]
   717   C0120285:green fluorescent protein [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "similar rates of palmitate oxidation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   726   C0871208:Rate [Activity]
   726   C1521828:Rate [Quantitative Concept]

Phrase: "at normal"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205307:Normal [Qualitative Concept]
  1000   C0439166:% normal [Quantitative Concept]
  1000   C2347086:% Normal [Quantitative Concept]

Phrase: "(5.0 mmol/"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0439190:MMOLE [Quantitative Concept]

Phrase: "l)"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "and"

Phrase: "high"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205250:High [Qualitative Concept]
  1000   C1299351:High [Qualitative Concept]
  1000   C2700149:HIGH [Intellectual Product]

Phrase: "(16.0 mmol/l) glucose concentrations"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   810   C0427743:Glucose concentration [Laboratory Procedure]
   810   C1287281:Glucose concentration [Laboratory or Test Result]
   799   C0086045:Concentrations [Mental Process]
   766 E C1446561:Concentration [Quantitative Concept]
   716 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "(Fig. 2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.142: Thus, adenoviral treatment itself had no effect on fatty acid oxidation. 

Phrase: "Thus,"

Phrase: "adenoviral treatment"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0039798:treatment [Functional Concept]
   861   C0087111:Treatment [Therapeutic or Preventive Procedure]
   861   C1522326:Treatment [Functional Concept]
   861   C1533734:Treatment [Therapeutic or Preventive Procedure]
   861   C1705169:Treatment [Conceptual Entity]
   861   C3538994:TREATMENT [Research Activity]

Phrase: "itself"

Phrase: "had"

Phrase: "no effect on fatty acid oxidation."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C1301751:No effect [Qualitative Concept]
   753   C1280500:Effect [Qualitative Concept]
   753   C2348382:Effect [Qualitative Concept]
Processing 00000000.tx.143: However, UCP3-infected myotubes oxidized 68% more palmitate in the presence of 5.0 mmol/l (P < 0.001) and 32% more palmitate in the presence of 16.0 mmol/l glucose (P < 0.01) compared with corresponding GFP-infected myotubes. 

Phrase: "However,"

Phrase: "UCP3-infected myotubes"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   804   C0242697:myotubes [Cell]
   804   C1704336:Myotubes [Cell]
   717   C0539733:uncoupling protein-3 [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   717   C1421315:UNCOUPLING PROTEIN 3 [Gene or Genome]

Phrase: "oxidized"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0030011:oxidize [Molecular Function]

Phrase: "68% more palmitate in the presence"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0030233:palmitate [Lipid]
   753   C3503116:palmitate [Biomedical or Dental Material,Lipid]

Phrase: "of 5.0 mmol/l (P < 0.001"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   818   C1532563:mmol/L [Quantitative Concept]
   795   C0439190:MMOLE [Quantitative Concept]

Phrase: ")"

Phrase: "and"

Phrase: "32% more palmitate in the presence"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0030233:palmitate [Lipid]
   753   C3503116:palmitate [Biomedical or Dental Material,Lipid]

Phrase: "of 16.0 mmol/l glucose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "(P < 0.01"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "compared with corresponding GFP-infected myotubes."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   800   C0120285:green fluorescent protein [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]
   744   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0242697:myotubes [Cell]
   744   C0303920:Fluorescent [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   744   C0332583:Green [Qualitative Concept]
   744   C0439663:Infected [Functional Concept]
   744   C1704336:Myotubes [Cell]
   744   C1707455:Compared [Activity]
Processing 00000000.tx.144: View larger version (21K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(21K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.145: 2. 

Phrase: "2."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]
Processing 00000000.tx.146: Palmitate oxidation is increased by moderate overexpression of UCP3 but is unaffected by mild chemical uncoupling. 

Phrase: "Palmitate oxidation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030011:Oxidation [Molecular Function]

Phrase: "is"

Phrase: "increased by moderate overexpression of UCP3"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   800   C0539733:uncoupling protein-3 [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   800   C1421315:UNCOUPLING PROTEIN 3 [Gene or Genome]
   767   C1514559:Protein Overexpression [Genetic Function]
           Overexpression
   744   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0205081:Moderate [Qualitative Concept]
   744   C0205217:Increased [Quantitative Concept]
   744   C0442805:Increased [Functional Concept]
   744   C1881878:Moderate [Qualitative Concept]

Phrase: "but"

Phrase: "is"

Phrase: "unaffected by mild chemical"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C2986417:Unaffected [Conceptual Entity]

Phrase: "uncoupling."
Processing 00000000.tx.147: Palmitate oxidation was measured in L6 myotubes incubated at normal (5 mmol/l; ) and high (16 mmol/l; ) concentrations of glucose in the presence of 0.2 mmol/l palmitate. 

Phrase: "Palmitate oxidation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030011:Oxidation [Molecular Function]

Phrase: "was"

Phrase: "measured in L6 myotubes"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   770   C0242697:myotubes [Cell]
   770   C0444706:Measured [Qualitative Concept]
   770   C1704336:Myotubes [Cell]
   770   C3541902:MEASURED [Diagnostic Procedure]
   737 E C0079809:Measure [Quantitative Concept]
   737 E C0242485:Measure [Functional Concept]

Phrase: "incubated at normal"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0205307:Normal [Qualitative Concept]
   790   C0439166:% normal [Quantitative Concept]
   790   C1439852:Incubated [Laboratory Procedure]
   790   C2347086:% Normal [Quantitative Concept]

Phrase: "(5 mmol/l"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   913   C2348935:.5 L [Quantitative Concept]
   901   C1532563:mmol/L [Quantitative Concept]

Phrase: ";"

Phrase: ")"

Phrase: "and"

Phrase: "high"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205250:High [Qualitative Concept]
  1000   C1299351:High [Qualitative Concept]
  1000   C2700149:HIGH [Intellectual Product]

Phrase: "(16 mmol/l"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   901   C1532563:mmol/L [Quantitative Concept]

Phrase: ";"

Phrase: ")"

Phrase: "concentrations of glucose"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   858   C0427743:concentrations glucose [Laboratory Procedure]
   858   C1287281:concentrations glucose [Laboratory or Test Result]
   790   C0086045:Concentrations [Mental Process]
   756 E C1446561:Concentration [Quantitative Concept]
   706 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "in the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "of 0.2 mmol/l palmitate."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0030233:palmitate [Lipid]
   804   C3503116:palmitate [Biomedical or Dental Material,Lipid]
Processing 00000000.tx.148: From left to right, results are shown for control (CON) (untreated) cells, GFP-infected cells, dinitrophenol (DNP)-treated cells, UCP3-infected cells, and control cells that were treated acutely with insulin (100 nmol/l). 

Phrase: "From left"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205091:Left [Spatial Concept]
  1000   C1552822:left [Functional Concept]

Phrase: "to right,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205090:Right [Spatial Concept]

Phrase: "results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "are"

Phrase: "shown for control"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0243148:control [Qualitative Concept]
   790   C1550141:Control [Substance]
   790   C1882979:Control [Conceptual Entity]
   790   C2587213:Control [Functional Concept]
   790   C3274648:Control [Qualitative Concept]
   756   C1547282:Show [Intellectual Product]

Phrase: "(CON"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: ")"

Phrase: "(untreated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332155:untreated [Finding]

Phrase: ")"

Phrase: "cells,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "GFP-infected cells,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   804   C0007634:Cells [Cell]
   804   C3282337:Cells [Cell]
   771 E C1269647:Cell [Cell]
   771 E C1704653:Cell [Medical Device]
   771 E C1948049:Cell [Spatial Concept]
   717   C0120285:green fluorescent protein [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]

Phrase: "dinitrophenol"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0012466:Dinitrophenol [Organic Chemical]

Phrase: "(DNP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0012466:Dinitrophenol [Organic Chemical]

Phrase: ")-"

Phrase: "treated cells,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "UCP3-infected cells,"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   804   C0007634:Cells [Cell]
   804   C3282337:Cells [Cell]
   771 E C1269647:Cell [Cell]
   771 E C1704653:Cell [Medical Device]
   771 E C1948049:Cell [Spatial Concept]
   717   C0539733:uncoupling protein-3 [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   717   C1421315:UNCOUPLING PROTEIN 3 [Gene or Genome]

Phrase: "and"

Phrase: "control cells"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   861   C0007634:Cells [Cell]
   861   C0243148:control [Qualitative Concept]
   861   C1550141:Control [Substance]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "that"

Phrase: "were"

Phrase: "treated"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332293:treated [Therapeutic or Preventive Procedure]
  1000   C1522326:Treated [Functional Concept]
   966 E C1292734:TREAT [Functional Concept]

Phrase: "acutely with insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   790   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   790   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   790   C1579433:Insulin [Pharmacologic Substance]
   734 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   706 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "(100 nmol/"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439191:NMOLE [Quantitative Concept]

Phrase: "l)."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.149: n = 816 for each treatment condition. 

Phrase: "n = 816 for each treatment condition."
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   753   C0012634:condition [Disease or Syndrome]
   753   C0039798:treatment [Functional Concept]
   753   C0087111:Treatment [Therapeutic or Preventive Procedure]
   753   C0348080:Condition [Qualitative Concept]
   753   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   753   C0441922:N+ [Intellectual Product]
   753   C1522326:Treatment [Functional Concept]
   753   C1533734:Treatment [Therapeutic or Preventive Procedure]
   753   C1553036:[n] [Quantitative Concept]
   753   C1705169:Treatment [Conceptual Entity]
   753   C1705253:Condition [Conceptual Entity]
   753   C3538994:TREATMENT [Research Activity]
Processing 00000000.tx.150: **P < 0.01; 

Phrase: "*"

Phrase: "*P < 0.01"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ";"
Processing 00000000.tx.151: ***P < 0.001.  

Phrase: "*"

Phrase: "*"

Phrase: "*P < 0.001."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.152: To test for any effect of chemical uncoupling of mitochondrial oxidative phosphorylation on fatty acid oxidation, cells were treated chronically with low concentrations of dinitrophenol (50 mol/l for 72 h). 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "test for any effect of chemical"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   783   C0201682:Chemical test, NOS [Laboratory Procedure]
   753   C0022885:Test [Laboratory Procedure]
   753   C0039593:Test [Functional Concept]
   753   C0220806:Chemical [Chemical]
   753   C0392366:test [Intellectual Product]
   753   C1280500:Effect [Qualitative Concept]
   753   C2348382:Effect [Qualitative Concept]
   753   C3272558:Chemical [Intellectual Product]

Phrase: "uncoupling of mitochondrial oxidative phosphorylation"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C0030013:Oxidative Phosphorylation [Molecular Function]
   760   C0026237:Mitochondrial [Cell Component]
   760   C0031715:Phosphorylation [Molecular Function]
   760   C0311404:Oxidative [Functional Concept]
   760   C0521451:Mitochondrial [Functional Concept]
   760   C1158886:Phosphorylation [Molecular Function]

Phrase: "on fatty acid oxidation,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1158366:fatty acid oxidation [Molecular Function]
   901   C0015684:Fatty acid [Lipid]
   827   C0001128:Acid [Chemical]
   827   C0030011:Oxidation [Molecular Function]
   827   C0202406:Acid [Laboratory Procedure]

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "treated"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332293:treated [Therapeutic or Preventive Procedure]
  1000   C1522326:Treated [Functional Concept]
   966 E C1292734:TREAT [Functional Concept]

Phrase: "chronically with low concentrations of dinitrophenol"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   753   C0012466:Dinitrophenol [Organic Chemical]
   753   C0086045:Concentrations [Mental Process]
   753   C0205251:low [Qualitative Concept]
   753   C1299352:Low [Qualitative Concept]
   753   C1550472:low [Idea or Concept]
   719 E C1446561:Concentration [Quantitative Concept]

Phrase: "(50 mol/l for 72 h"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   820   C2827807:h*mol/L [Quantitative Concept]
   820   C2827890:mol/L/h [Quantitative Concept]
   790   C0347982:mol/L [Quantitative Concept]
   783   C2346686:h l [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.153: Results showed that dinitrophenol had no effect on palmitate oxidation at either normal or high concentrations of glucose (P > 0.05). 

Phrase: "Results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that dinitrophenol"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0012466:Dinitrophenol [Organic Chemical]

Phrase: "had"

Phrase: "no effect on palmitate oxidation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C1301751:No effect [Qualitative Concept]
   760   C1280500:Effect [Qualitative Concept]
   760   C2348382:Effect [Qualitative Concept]

Phrase: "at either normal"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205307:Normal [Qualitative Concept]
   861   C0439166:% normal [Quantitative Concept]
   861   C2347086:% Normal [Quantitative Concept]

Phrase: "or"

Phrase: "high concentrations of glucose"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   819   C0427743:concentrations glucose [Laboratory Procedure]
   819   C1287281:concentrations glucose [Laboratory or Test Result]
   770   C0086045:Concentrations [Mental Process]
   737 E C1446561:Concentration [Quantitative Concept]

Phrase: "(P > 0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.154: The effect of high glucose concentrations on the oxidation of this fatty acid was also assessed. 

Phrase: "The effect of high glucose concentrations"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   783   C1158774:glucose effect [Genetic Function]
   753   C1280500:Effect [Qualitative Concept]
   753   C2348382:Effect [Qualitative Concept]

Phrase: "on the oxidation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030011:Oxidation [Molecular Function]

Phrase: "of this fatty acid"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0015684:Fatty acid [Lipid]
   861   C0001128:Acid [Chemical]
   861   C0202406:Acid [Laboratory Procedure]

Phrase: "was"

Phrase: "also"

Phrase: "assessed."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1516048:Assessed [Activity]
Processing 00000000.tx.155: Incubation in the presence of high concentrations of glucose (16 mmol/l) led to statistically significant decreases in palmitate oxidation in control cells, dinitrophenol-treated cells, and UCP3-infected cells compared with oxidation rates under normoglycemic (5 mmol/l) conditions (P < 0.05). 

Phrase: "Incubation in the presence of high concentrations of glucose"

Phrase: "(16 mmol/"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439190:MMOLE [Quantitative Concept]

Phrase: "l)"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "led"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C1708698:LED [Manufactured Object]
   966 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   966 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   966 E C1522538:Lead [Functional Concept]
   966 E C2348269:Lead [Element, Ion, or Isotope]
   966 E C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "to statistically significant decreases in palmitate oxidation"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   748   C0547047:decreases [Quantitative Concept]
   714 E C0392756:Decrease [Qualitative Concept]

Phrase: "in control cells,"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   861   C0007634:Cells [Cell]
   861   C0243148:control [Qualitative Concept]
   861   C1550141:Control [Substance]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "dinitrophenol-treated cells,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "UCP3-infected cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   804   C0007634:Cells [Cell]
   804   C3282337:Cells [Cell]
   771 E C1269647:Cell [Cell]
   771 E C1704653:Cell [Medical Device]
   771 E C1948049:Cell [Spatial Concept]
   717   C0539733:uncoupling protein-3 [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   717   C1421315:UNCOUPLING PROTEIN 3 [Gene or Genome]

Phrase: "compared with oxidation rates"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0030011:Oxidation [Molecular Function]
   770   C1707455:Compared [Activity]
   737   C0871208:Rate [Activity]
   737   C1521828:Rate [Quantitative Concept]

Phrase: "under normoglycemic"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0580545:Normoglycaemic [Finding]

Phrase: "(5 mmol/l) conditions"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   779   C0012634:condition [Disease or Syndrome]
   779   C0348080:Condition [Qualitative Concept]
   779   C1705253:Condition [Conceptual Entity]
   729 E C0009647:Conditioned [Mental Process]
   729 E C1701901:Conditional [Qualitative Concept]
   729 E C1963686:Conditional [Functional Concept]
   708   C2348935:.5 L [Quantitative Concept]
   706 E C1519605:Conditionality [Conceptual Entity]

Phrase: "(P < 0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.156: Glucose oxidation is unaltered by moderate overexpression of UCP3 but is increased by dinitrophenol-mediated uncoupling. 

Phrase: "Glucose oxidation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030011:Oxidation [Molecular Function]

Phrase: "is"

Phrase: "unaltered by moderate overexpression of UCP3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1709843:Unaltered [Qualitative Concept]

Phrase: "but"

Phrase: "is"

Phrase: "increased by dinitrophenol-"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0012466:Dinitrophenol [Organic Chemical]
   790   C0205217:Increased [Quantitative Concept]
   790   C0442805:Increased [Functional Concept]
   718 E C1517378:Gain [Quantitative Concept]

Phrase: "mediated"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0086597:mediated [Social Behavior]
  1000   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]

Phrase: "uncoupling."
Processing 00000000.tx.157: Uninfected control myotubes, GFP-infected myotubes, and UCP3-infected myotubes demonstrated similar rates of glucose oxidation in the presence of 0.05 and 0.2 mmol/l palmitate (Fig. 3). 

Phrase: "Uninfected control myotubes,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0242697:myotubes [Cell]
   827   C1704336:Myotubes [Cell]

Phrase: "GFP-infected myotubes,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0242697:myotubes [Cell]
   804   C1704336:Myotubes [Cell]
   717   C0120285:green fluorescent protein [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]

Phrase: "and"

Phrase: "UCP3-infected myotubes"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   804   C0242697:myotubes [Cell]
   804   C1704336:Myotubes [Cell]
   717   C0539733:uncoupling protein-3 [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   717   C1421315:UNCOUPLING PROTEIN 3 [Gene or Genome]

Phrase: "demonstrated"

Phrase: "similar rates of glucose oxidation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   726   C0871208:Rate [Activity]
   726   C1521828:Rate [Quantitative Concept]

Phrase: "in the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "of 0.05"

Phrase: "and"

Phrase: "0.2 mmol/l palmitate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0030233:palmitate [Lipid]
   804   C3503116:palmitate [Biomedical or Dental Material,Lipid]

Phrase: "(Fig. 3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.158: However, treatment with the chemical uncoupler dinitrophenol (50 mol/l) dramatically increased glucose oxidation in the presence of either 0.05 or 0.2 mmol/l palmitate compared with control myotubes and GFP-infected myotubes (all P < 0.01). 

Phrase: "However,"

Phrase: "treatment with the chemical uncoupler dinitrophenol"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0039798:treatment [Functional Concept]
   753   C0087111:Treatment [Therapeutic or Preventive Procedure]
   753   C1522326:Treatment [Functional Concept]
   753   C1533734:Treatment [Therapeutic or Preventive Procedure]
   753   C1705169:Treatment [Conceptual Entity]
   753   C3538994:TREATMENT [Research Activity]

Phrase: "(50 mol/l) dramatically increased glucose oxidation in the presence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C0030011:Oxidation [Molecular Function]

Phrase: "of either 0.05"

Phrase: "or"

Phrase: "0.2 mmol/l palmitate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0030233:palmitate [Lipid]
   804   C3503116:palmitate [Biomedical or Dental Material,Lipid]

Phrase: "compared with control myotubes"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   770   C0242697:myotubes [Cell]
   770   C0243148:control [Qualitative Concept]
   770   C1550141:Control [Substance]
   770   C1704336:Myotubes [Cell]
   770   C1707455:Compared [Activity]
   770   C1882979:Control [Conceptual Entity]
   770   C2587213:Control [Functional Concept]
   770   C3274648:Control [Qualitative Concept]

Phrase: "and"

Phrase: "GFP-infected myotubes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0242697:myotubes [Cell]
   804   C1704336:Myotubes [Cell]
   717   C0120285:green fluorescent protein [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]

Phrase: "("

Phrase: "all P < 0.01"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.159: As expected, insulin (100 nmol/l) increased glucose oxidation in the presence of 0.05 or 0.2 mmol/l palmitate compared with either control myotubes or GFP-infected myotubes (all P < 0.01). 

Phrase: "As"

Phrase: "expected"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1517001:Expected [Idea or Concept]

Phrase: ","

Phrase: "insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "(100 nmol/l) increased glucose oxidation in the presence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0030011:Oxidation [Molecular Function]

Phrase: "of 0.05"

Phrase: "or"

Phrase: "0.2 mmol/l palmitate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0030233:palmitate [Lipid]
   804   C3503116:palmitate [Biomedical or Dental Material,Lipid]

Phrase: "compared with either control myotubes"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   760   C0242697:myotubes [Cell]
   760   C0243148:control [Qualitative Concept]
   760   C1550141:Control [Substance]
   760   C1704336:Myotubes [Cell]
   760   C1707455:Compared [Activity]
   760   C1882979:Control [Conceptual Entity]
   760   C2587213:Control [Functional Concept]
   760   C3274648:Control [Qualitative Concept]

Phrase: "or"

Phrase: "GFP-infected myotubes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0242697:myotubes [Cell]
   804   C1704336:Myotubes [Cell]
   717   C0120285:green fluorescent protein [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]

Phrase: "("

Phrase: "all P < 0.01"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.160: View larger version (20K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(20K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.161: 3. 

Phrase: "3."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]
Processing 00000000.tx.162: Glucose oxidation is unaltered by moderate overexpression of UCP3 but is increased by mild chemical uncoupling. 

Phrase: "Glucose oxidation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030011:Oxidation [Molecular Function]

Phrase: "is"

Phrase: "unaltered by moderate overexpression of UCP3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1709843:Unaltered [Qualitative Concept]

Phrase: "but"

Phrase: "is"

Phrase: "increased by mild chemical"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0205217:Increased [Quantitative Concept]
   770   C0220806:Chemical [Chemical]
   770   C0442805:Increased [Functional Concept]
   770   C2945599:Mild [Qualitative Concept]
   770   C3272558:Chemical [Intellectual Product]

Phrase: "uncoupling."
Processing 00000000.tx.163: Glucose oxidation was measured in L6 myotubes incubated at low (0.05 mmol/l; ) and high (0.20 mmol/l; ) concentrations of palmitate in the presence of 16 mmol/l glucose. 

Phrase: "Glucose oxidation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030011:Oxidation [Molecular Function]

Phrase: "was"

Phrase: "measured in L6 myotubes"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   770   C0242697:myotubes [Cell]
   770   C0444706:Measured [Qualitative Concept]
   770   C1704336:Myotubes [Cell]
   770   C3541902:MEASURED [Diagnostic Procedure]
   737 E C0079809:Measure [Quantitative Concept]
   737 E C0242485:Measure [Functional Concept]

Phrase: "incubated at low"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0205251:low [Qualitative Concept]
   790   C1299352:Low [Qualitative Concept]
   790   C1439852:Incubated [Laboratory Procedure]
   790   C1550472:low [Idea or Concept]

Phrase: "(0.05 mmol/l"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1532563:mmol/L [Quantitative Concept]

Phrase: ";"

Phrase: ")"

Phrase: "and"

Phrase: "high"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205250:High [Qualitative Concept]
  1000   C1299351:High [Qualitative Concept]
  1000   C2700149:HIGH [Intellectual Product]

Phrase: "(0.20 mmol/l"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1532563:mmol/L [Quantitative Concept]

Phrase: ";"

Phrase: ")"

Phrase: "concentrations of palmitate"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   790   C0086045:Concentrations [Mental Process]
   756 E C1446561:Concentration [Quantitative Concept]
   706 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "in the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "of 16 mmol/l glucose."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
Processing 00000000.tx.164: From left to right, results are shown for control (CON) (untreated) cells, GFP-infected cells, dinitrophenol (DNP)-treated cells, UCP3-infected cells, and control cells that were treated acutely with insulin (100 nmol/l). 

Phrase: "From left"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205091:Left [Spatial Concept]
  1000   C1552822:left [Functional Concept]

Phrase: "to right,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205090:Right [Spatial Concept]

Phrase: "results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "are"

Phrase: "shown for control"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0243148:control [Qualitative Concept]
   790   C1550141:Control [Substance]
   790   C1882979:Control [Conceptual Entity]
   790   C2587213:Control [Functional Concept]
   790   C3274648:Control [Qualitative Concept]
   756   C1547282:Show [Intellectual Product]

Phrase: "(CON"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: ")"

Phrase: "(untreated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332155:untreated [Finding]

Phrase: ")"

Phrase: "cells,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "GFP-infected cells,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   804   C0007634:Cells [Cell]
   804   C3282337:Cells [Cell]
   771 E C1269647:Cell [Cell]
   771 E C1704653:Cell [Medical Device]
   771 E C1948049:Cell [Spatial Concept]
   717   C0120285:green fluorescent protein [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]

Phrase: "dinitrophenol"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0012466:Dinitrophenol [Organic Chemical]

Phrase: "(DNP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0012466:Dinitrophenol [Organic Chemical]

Phrase: ")-"

Phrase: "treated cells,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "UCP3-infected cells,"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   804   C0007634:Cells [Cell]
   804   C3282337:Cells [Cell]
   771 E C1269647:Cell [Cell]
   771 E C1704653:Cell [Medical Device]
   771 E C1948049:Cell [Spatial Concept]
   717   C0539733:uncoupling protein-3 [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   717   C1421315:UNCOUPLING PROTEIN 3 [Gene or Genome]

Phrase: "and"

Phrase: "control cells"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   861   C0007634:Cells [Cell]
   861   C0243148:control [Qualitative Concept]
   861   C1550141:Control [Substance]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "that"

Phrase: "were"

Phrase: "treated"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332293:treated [Therapeutic or Preventive Procedure]
  1000   C1522326:Treated [Functional Concept]
   966 E C1292734:TREAT [Functional Concept]

Phrase: "acutely with insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   790   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   790   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   790   C1579433:Insulin [Pharmacologic Substance]
   734 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   706 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "(100 nmol/"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439191:NMOLE [Quantitative Concept]

Phrase: "l)."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.165: n = 515 for each treatment condition. 

Phrase: "n = 515 for each treatment condition."
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   753   C0012634:condition [Disease or Syndrome]
   753   C0039798:treatment [Functional Concept]
   753   C0087111:Treatment [Therapeutic or Preventive Procedure]
   753   C0348080:Condition [Qualitative Concept]
   753   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   753   C0441922:N+ [Intellectual Product]
   753   C1522326:Treatment [Functional Concept]
   753   C1533734:Treatment [Therapeutic or Preventive Procedure]
   753   C1553036:[n] [Quantitative Concept]
   753   C1705169:Treatment [Conceptual Entity]
   753   C1705253:Condition [Conceptual Entity]
   753   C3538994:TREATMENT [Research Activity]
Processing 00000000.tx.166: **P < 0.01; 

Phrase: "*"

Phrase: "*P < 0.01"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ";"
Processing 00000000.tx.167: ***P < 0.001.  

Phrase: "*"

Phrase: "*"

Phrase: "*P < 0.001."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.168: Moderate overexpression of UCP3 does not significantly increase basal cellular oxygen consumption. 

Phrase: "Moderate overexpression of UCP3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   783   C1514559:Protein Overexpression [Genetic Function]
           Overexpression

Phrase: "does"

Phrase: "not significantly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1518422:Not [Functional Concept]

Phrase: "increase"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "basal cellular oxygen consumption."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0030055:Oxygen Consumption [Clinical Attribute]
   861   C1305742:oxygen consumption [Diagnostic Procedure]
   812   C0009830:Consumption [Activity]
   812   C0030054:Oxygen [Element, Ion, or Isotope,Pharmacologic Substance]
   812   C1947907:Consumption [Physiologic Function]
Processing 00000000.tx.169: Basal cellular oxygen consumption of cells was assessed in situ using self-referencing microelectrodes (see above). 

Phrase: "Basal cellular oxygen consumption of cells"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0030055:Oxygen Consumption [Clinical Attribute]
   790   C1305742:oxygen consumption [Diagnostic Procedure]
   753   C0009830:Consumption [Activity]
   753   C0030054:Oxygen [Element, Ion, or Isotope,Pharmacologic Substance]
   753   C1947907:Consumption [Physiologic Function]

Phrase: "was"

Phrase: "assessed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1516048:Assessed [Activity]

Phrase: "in situ"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0444498:In situ [Spatial Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "self-referencing microelectrodes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0025973:Microelectrodes [Medical Device]

Phrase: "("

Phrase: "see"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042789:see [Organism Function]
  1000   C1947903:See [Activity]

Phrase: "above"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1282910:Above [Spatial Concept]
  1000   C1552828:above [Idea or Concept]

Phrase: ")."
Processing 00000000.tx.170: The oxygen consumption of myotubes infected with GFP or UCP3 was similar to that of uninfected control myotubes (Fig. 4). 

Phrase: "The oxygen consumption of myotubes"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C0030055:Oxygen Consumption [Clinical Attribute]
   806   C1305742:oxygen consumption [Diagnostic Procedure]
   760   C0009830:Consumption [Activity]
   760   C0030054:Oxygen [Element, Ion, or Isotope,Pharmacologic Substance]
   760   C1947907:Consumption [Physiologic Function]

Phrase: "infected with GFP"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   862   C0120285:green fluorescent protein [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]
   760   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0303920:Fluorescent [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   760   C0332583:Green [Qualitative Concept]
   760   C0439663:Infected [Functional Concept]

Phrase: "or"

Phrase: "UCP3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0539733:uncoupling protein-3 [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
  1000   C1421315:UNCOUPLING PROTEIN 3 [Gene or Genome]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "was"

Phrase: "similar to that of uninfected control myotubes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C2348205:Similar [Qualitative Concept]

Phrase: "(Fig. 4"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.171: However, oxygen uptake of myotubes treated chronically with low concentrations of dinitrophenol was significantly elevated compared with uninfected controls (80% increase; P < 0.001) and GFP-infected cells (64% increase; P < 0.01). 

Phrase: "However,"

Phrase: "oxygen uptake of myotubes"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0429627:Oxygen uptake [Finding]
   770   C0030054:Oxygen [Element, Ion, or Isotope,Pharmacologic Substance]
   770   C0243144:Uptake [Physiologic Function]
   770   C0347980:% uptake [Quantitative Concept]

Phrase: "treated"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332293:treated [Therapeutic or Preventive Procedure]
  1000   C1522326:Treated [Functional Concept]
   966 E C1292734:TREAT [Functional Concept]

Phrase: "chronically with low concentrations of dinitrophenol"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   753   C0012466:Dinitrophenol [Organic Chemical]
   753   C0086045:Concentrations [Mental Process]
   753   C0205251:low [Qualitative Concept]
   753   C1299352:Low [Qualitative Concept]
   753   C1550472:low [Idea or Concept]
   719 E C1446561:Concentration [Quantitative Concept]

Phrase: "was"

Phrase: "significantly"

Phrase: "elevated"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205250:Elevated [Qualitative Concept]
  1000   C3163633:Elevated [Qualitative Concept]

Phrase: "compared with uninfected controls"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C1707455:Compared [Activity]
   737   C0243148:control [Qualitative Concept]
   737   C1550141:Control [Substance]
   737   C1882979:Control [Conceptual Entity]
   737   C2587213:Control [Functional Concept]
   737   C3274648:Control [Qualitative Concept]

Phrase: "(80% increase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0442805:Increase [Functional Concept]

Phrase: "; P < 0.001"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "and"

Phrase: "GFP-infected cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   804   C0007634:Cells [Cell]
   804   C3282337:Cells [Cell]
   771 E C1269647:Cell [Cell]
   771 E C1704653:Cell [Medical Device]
   771 E C1948049:Cell [Spatial Concept]
   717   C0120285:green fluorescent protein [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]

Phrase: "(64% increase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0442805:Increase [Functional Concept]

Phrase: "; P < 0.01"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.172: View larger version (19K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(19K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.173: 4. 

Phrase: "4."
Processing 00000000.tx.174: L6 cellular oxygen consumption is not significantly increased by moderate overexpression of UCP3 but is increased by mild chemical uncoupling. 

Phrase: "L6 cellular oxygen consumption"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0030055:Oxygen Consumption [Clinical Attribute]
   861   C1305742:oxygen consumption [Diagnostic Procedure]
   812   C0009830:Consumption [Activity]
   812   C0030054:Oxygen [Element, Ion, or Isotope,Pharmacologic Substance]
   812   C1947907:Consumption [Physiologic Function]

Phrase: "is"

Phrase: "not significantly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1518422:Not [Functional Concept]

Phrase: "increased by moderate overexpression of UCP3"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   800   C0539733:uncoupling protein-3 [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   800   C1421315:UNCOUPLING PROTEIN 3 [Gene or Genome]
   767   C1514559:Protein Overexpression [Genetic Function]
           Overexpression
   744   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0205081:Moderate [Qualitative Concept]
   744   C0205217:Increased [Quantitative Concept]
   744   C0442805:Increased [Functional Concept]
   744   C1881878:Moderate [Qualitative Concept]

Phrase: "but"

Phrase: "is"

Phrase: "increased by mild chemical"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0205217:Increased [Quantitative Concept]
   770   C0220806:Chemical [Chemical]
   770   C0442805:Increased [Functional Concept]
   770   C2945599:Mild [Qualitative Concept]
   770   C3272558:Chemical [Intellectual Product]

Phrase: "uncoupling."
Processing 00000000.tx.175: In situ oxygen consumption of L6 cells was measured using oxygen-sensitive microelectrodes as described in the text. 

Phrase: "In situ oxygen consumption of L6 cells"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   778   C0030055:Oxygen Consumption [Clinical Attribute]
   778   C1305742:oxygen consumption [Diagnostic Procedure]
   748   C0009830:Consumption [Activity]
   748   C0030054:Oxygen [Element, Ion, or Isotope,Pharmacologic Substance]
   748   C1947907:Consumption [Physiologic Function]

Phrase: "was"

Phrase: "measured"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0444706:Measured [Qualitative Concept]
  1000   C3541902:MEASURED [Diagnostic Procedure]
   966 E C0079809:Measure [Quantitative Concept]
   966 E C0242485:Measure [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "oxygen-sensitive microelectrodes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   896   C0597155:oxygen microelectrode [Medical Device]
   827   C0025973:Microelectrodes [Medical Device]

Phrase: "as"

Phrase: "described in the text."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C1527021:Text [Intellectual Product]
   770   C1552738:described [Idea or Concept]
   770   C1554111:Text [Idea or Concept]
   770   C1705606:Text [Intellectual Product]
   770   C3541382:Text [Intellectual Product]
Processing 00000000.tx.176: From left to right, results are shown for control (CON) (untreated) cells, GFP-infected cells, dinitrophenol (DNP)-treated cells, and UCP3-infected cells. n = 810 for each treatment condition. 

Phrase: "From left"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205091:Left [Spatial Concept]
  1000   C1552822:left [Functional Concept]

Phrase: "to right,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205090:Right [Spatial Concept]

Phrase: "results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "are"

Phrase: "shown for control"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0243148:control [Qualitative Concept]
   790   C1550141:Control [Substance]
   790   C1882979:Control [Conceptual Entity]
   790   C2587213:Control [Functional Concept]
   790   C3274648:Control [Qualitative Concept]
   756   C1547282:Show [Intellectual Product]

Phrase: "(CON"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: ")"

Phrase: "(untreated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332155:untreated [Finding]

Phrase: ")"

Phrase: "cells,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "GFP-infected cells,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   804   C0007634:Cells [Cell]
   804   C3282337:Cells [Cell]
   771 E C1269647:Cell [Cell]
   771 E C1704653:Cell [Medical Device]
   771 E C1948049:Cell [Spatial Concept]
   717   C0120285:green fluorescent protein [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]

Phrase: "dinitrophenol"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0012466:Dinitrophenol [Organic Chemical]

Phrase: "(DNP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0012466:Dinitrophenol [Organic Chemical]

Phrase: ")-"

Phrase: "treated cells,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "UCP3-infected cells. n = 810"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   845   C0539733:uncoupling protein-3 [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   845   C1421315:UNCOUPLING PROTEIN 3 [Gene or Genome]
   795   C0007634:Cells [Cell]
   795   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   795   C0439663:Infected [Functional Concept]
   795   C3282337:Cells [Cell]
   762 E C1269647:Cell [Cell]
   762 E C1704653:Cell [Medical Device]
   762 E C1948049:Cell [Spatial Concept]

Phrase: "for each treatment condition."
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   861   C0012634:condition [Disease or Syndrome]
   861   C0348080:Condition [Qualitative Concept]
   861   C1705253:Condition [Conceptual Entity]
   789 E C0009647:Conditioned [Mental Process]
   789 E C1701901:Conditional [Qualitative Concept]
   789 E C1963686:Conditional [Functional Concept]
   761 E C1519605:Conditionality [Conceptual Entity]
Processing 00000000.tx.177: **P < 0.01; 

Phrase: "*"

Phrase: "*P < 0.01"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ";"
Processing 00000000.tx.178: ***P < 0.001.  

Phrase: "*"

Phrase: "*"

Phrase: "*P < 0.001."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.179: Mitochondrial membrane potential is unaffected by moderate overexpression of UCP3. 

Phrase: "Mitochondrial membrane potential"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
  1000   C1720920:Membrane Potential, Mitochondrial [Cell Function]
   901   C0025251:Membrane Potential [Cell Function]
   901   C0596952:Mitochondrial membrane [Cell Component]
   827   C0025255:Membrane [Tissue]
   827   C0026237:Mitochondrial [Cell Component]
   827   C0521451:Mitochondrial [Functional Concept]
   827   C0596901:Membrane [Cell Component]
   827   C1706182:Membrane [Manufactured Object]
   827   C3245505:Potential [Qualitative Concept]
   755 E C0205287:Membranous [Qualitative Concept]

Phrase: "is"

Phrase: "unaffected by moderate overexpression of UCP3."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C2986417:Unaffected [Conceptual Entity]
Processing 00000000.tx.180: To determine whether infection with UCP3 was associated with any inherent decreases in mitochondrial membrane potential, the latter was assessed using TMRE fluorescence. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "determine"

Phrase: "whether"

Phrase: "infection with UCP3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0009450:Infection, NOS [Disease or Syndrome]

Phrase: "was"

Phrase: "associated with any inherent decreases"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   806   C0332281:Associated with [Qualitative Concept]
           Associated
   760   C0547047:decreases [Quantitative Concept]
   726 E C0392756:Decrease [Qualitative Concept]
   726 E C0750490:Associate [Idea or Concept]
   726 E C1706221:Associate [Professional or Occupational Group]

Phrase: "in mitochondrial membrane potential,"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
  1000   C1720920:Membrane Potential, Mitochondrial [Cell Function]
   901   C0025251:Membrane Potential [Cell Function]
   901   C0596952:Mitochondrial membrane [Cell Component]
   827   C0025255:Membrane [Tissue]
   827   C0026237:Mitochondrial [Cell Component]
   827   C0521451:Mitochondrial [Functional Concept]
   827   C0596901:Membrane [Cell Component]
   827   C1706182:Membrane [Manufactured Object]
   827   C3245505:Potential [Qualitative Concept]
   755 E C0205287:Membranous [Qualitative Concept]

Phrase: "the latter"

Phrase: "was"

Phrase: "assessed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1516048:Assessed [Activity]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "TMRE fluorescence."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   812   C0016315:Fluorescence [Natural Phenomenon or Process]
   756   C0672030:tetramethyl rhodamine ethyl ester [Organic Chemical,Pharmacologic Substance]
   741 E C0303920:Fluorescent [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
Processing 00000000.tx.181: During these measurements, the incubation medium was the one in which cells were maintained (differentiation medium; see above). 

Phrase: "During these measurements,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0242485:measurements [Functional Concept]

Phrase: "the incubation medium"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0009458:Medium [Intellectual Product]
   861   C0439536:Medium [Quantitative Concept]
   861   C1705217:Medium [Substance]
   861   C3244283:medium [Intellectual Product]

Phrase: "was"

Phrase: "the one in which cells"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0205447:One [Quantitative Concept]

Phrase: "were"

Phrase: "maintained"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1314677:Maintained [Functional Concept]
   966 E C0024501:Maintain [Activity]

Phrase: "(differentiation medium"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0009458:Medium [Intellectual Product]
   861   C0439536:Medium [Quantitative Concept]
   861   C1705217:Medium [Substance]
   861   C3244283:medium [Intellectual Product]

Phrase: ";"

Phrase: "see"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042789:see [Organism Function]
  1000   C1947903:See [Activity]

Phrase: "above"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1282910:Above [Spatial Concept]
  1000   C1552828:above [Idea or Concept]

Phrase: ")."
Processing 00000000.tx.182: Results in Fig. 

Phrase: "Results in Fig."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   756   C1274040:Result [Functional Concept]
   756   C1546471:Result [Idea or Concept]
   756   C2825142:Result [Finding]
Processing 00000000.tx.183: 5 demonstrate that dinitrophenol (chronic treatment, as above) significantly lowered mitochondrial membrane potential (P < 0.001). 

Phrase: "5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "demonstrate"

Phrase: "that dinitrophenol"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0012466:Dinitrophenol [Organic Chemical]

Phrase: "(chronic treatment,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0039798:treatment [Functional Concept]
   861   C0087111:Treatment [Therapeutic or Preventive Procedure]
   861   C1522326:Treatment [Functional Concept]
   861   C1533734:Treatment [Therapeutic or Preventive Procedure]
   861   C1705169:Treatment [Conceptual Entity]
   861   C3538994:TREATMENT [Research Activity]

Phrase: "as"

Phrase: "above"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1282910:Above [Spatial Concept]
  1000   C1552828:above [Idea or Concept]

Phrase: ")"

Phrase: "significantly"

Phrase: "lowered"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0441994:lowered [Spatial Concept]
  1000   C1272755:Lowered [Quantitative Concept]
  1000   C2003888:Lowered [Activity]
   966 E C1548802:Lower [Body Location or Region]

Phrase: "mitochondrial membrane potential"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
  1000   C1720920:Membrane Potential, Mitochondrial [Cell Function]
   901   C0025251:Membrane Potential [Cell Function]
   901   C0596952:Mitochondrial membrane [Cell Component]
   827   C0025255:Membrane [Tissue]
   827   C0026237:Mitochondrial [Cell Component]
   827   C0521451:Mitochondrial [Functional Concept]
   827   C0596901:Membrane [Cell Component]
   827   C1706182:Membrane [Manufactured Object]
   827   C3245505:Potential [Qualitative Concept]
   755 E C0205287:Membranous [Qualitative Concept]

Phrase: "(P < 0.001"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.184: However, L6 myotubes infected with UCP3 had membrane potentials that were not significantly different from uninfected control cells and GFP-infected cells (P > 0.05). 

Phrase: "However,"

Phrase: "L6 myotubes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0242697:myotubes [Cell]
   861   C1704336:Myotubes [Cell]

Phrase: "infected with UCP3"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   862   C0539733:uncoupling protein-3 [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   862   C1421315:UNCOUPLING PROTEIN 3 [Gene or Genome]
   760   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0439663:Infected [Functional Concept]

Phrase: "had"

Phrase: "membrane potentials"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C0025251:Membrane Potentials [Cell Function]
   861   C0025255:Membrane [Tissue]
   861   C0596901:Membrane [Cell Component]
   861   C1706182:Membrane [Manufactured Object]
   861   C3245505:potentials [Qualitative Concept]
   789 E C0205287:Membranous [Qualitative Concept]

Phrase: "that"

Phrase: "were"

Phrase: "not significantly different from uninfected control cells"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1705242:Different [Qualitative Concept]

Phrase: "and"

Phrase: "GFP-infected cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   804   C0007634:Cells [Cell]
   804   C3282337:Cells [Cell]
   771 E C1269647:Cell [Cell]
   771 E C1704653:Cell [Medical Device]
   771 E C1948049:Cell [Spatial Concept]
   717   C0120285:green fluorescent protein [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]

Phrase: "(P > 0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.185: View larger version (18K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(18K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.186: 5. 

Phrase: "5."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]
Processing 00000000.tx.187: Mitochondrial membrane potential is unaffected by moderate overexpression of UCP3. 

Phrase: "Mitochondrial membrane potential"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
  1000   C1720920:Membrane Potential, Mitochondrial [Cell Function]
   901   C0025251:Membrane Potential [Cell Function]
   901   C0596952:Mitochondrial membrane [Cell Component]
   827   C0025255:Membrane [Tissue]
   827   C0026237:Mitochondrial [Cell Component]
   827   C0521451:Mitochondrial [Functional Concept]
   827   C0596901:Membrane [Cell Component]
   827   C1706182:Membrane [Manufactured Object]
   827   C3245505:Potential [Qualitative Concept]
   755 E C0205287:Membranous [Qualitative Concept]

Phrase: "is"

Phrase: "unaffected by moderate overexpression of UCP3."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C2986417:Unaffected [Conceptual Entity]
Processing 00000000.tx.188: Mitochondrial membrane potential was assessed in intact L6 myotubes using the fluorescent marker TMRE as described in the text. 

Phrase: "Mitochondrial membrane potential"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
  1000   C1720920:Membrane Potential, Mitochondrial [Cell Function]
   901   C0025251:Membrane Potential [Cell Function]
   901   C0596952:Mitochondrial membrane [Cell Component]
   827   C0025255:Membrane [Tissue]
   827   C0026237:Mitochondrial [Cell Component]
   827   C0521451:Mitochondrial [Functional Concept]
   827   C0596901:Membrane [Cell Component]
   827   C1706182:Membrane [Manufactured Object]
   827   C3245505:Potential [Qualitative Concept]
   755 E C0205287:Membranous [Qualitative Concept]

Phrase: "was"

Phrase: "assessed in intact L6 myotubes"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0205266:Intact [Qualitative Concept]
   760   C0242697:myotubes [Cell]
   760   C1516048:Assessed [Activity]
   760   C1554187:Intact [Idea or Concept]
   760   C1704336:Myotubes [Cell]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the fluorescent marker TMRE"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   884   C0672030:tetramethyl rhodamine ethyl ester [Organic Chemical,Pharmacologic Substance]
   804   C0014898:Ester [Organic Chemical]

Phrase: "as"

Phrase: "described in the text."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C1527021:Text [Intellectual Product]
   770   C1552738:described [Idea or Concept]
   770   C1554111:Text [Idea or Concept]
   770   C1705606:Text [Intellectual Product]
   770   C3541382:Text [Intellectual Product]
Processing 00000000.tx.189: From left to right, results are shown for control (CON) (untreated) cells, GFP-infected cells, dinitrophenol (DNP)-treated cells, and UCP3-infected cells. n = 5 for each treatment condition. 

Phrase: "From left"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205091:Left [Spatial Concept]
  1000   C1552822:left [Functional Concept]

Phrase: "to right,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205090:Right [Spatial Concept]

Phrase: "results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "are"

Phrase: "shown for control"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0243148:control [Qualitative Concept]
   790   C1550141:Control [Substance]
   790   C1882979:Control [Conceptual Entity]
   790   C2587213:Control [Functional Concept]
   790   C3274648:Control [Qualitative Concept]
   756   C1547282:Show [Intellectual Product]

Phrase: "(CON"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: ")"

Phrase: "(untreated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332155:untreated [Finding]

Phrase: ")"

Phrase: "cells,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "GFP-infected cells,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   804   C0007634:Cells [Cell]
   804   C3282337:Cells [Cell]
   771 E C1269647:Cell [Cell]
   771 E C1704653:Cell [Medical Device]
   771 E C1948049:Cell [Spatial Concept]
   717   C0120285:green fluorescent protein [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]

Phrase: "dinitrophenol"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0012466:Dinitrophenol [Organic Chemical]

Phrase: "(DNP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0012466:Dinitrophenol [Organic Chemical]

Phrase: ")-"

Phrase: "treated cells,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "UCP3-infected cells. n = 5"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   900   C1420155:UNCOUPLING PROTEIN 5 [Gene or Genome]
   845   C0539733:uncoupling protein-3 [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   845   C1421315:UNCOUPLING PROTEIN 3 [Gene or Genome]
   795   C0007634:Cells [Cell]
   795   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   795   C0439663:Infected [Functional Concept]
   795   C3282337:Cells [Cell]
   762 E C1269647:Cell [Cell]
   762 E C1704653:Cell [Medical Device]
   762 E C1948049:Cell [Spatial Concept]

Phrase: "for each treatment condition."
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   861   C0012634:condition [Disease or Syndrome]
   861   C0348080:Condition [Qualitative Concept]
   861   C1705253:Condition [Conceptual Entity]
   789 E C0009647:Conditioned [Mental Process]
   789 E C1701901:Conditional [Qualitative Concept]
   789 E C1963686:Conditional [Functional Concept]
   761 E C1519605:Conditionality [Conceptual Entity]
Processing 00000000.tx.190: **P < 0.01; 

Phrase: "*"

Phrase: "*P < 0.01"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ";"
Processing 00000000.tx.191: ***P < 0.001.  

Phrase: "*"

Phrase: "*"

Phrase: "*P < 0.001."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.192: Cellular ROS production is decreased by moderate overexpression of UCP3. 

Phrase: "Cellular ROS production"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0033268:production [Occupational Activity]
   717   C0162772:Reactive Oxygen Species [Biologically Active Substance,Element, Ion, or Isotope]

Phrase: "is"

Phrase: "decreased by moderate overexpression of UCP3."
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   800   C0539733:uncoupling protein-3 [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   800   C1421315:UNCOUPLING PROTEIN 3 [Gene or Genome]
   767   C1514559:Protein Overexpression [Genetic Function]
           Overexpression
   744   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0205081:Moderate [Qualitative Concept]
   744   C0205216:Decreased [Quantitative Concept]
   744   C0392756:Decreased [Qualitative Concept]
   744   C0442797:decreased [Qualitative Concept]
   744   C1881878:Moderate [Qualitative Concept]
   711 E C0547047:Decrease [Quantitative Concept]
Processing 00000000.tx.193: Increased expression of UCP3 in L6 myotubes decreased the rate of cellular ROS production, as assessed by DCFDA fluorescence, compared with that in uninfected control cells and GFP-infected cells (P < 0.001 and < 0.01, respectively) (Fig. 6). 

Phrase: "Increased expression of UCP3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   783   C1171362:expression protein [Genetic Function]
   753   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "in L6 myotubes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0242697:myotubes [Cell]
   861   C1704336:Myotubes [Cell]

Phrase: "decreased"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0205216:Decreased [Quantitative Concept]
  1000   C0392756:Decreased [Qualitative Concept]
  1000   C0442797:decreased [Qualitative Concept]
   966 E C0547047:Decrease [Quantitative Concept]

Phrase: "the rate of cellular ROS production,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0871208:Rate [Activity]
   744   C1521828:Rate [Quantitative Concept]

Phrase: "as"

Phrase: "assessed by DCFDA fluorescence,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0016315:Fluorescence [Natural Phenomenon or Process]
   770   C0057672:DCFDA [Organic Chemical]
   770   C1516048:Assessed [Activity]

Phrase: "compared with that"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1707455:Compared [Activity]

Phrase: "in uninfected control cells"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   827   C0007634:Cells [Cell]
   827   C0243148:control [Qualitative Concept]
   827   C1550141:Control [Substance]
   827   C1882979:Control [Conceptual Entity]
   827   C2587213:Control [Functional Concept]
   827   C3274648:Control [Qualitative Concept]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "GFP-infected cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   804   C0007634:Cells [Cell]
   804   C3282337:Cells [Cell]
   771 E C1269647:Cell [Cell]
   771 E C1704653:Cell [Medical Device]
   771 E C1948049:Cell [Spatial Concept]
   717   C0120285:green fluorescent protein [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]

Phrase: "(P < 0.001"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "and <"

Phrase: "0.01,"

Phrase: "respectively"

Phrase: ")"

Phrase: "(Fig. 6"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.194: Chronic treatment with low concentrations of dinitrophenol also significantly reduced ROS production in L6 myotubes compared with uninfected control cells and GFP-infected cells (P < 0.001 for both). 

Phrase: "Chronic treatment with low concentrations of dinitrophenol also significantly"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   742   C0039798:treatment [Functional Concept]
   742   C0087111:Treatment [Therapeutic or Preventive Procedure]
   742   C1522326:Treatment [Functional Concept]
   742   C1533734:Treatment [Therapeutic or Preventive Procedure]
   742   C1705169:Treatment [Conceptual Entity]
   742   C3538994:TREATMENT [Research Activity]

Phrase: "reduced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392756:Reduced [Qualitative Concept]

Phrase: "ROS production in L6 myotubes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0033268:production [Occupational Activity]

Phrase: "compared with uninfected control cells"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   760   C0007634:Cells [Cell]
   760   C0243148:control [Qualitative Concept]
   760   C1550141:Control [Substance]
   760   C1707455:Compared [Activity]
   760   C1882979:Control [Conceptual Entity]
   760   C2587213:Control [Functional Concept]
   760   C3274648:Control [Qualitative Concept]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "GFP-infected cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   804   C0007634:Cells [Cell]
   804   C3282337:Cells [Cell]
   771 E C1269647:Cell [Cell]
   771 E C1704653:Cell [Medical Device]
   771 E C1948049:Cell [Spatial Concept]
   717   C0120285:green fluorescent protein [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]

Phrase: "(P < 0.001 for both"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.195: View larger version (17K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(17K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.196: 6. 

Phrase: "6."
Processing 00000000.tx.197: L6 cellular ROS production is decreased by moderate overexpression of UCP3 and by mild chemical uncoupling. 

Phrase: "L6 cellular ROS production"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0033268:production [Occupational Activity]

Phrase: "is"

Phrase: "decreased by moderate overexpression of UCP3"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   800   C0539733:uncoupling protein-3 [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   800   C1421315:UNCOUPLING PROTEIN 3 [Gene or Genome]
   767   C1514559:Protein Overexpression [Genetic Function]
           Overexpression
   744   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0205081:Moderate [Qualitative Concept]
   744   C0205216:Decreased [Quantitative Concept]
   744   C0392756:Decreased [Qualitative Concept]
   744   C0442797:decreased [Qualitative Concept]
   744   C1881878:Moderate [Qualitative Concept]
   711 E C0547047:Decrease [Quantitative Concept]

Phrase: "and by mild chemical"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0220806:Chemical [Chemical]
   770   C1515981:And [Idea or Concept]
   770   C2945599:Mild [Qualitative Concept]
   770   C3272558:Chemical [Intellectual Product]

Phrase: "uncoupling."
Processing 00000000.tx.198: ROS production was assessed in intact L6 myotubes using the fluorescent marker, carboxy-H2-DCFDA, as described in the text. 

Phrase: "ROS production"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0033268:production [Occupational Activity]
   756   C0162772:Reactive Oxygen Species [Biologically Active Substance,Element, Ion, or Isotope]

Phrase: "was"

Phrase: "assessed in intact L6 myotubes"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0205266:Intact [Qualitative Concept]
   760   C0242697:myotubes [Cell]
   760   C1516048:Assessed [Activity]
   760   C1554187:Intact [Idea or Concept]
   760   C1704336:Myotubes [Cell]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the fluorescent marker,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0005516:Marker [Clinical Attribute]

Phrase: "carboxy-H2-DCFDA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0057672:DCFDA [Organic Chemical]

Phrase: "as"

Phrase: "described in the text."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C1527021:Text [Intellectual Product]
   770   C1552738:described [Idea or Concept]
   770   C1554111:Text [Idea or Concept]
   770   C1705606:Text [Intellectual Product]
   770   C3541382:Text [Intellectual Product]
Processing 00000000.tx.199: From left to right, results are shown for control (CON) (untreated) cells, GFP-infected cells, dinitrophenol (DNP)-treated cells, and UCP3-infected cells. n = 1013 for each treatment condition. 

Phrase: "From left"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205091:Left [Spatial Concept]
  1000   C1552822:left [Functional Concept]

Phrase: "to right,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205090:Right [Spatial Concept]

Phrase: "results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "are"

Phrase: "shown for control"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0243148:control [Qualitative Concept]
   790   C1550141:Control [Substance]
   790   C1882979:Control [Conceptual Entity]
   790   C2587213:Control [Functional Concept]
   790   C3274648:Control [Qualitative Concept]
   756   C1547282:Show [Intellectual Product]

Phrase: "(CON"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: ")"

Phrase: "(untreated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332155:untreated [Finding]

Phrase: ")"

Phrase: "cells,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "GFP-infected cells,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   804   C0007634:Cells [Cell]
   804   C3282337:Cells [Cell]
   771 E C1269647:Cell [Cell]
   771 E C1704653:Cell [Medical Device]
   771 E C1948049:Cell [Spatial Concept]
   717   C0120285:green fluorescent protein [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]

Phrase: "dinitrophenol"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0012466:Dinitrophenol [Organic Chemical]

Phrase: "(DNP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0012466:Dinitrophenol [Organic Chemical]

Phrase: ")-"

Phrase: "treated cells,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "UCP3-infected cells. n = 1013"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   845   C0539733:uncoupling protein-3 [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   845   C1421315:UNCOUPLING PROTEIN 3 [Gene or Genome]
   795   C0007634:Cells [Cell]
   795   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   795   C0439663:Infected [Functional Concept]
   795   C3282337:Cells [Cell]
   762 E C1269647:Cell [Cell]
   762 E C1704653:Cell [Medical Device]
   762 E C1948049:Cell [Spatial Concept]

Phrase: "for each treatment condition."
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   861   C0012634:condition [Disease or Syndrome]
   861   C0348080:Condition [Qualitative Concept]
   861   C1705253:Condition [Conceptual Entity]
   789 E C0009647:Conditioned [Mental Process]
   789 E C1701901:Conditional [Qualitative Concept]
   789 E C1963686:Conditional [Functional Concept]
   761 E C1519605:Conditionality [Conceptual Entity]
Processing 00000000.tx.200: RF, relative fluorescence. 

Phrase: "RF,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0035448:RF [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0201660:RF [Laboratory Procedure]
  1000   C0748398:RF [Finding]

Phrase: "relative fluorescence."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0016315:Fluorescence [Natural Phenomenon or Process]
   789 E C0303920:Fluorescent [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
Processing 00000000.tx.201: **P < 0.01; 

Phrase: "*"

Phrase: "*P < 0.01"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ";"
Processing 00000000.tx.202: ***P < 0.001.   

Phrase: "*"

Phrase: "*"

Phrase: "*P < 0.001."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.203: DISCUSSION TOP ABSTRACT RESEARCH DESIGN AND METHODS RESULTS DISCUSSION REFERENCES  The upregulation of UCP3 in skeletal muscle in response to fasting, a period characterized by energy conservation and increased fatty acid oxidation rates, strongly suggests that the physiological function of UCP3 (unlike that of UCP1) is not thermoregulation. 

Phrase: "DISCUSSION TOP ABSTRACT RESEARCH DESIGN"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   840   C0035171:Research Design [Research Activity]
   804   C0035168:research [Research Activity]
   804   C0242481:Research [Research Activity]
   804   C1707689:Design [Activity]
   804   C2983265:DESIGN [Intellectual Product]

Phrase: "AND"

Phrase: "METHODS RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "The upregulation of UCP3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0041904:Up-Regulation [Cell Function,Molecular Function]
   753   C0162493:Up-Regulation [Genetic Function]

Phrase: "in skeletal muscle"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C0242692:Muscle, Skeletal [Tissue]
  1000   C1280260:Skeletal muscle [Body Part, Organ, or Organ Component]
   861   C0026845:Muscle [Tissue]
   861   C0037253:skeletal [Body System]
   861   C0521324:Skeletal [Spatial Concept]
   789 E C0442025:Muscular [Spatial Concept]

Phrase: "in response"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0871261:Response [Organism Attribute]
  1000   C1704632:Response [Finding]
  1000   C1706817:Response [Intellectual Product]
  1000   C2911692:Response [Mental Process]

Phrase: "to fasting,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0015663:Fasting [Finding]
  1000   C1550565:fasting [Intellectual Product]
   966 E C0456962:Fast [Qualitative Concept]

Phrase: "a period"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0439531:/period [Temporal Concept]
  1000   C1948053:Period [Temporal Concept]
   928 E C0332182:Periodic [Temporal Concept]
   928 E C1706381:PERIODIC [Intellectual Product]
   900 E C0031084:Periodicities [Temporal Concept]

Phrase: "characterized by energy conservation"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   833   C0150210:energy conservation [Individual Behavior]
   833   C0684283:energy conservation [Natural Phenomenon or Process]
   833   C1621943:Energy conservation [Health Care Activity]
   770   C0424589:Energy [Finding]
   770   C0542479:Energy [Natural Phenomenon or Process]
   770   C1442080:Energy [Quantitative Concept]
   770   C1880022:Characterized [Activity]
   770   C2347858:Conservation [Qualitative Concept]

Phrase: "and"

Phrase: "increased fatty acid oxidation rates,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   884   C1158366:fatty acid oxidation [Molecular Function]
   840   C0015684:Fatty acid [Lipid]
   804   C0001128:Acid [Chemical]
   804   C0030011:Oxidation [Molecular Function]
   804   C0202406:Acid [Laboratory Procedure]
   771   C0871208:Rate [Activity]
   771   C1521828:Rate [Quantitative Concept]

Phrase: "strongly"

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the physiological function of UCP3"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   774   C0815043:function protein [Amino Acid, Peptide, or Protein]
   774   C1527118:Protein Function [Molecular Function]
   748   C0031843:function [Physiologic Function]
   748   C0542341:Function [Functional Concept]
   748   C0700205:FUNCTION [Classification]
   748   C1705273:Function [Intellectual Product]

Phrase: "("

Phrase: "unlike that"

Phrase: "of UCP1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1421313:UCP1 [Gene or Genome]

Phrase: ")"

Phrase: "is"

Phrase: "not thermoregulation."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0005905:Thermoregulation [Organism Function]
   861   C0262758:thermoregulation [Therapeutic or Preventive Procedure]
Processing 00000000.tx.204: Free fatty acids are reported as being obligatory for UCP3 activity (31) and are known agonists of peroxisome proliferatoractivated receptors, which may activate UCP3 gene expression through the putative peroxisome proliferator response elements in the promoter region of the UCP3 gene (32). 

Phrase: "Free fatty acids"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C0015688:Free Fatty Acids [Lipid]
   966 E C2698488:Free Fatty Acid [Laboratory Procedure]
   901   C0015684:Fatty Acids [Lipid]
   827   C0001128:Acids [Chemical]
   827   C0332296:free [Functional Concept]
   827   C1880497:Free [Qualitative Concept]
   827   C1996904:Free [Qualitative Concept]
   793 E C0202406:Acid [Laboratory Procedure]

Phrase: "are"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "as"

Phrase: "being"

Phrase: "obligatory for UCP3 activity"

Phrase: "(31"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450355:31 [Intellectual Product]

Phrase: ")"

Phrase: "and"

Phrase: "are"

Phrase: "known"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205309:Known [Qualitative Concept]

Phrase: "agonists of peroxisome proliferatoractivated receptors,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0243192:agonists [Pharmacologic Substance]
   760   C2987634:agonists [Pharmacologic Substance]

Phrase: "which"

Phrase: "may"

Phrase: "activate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515877:Activate [Functional Concept]
  1000   C1879547:Activate [Activity]

Phrase: "UCP3 gene expression through the putative peroxisome proliferator response elements"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0017262:Gene Expression [Genetic Function]
   751   C0751455:gene protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   751   C1171362:expression protein [Genetic Function]
   736   C0017337:Gene [Gene or Genome]
   736   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "in the promoter region"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C0033413:Region, Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0017446:Region [Geographic Area]
   861   C0086860:Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0205147:Region [Spatial Concept]
   789 E C0205276:Regional [Spatial Concept]
   789 E C1947913:Regional [Spatial Concept]

Phrase: "of the UCP3 gene"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   875   C0751455:protein gene [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0017337:Gene [Gene or Genome]
   756   C0539733:uncoupling protein-3 [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   756   C1421315:UNCOUPLING PROTEIN 3 [Gene or Genome]

Phrase: "(32"

Phrase: ")."
Processing 00000000.tx.205: There is a high correlation between UCP3 expression patterns and conditions in which free fatty acids are the predominant fuel source, such as fasting, free fatty acid infusion, and high-fat feeding (33,34). 

Phrase: "There"

Phrase: "is"

Phrase: "a high correlation between UCP3 expression patterns"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C1707520:Correlation [Qualitative Concept]

Phrase: "and"

Phrase: "conditions in which free fatty acids"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   833   C0015688:Free Fatty Acids [Lipid]
   799 E C2698488:Free Fatty Acid [Laboratory Procedure]
   790   C0015684:Fatty Acids [Lipid]
   753   C0001128:Acids [Chemical]
   753   C0012634:condition [Disease or Syndrome]
   753   C0332296:free [Functional Concept]
   753   C0348080:Condition [Qualitative Concept]
   753   C1705253:Condition [Conceptual Entity]
   753   C1880497:Free [Qualitative Concept]
   753   C1996904:Free [Qualitative Concept]
   719 E C0202406:Acid [Laboratory Procedure]

Phrase: "are"

Phrase: "the predominant fuel source,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0449416:Source [Finding]
   827   C1705919:Source [Idea or Concept]

Phrase: "such as fasting,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0015663:Fasting [Finding]
  1000   C1550565:fasting [Intellectual Product]
   966 E C0456962:Fast [Qualitative Concept]

Phrase: "free fatty acid infusion,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0574032:Infusion [Therapeutic or Preventive Procedure]
   812   C1827465:Infusion [Functional Concept]
   756   C0015688:free fatty acid [Lipid]
   756   C2698488:Free Fatty Acid [Laboratory Procedure]

Phrase: "and"

Phrase: "high-fat feeding"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0204695:Feeding [Health Care Activity]
   827   C2987508:Feeding [Activity]

Phrase: "(33,"

Phrase: "34"

Phrase: ")."
Processing 00000000.tx.206: The physiological function of UCP3 is as yet unknown, but its association with enhanced fatty acid metabolism and increased insulin responsiveness in muscle lead to the possibility that it may be involved in protection from lipotoxicity in muscle. 

Phrase: "The physiological function of UCP3"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   774   C0815043:function protein [Amino Acid, Peptide, or Protein]
   774   C1527118:Protein Function [Molecular Function]
   748   C0031843:function [Physiologic Function]
   748   C0542341:Function [Functional Concept]
   748   C0700205:FUNCTION [Classification]
   748   C1705273:Function [Intellectual Product]

Phrase: "is as yet unknown,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0439673:Unknown [Qualitative Concept]

Phrase: "but"

Phrase: "its association with enhanced fatty acid metabolism"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0004083:Association [Mental Process]
   748   C0439849:Association [Qualitative Concept]
   748   C0596306:Association [Phenomenon or Process]
   748   C0699792:association [Social Behavior]

Phrase: "and"

Phrase: "increased insulin responsiveness in muscle"

Phrase: "lead to the possibility"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   770   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   770   C1522538:Lead [Functional Concept]
   770   C2348269:Lead [Element, Ion, or Isotope]
   770   C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "that"

Phrase: "it"

Phrase: "may"

Phrase: "be"

Phrase: "involved in protection"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1314939:Involved [Functional Concept]
   790   C1545588:Protection [Finding]

Phrase: "from lipotoxicity"

Phrase: "in muscle."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0026845:Muscle [Tissue]
   928 E C0442025:Muscular [Spatial Concept]
Processing 00000000.tx.207: Two hypotheses have been forwarded to outline mechanistic roles for UCP3 in fatty acid metabolism (mechanisms 1 and 2 in Fig. 7). 

Phrase: "Two hypotheses"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1512571:Hypothesis [Idea or Concept]

Phrase: "have"

Phrase: "been"

Phrase: "forwarded"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439780:forwarded [Spatial Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "outline"

Phrase: "mechanistic roles for UCP3"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C0035820:Roles [Social Behavior]
   719 E C1705810:Role [Conceptual Entity]

Phrase: "in fatty acid metabolism"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0596563:Fatty Acid Metabolism [Molecular Function]
   827   C0025519:Metabolism [Organism Function]
   827   C0025520:metabolism [Functional Concept]
   734   C0015684:Fatty acid [Lipid]

Phrase: "(mechanisms 1"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0441712:Mechanisms [Functional Concept]
   827 E C1706376:Mechanism [Manufactured Object]

Phrase: "and"

Phrase: "2 in Fig. 7"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0349966:Fig [Food]
   770   C0740116:+2 [Quantitative Concept]
   770   C1337208:FIG [Food]
   770   C2827735:2+ [Quantitative Concept]
   770   C2981700:2+ [Classification]

Phrase: ")."
Processing 00000000.tx.208: The first proposed that UCP3 and mitochondrial thioesterase 1 (MTE1) function in tandem to facilitate high rates of fatty acid oxidation (35). 

Phrase: "The first"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205435:First [Quantitative Concept]
  1000   C1279901:First [Qualitative Concept]

Phrase: "proposed"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1441414:PROPOSED [Idea or Concept]
  1000   C1553874:Proposed [Qualitative Concept]
  1000   C1578820:Proposed [Idea or Concept]

Phrase: "that UCP3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0539733:uncoupling protein-3 [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
  1000   C1421315:UNCOUPLING PROTEIN 3 [Gene or Genome]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "mitochondrial thioesterase 1 (MTE1) function in tandem to"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   795   C0026237:Mitochondrial [Cell Component]
   795   C0031843:function [Physiologic Function]
   795   C0075804:TANDEM [Organic Chemical,Pharmacologic Substance]
   795   C0521451:Mitochondrial [Functional Concept]
   795   C0542341:Function [Functional Concept]
   795   C0700205:FUNCTION [Classification]
   795   C1705273:Function [Intellectual Product]
   724 E C0205245:Functional [Functional Concept]
   724 E C2700217:Functional [Conceptual Entity]

Phrase: "facilitate"

Phrase: "high rates of fatty acid oxidation"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0205250:High [Qualitative Concept]
   753   C1299351:High [Qualitative Concept]
   753   C2700149:HIGH [Intellectual Product]
   719   C0871208:Rate [Activity]
   719   C1521828:Rate [Quantitative Concept]

Phrase: "(35"

Phrase: ")."
Processing 00000000.tx.209: During periods of elevated fatty acid oxidation, when 90% of mitochondrial uncombined CoA (CoASH) is bound to free fatty acids (36,37), MTE1 liberates CoASH to support fatty acid oxidation. 

Phrase: "During periods"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   966   C0439531:/period [Temporal Concept]
   966   C1948053:Period [Temporal Concept]
   916 E C0332182:Periodic [Temporal Concept]
   916 E C1706381:PERIODIC [Intellectual Product]
   893 E C0031084:Periodicities [Temporal Concept]

Phrase: "of elevated fatty acid oxidation,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   923   C1158366:fatty acid oxidation [Molecular Function]
   861   C0015684:Fatty acid [Lipid]
   812   C0001128:Acid [Chemical]
   812   C0030011:Oxidation [Molecular Function]
   812   C0202406:Acid [Laboratory Procedure]

Phrase: "when"

Phrase: "90% of mitochondrial uncombined CoA (CoASH"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0009140:CoASH [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   753   C0026237:Mitochondrial [Cell Component]
   753   C0439083:>90 [Quantitative Concept]
   753   C0439087:<90 [Quantitative Concept]
   753   C0521451:Mitochondrial [Functional Concept]

Phrase: ")"

Phrase: "is"

Phrase: "bound to free fatty acids"
Meta Candidates (Total=13; Excluded=2; Pruned=0; Remaining=11)
   862   C0015688:Free Fatty Acids [Lipid]
   828 E C2698488:Free Fatty Acid [Laboratory Procedure]
   806   C0015684:Fatty Acids [Lipid]
   760   C0001128:Acids [Chemical]
   760   C0332296:free [Functional Concept]
   760   C0332297:bound [Spatial Concept]
   760   C1145667:Bound [Activity]
   760   C1167622:Bound [Molecular Function]
   760   C1689898:% bound [Quantitative Concept]
   760   C1880497:Free [Qualitative Concept]
   760   C1996904:Free [Qualitative Concept]
   760   C2349209:Bound [Conceptual Entity]
   726 E C0202406:Acid [Laboratory Procedure]

Phrase: "(36,"

Phrase: "37"

Phrase: ")"

Phrase: ","

Phrase: "MTE1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0026237:Mitochondrial [Cell Component]
   827   C0521451:Mitochondrial [Functional Concept]

Phrase: "liberates"

Phrase: "CoASH to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0009140:CoASH [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "support"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0183683:Support [Medical Device]
  1000   C1521721:Support [Conceptual Entity]

Phrase: "fatty acid oxidation."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1158366:fatty acid oxidation [Molecular Function]
   901   C0015684:Fatty acid [Lipid]
   827   C0001128:Acid [Chemical]
   827   C0030011:Oxidation [Molecular Function]
   827   C0202406:Acid [Laboratory Procedure]
Processing 00000000.tx.210: CoASH-requiring steps include fatty acid entry into the mitochondria through carnitine palmitoyl transferase (CPT)2, -ketoglutarate dehydrogenase in the Krebs cycle, and -ketothiolase in the -oxidation pathway. 

Phrase: "CoASH-requiring steps"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   827   C1261552:steps [Conceptual Entity]
   793 E C1704379:Step [Functional Concept]
   793 E C1705117:Step [Quantitative Concept]
   793 E C2825408:Step [Manufactured Object]

Phrase: "include"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332257:include [Functional Concept]
  1000   C1552866:include [Idea or Concept]
  1000   C2700399:Include [Activity]

Phrase: "fatty acid entry into the mitochondria"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1705654:Entry [Intellectual Product]

Phrase: "through carnitine palmitoyl transferase (CPT)2, -"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0524513:Carnitine Palmitoyltransferase II [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1413690:carnitine palmitoyltransferase 2 [Gene or Genome]
  1000   C2598068:Carnitine palmitoyltransferase 2 [Amino Acid, Peptide, or Protein,Enzyme]
   923   C0007262:Carnitine Palmitoyltransferase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0729572:Palmitoyltransferase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0007258:Carnitine [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   812   C0040676:Transferase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0087163:Carnitine [Organic Chemical,Pharmacologic Substance,Vitamin]

Phrase: "ketoglutarate dehydrogenase in the Krebs cycle,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0599061:ketoglutarate dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0030016:Dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and -"

Phrase: "ketothiolase in the -oxidation pathway."
Processing 00000000.tx.211: The expression of MTE1, like that of UCP3, is regulated by peroxisome proliferatoractivated receptors (37), and recent studies show that expression patterns of the two genes are similar (38,39). 

Phrase: "The expression of MTE1,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "like that"

Phrase: "of UCP3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0539733:uncoupling protein-3 [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
  1000   C1421315:UNCOUPLING PROTEIN 3 [Gene or Genome]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "is"

Phrase: "regulated by peroxisome proliferatoractivated receptors"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]
   760   C0752063:Peroxysome [Cell Component]
   760   C0851285:Regulated [Governmental or Regulatory Activity]
   760   C2984308:Peroxisome [Functional Concept]

Phrase: "(37"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "recent studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "that expression patterns of the two genes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0449774:Patterns [Spatial Concept]

Phrase: "are"

Phrase: "similar"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2348205:Similar [Qualitative Concept]

Phrase: "(38,"

Phrase: "39"

Phrase: ")."
Processing 00000000.tx.212: In mechanism 1, UCP3 is proposed to export the MTE-liberated fatty acid anions, which cannot be reesterified to CoASH in the matrix due to the absence of acyl-CoA synthetase. 

Phrase: "In mechanism 1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0441712:Mechanism [Functional Concept]
   861   C1706376:Mechanism [Manufactured Object]

Phrase: "UCP3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0539733:uncoupling protein-3 [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
  1000   C1421315:UNCOUPLING PROTEIN 3 [Gene or Genome]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "is"

Phrase: "proposed"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1441414:PROPOSED [Idea or Concept]
  1000   C1553874:Proposed [Qualitative Concept]
  1000   C1578820:Proposed [Idea or Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "export"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0699789:Export [Phenomenon or Process]

Phrase: "the MTE-liberated fatty acid anions,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   867   C2316831:Fatty acid anion [Organic Chemical]
   804   C0003075:Anions [Element, Ion, or Isotope]

Phrase: "which"

Phrase: "cannot"

Phrase: "be"

Phrase: "reesterified to CoASH"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0009140:CoASH [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "in the matrix"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1704640:Matrix [Spatial Concept]
  1000   C1706515:Matrix [Body Substance]

Phrase: "due to the absence"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332197:absence [Quantitative Concept]
  1000   C1689985:Absence [Anatomical Abnormality]
   928 E C2699517:ABSENT [Finding]

Phrase: "of acyl-CoA synthetase."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0050691:Acyl-CoA synthetase [Amino Acid, Peptide, or Protein,Enzyme]
   901   C0001374:Acyl CoA [Biologically Active Substance,Lipid,Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0023689:Synthetase [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.213: Thus, UCP3 is proposed to export the potentially detrimental fatty acid anions to the intermembrane space and cytosol where they can be reesterified to CoASH for subsequent use in other pathways (e.g., phospholipids, triacylglycerol synthesis, or reentry into the matrix for oxidation). 

Phrase: "Thus,"

Phrase: "UCP3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0539733:uncoupling protein-3 [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
  1000   C1421315:UNCOUPLING PROTEIN 3 [Gene or Genome]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "is"

Phrase: "proposed"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1441414:PROPOSED [Idea or Concept]
  1000   C1553874:Proposed [Qualitative Concept]
  1000   C1578820:Proposed [Idea or Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "export"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0699789:Export [Phenomenon or Process]

Phrase: "the potentially detrimental fatty acid anions to the intermembrane space"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   765   C2316831:Fatty acid anion [Organic Chemical]
   739   C0003075:Anions [Element, Ion, or Isotope]

Phrase: "and"

Phrase: "cytosol where"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1383501:Cytosol [Cell Component]

Phrase: "they"

Phrase: "can"

Phrase: "be"

Phrase: "reesterified to CoASH"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0009140:CoASH [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "for subsequent use"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0042153:use [Functional Concept]
   861   C0457083:Use [Functional Concept]
   861   C1947944:Use [Intellectual Product]

Phrase: "in other pathways"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1704259:Pathways [Molecular Function]
  1000   C1705987:Pathways [Conceptual Entity]

Phrase: "("

Phrase: "e.g."

Phrase: ","

Phrase: "phospholipids,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0031676:Phospholipids [Biologically Active Substance,Lipid]
   966 E C0202177:Phospholipid [Laboratory Procedure]

Phrase: "triacylglycerol synthesis,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0220781:synthesis [Biologic Function]
   861   C1883254:Synthesis [Activity]

Phrase: "or"

Phrase: "reentry into the matrix"

Phrase: "for oxidation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030011:Oxidation [Molecular Function]

Phrase: ")."
Processing 00000000.tx.214: View larger version (45K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(45K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.215: 7. 

Phrase: "7."
Processing 00000000.tx.216: Hypothesized functions of UCP3. 

Phrase: "Hypothesized functions of UCP3."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   767   C0815043:function protein [Amino Acid, Peptide, or Protein]
   767   C1527118:Protein Function [Molecular Function]
   753   C0542341:Functions [Functional Concept]
   719 E C0031843:function [Physiologic Function]
   719 E C0700205:FUNCTION [Classification]
   719 E C1705273:Function [Intellectual Product]
Processing 00000000.tx.217: The function of UCP3 is as yet unresolved, but four functions have been proposed and are presented in their chronological order of publication. 

Phrase: "The function of UCP3"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   783   C0815043:function protein [Amino Acid, Peptide, or Protein]
   783   C1527118:Protein Function [Molecular Function]
   753   C0031843:function [Physiologic Function]
   753   C0542341:Function [Functional Concept]
   753   C0700205:FUNCTION [Classification]
   753   C1705273:Function [Intellectual Product]

Phrase: "is as yet unresolved,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0443342:Unresolved [Qualitative Concept]

Phrase: "but"

Phrase: "four functions"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   861   C0542341:Functions [Functional Concept]
   827 E C0031843:function [Physiologic Function]
   827 E C0700205:FUNCTION [Classification]
   827 E C1705273:Function [Intellectual Product]
   777 E C0205245:Functional [Functional Concept]
   777 E C2700217:Functional [Conceptual Entity]

Phrase: "have"

Phrase: "been"

Phrase: "proposed"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1441414:PROPOSED [Idea or Concept]
  1000   C1553874:Proposed [Qualitative Concept]
  1000   C1578820:Proposed [Idea or Concept]

Phrase: "and"

Phrase: "are"

Phrase: "presented in their chronological order of publication."
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   748   C0034036:Publication [Intellectual Product,Manufactured Object]
   748   C0034037:Publication [Occupational Activity]
   748   C0449450:Presented [Idea or Concept]
   748   C1704324:Publication [Intellectual Product]
   748   C1705175:Order [Intellectual Product]
   748   C1705176:Order [Qualitative Concept]
   748   C1705177:Order [Classification]
   748   C1705178:Order [Activity]
   748   C1882348:Order [Qualitative Concept]
   714 E C0150312:Present [Quantitative Concept]
Processing 00000000.tx.218: 1) UCP3 removes long-chain fatty acids (LCFA) produced by MTE1; 

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ")"

Phrase: "UCP3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0539733:uncoupling protein-3 [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
  1000   C1421315:UNCOUPLING PROTEIN 3 [Gene or Genome]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "removes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0849355:remove [Qualitative Concept]
  1000   C1883720:Remove [Activity]
  1000   C3244314:remove [Functional Concept]

Phrase: "long-chain fatty acids (LCFA)"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   966   C0522095:Long chain fatty acid [Biologically Active Substance,Lipid]
   861   C0015684:Fatty Acids [Lipid]
   812   C0001128:Acids [Chemical]
   812   C0205166:Long [Qualitative Concept]
   812   C0337112:Chain [Manufactured Object]
   812   C1524075:Chain [Idea or Concept]
   812   C1706317:Long [Qualitative Concept]
   779 E C0202406:Acid [Laboratory Procedure]

Phrase: "produced by MTE1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0026237:Mitochondrial [Cell Component]
   760   C0521451:Mitochondrial [Functional Concept]

Phrase: ";"
Processing 00000000.tx.219: the latter liberates mitochondrial matrix CoASH, a rate-limiting coenzyme for -oxidation and the Krebs cycle. 

Phrase: "the latter"

Phrase: "liberates"

Phrase: "mitochondrial matrix CoASH,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0009140:CoASH [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   734   C1510421:Mitochondrial matrix [Cell Component]

Phrase: "a rate-limiting coenzyme for -oxidation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   783   C0009226:Coenzyme A [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   753   C0009235:Coenzyme [Biologically Active Substance,Organic Chemical]

Phrase: "and"

Phrase: "the Krebs cycle."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0008858:Krebs Cycle [Molecular Function]
   861   C1511572:Cycle [Temporal Concept]
Processing 00000000.tx.220: Long-chain fatty acids are exported from the matrix by UCP3 for reactivation by acyl-CoA synthase in the intermembrane space. 

Phrase: "Long-chain fatty acids"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   966   C0522095:Long chain fatty acid [Biologically Active Substance,Lipid]
   861   C0015684:Fatty Acids [Lipid]
   812   C0001128:Acids [Chemical]
   812   C0205166:Long [Qualitative Concept]
   812   C0337112:Chain [Manufactured Object]
   812   C1524075:Chain [Idea or Concept]
   812   C1706317:Long [Qualitative Concept]
   779 E C0202406:Acid [Laboratory Procedure]

Phrase: "are"

Phrase: "exported from the matrix"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0699789:Exported [Phenomenon or Process]
   770   C1704640:Matrix [Spatial Concept]
   770   C1706515:Matrix [Body Substance]

Phrase: "by UCP3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0539733:uncoupling protein-3 [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
  1000   C1421315:UNCOUPLING PROTEIN 3 [Gene or Genome]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "for reactivation"

Phrase: "by acyl-CoA synthase"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C1428910:CoA synthase [Gene or Genome]
   827   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]
   734   C0001374:Acyl CoA [Biologically Active Substance,Lipid,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "in the intermembrane space."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1179889:Intermembrane Space [Cell Component]
   861   C1883067:Space [Spatial Concept]
Processing 00000000.tx.221: Thus, MTE1 and UCP3 are proposed to function in tandem to facilitate fatty acid oxidation (35). 

Phrase: "Thus,"

Phrase: "MTE1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0026237:Mitochondrial [Cell Component]
   827   C0521451:Mitochondrial [Functional Concept]

Phrase: "and"

Phrase: "UCP3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0539733:uncoupling protein-3 [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
  1000   C1421315:UNCOUPLING PROTEIN 3 [Gene or Genome]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "are"

Phrase: "proposed"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1441414:PROPOSED [Idea or Concept]
  1000   C1553874:Proposed [Qualitative Concept]
  1000   C1578820:Proposed [Idea or Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "function"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0031843:function [Physiologic Function]
  1000   C0542341:Function [Functional Concept]
  1000   C0700205:FUNCTION [Classification]
  1000   C1705273:Function [Intellectual Product]

Phrase: "in tandem to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0075804:TANDEM [Organic Chemical,Pharmacologic Substance]

Phrase: "facilitate"

Phrase: "fatty acid oxidation"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1158366:fatty acid oxidation [Molecular Function]
   901   C0015684:Fatty acid [Lipid]
   827   C0001128:Acid [Chemical]
   827   C0030011:Oxidation [Molecular Function]
   827   C0202406:Acid [Laboratory Procedure]

Phrase: "(35"

Phrase: ")."
Processing 00000000.tx.222: 2) UCP3 removes excess long-chain fatty acids that have entered the mitochondrial matrix independently of the CPT system. 

Phrase: "2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: ")"

Phrase: "UCP3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0539733:uncoupling protein-3 [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
  1000   C1421315:UNCOUPLING PROTEIN 3 [Gene or Genome]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "removes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0849355:remove [Qualitative Concept]
  1000   C1883720:Remove [Activity]
  1000   C3244314:remove [Functional Concept]

Phrase: "excess long-chain fatty acids"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   904   C0522095:Long chain fatty acid [Biologically Active Substance,Lipid]
   881   C0728725:excess acid [Finding]
   840   C0015684:Fatty Acids [Lipid]
   804   C0001128:Acids [Chemical]
   804   C0205166:Long [Qualitative Concept]
   804   C0337112:Chain [Manufactured Object]
   804   C1524075:Chain [Idea or Concept]
   804   C1706317:Long [Qualitative Concept]
   771 E C0202406:Acid [Laboratory Procedure]

Phrase: "that"

Phrase: "have"

Phrase: "entered"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1521975:Entered [Qualitative Concept]
   966 E C1522196:ENTER [Functional Concept]

Phrase: "the mitochondrial matrix independently of the CPT system."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C1510421:Mitochondrial matrix [Cell Component]
   739   C0026237:Mitochondrial [Cell Component]
   739   C0521451:Mitochondrial [Functional Concept]
   739   C1704640:Matrix [Spatial Concept]
   739   C1706515:Matrix [Body Substance]
Processing 00000000.tx.223: This would serve to remove potentially damaging fatty acid anions from the matrix (40). 

Phrase: "This"

Phrase: "would"

Phrase: "serve"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "remove"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0849355:remove [Qualitative Concept]
  1000   C1883720:Remove [Activity]
  1000   C3244314:remove [Functional Concept]

Phrase: "potentially"

Phrase: "damaging"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0010957:Damage [Injury or Poisoning]
   966   C1883709:Damage [Functional Concept]

Phrase: "fatty acid anions from the matrix"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   816   C2316831:Fatty acid anion [Organic Chemical]
   753   C0003075:Anions [Element, Ion, or Isotope]

Phrase: "(40"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439509:/40 [Temporal Concept]

Phrase: ")."
Processing 00000000.tx.224: 3) UCP3 translocates lipid peroxide anions, generated from the interaction of matrix ROS with unsaturated fatty acids of the inner leaflet, from the inner to the outer leaflets of the mitochondrial inner membrane (44). 

Phrase: "3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: ")"

Phrase: "UCP3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0539733:uncoupling protein-3 [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
  1000   C1421315:UNCOUPLING PROTEIN 3 [Gene or Genome]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "translocates"

Phrase: "lipid peroxide anions,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0003075:Anions [Element, Ion, or Isotope]
   734   C0023776:lipid peroxide [Lipid]

Phrase: "generated from the interaction of matrix ROS"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   790   C0162772:Reactive Oxygen Species [Biologically Active Substance,Element, Ion, or Isotope]
   742   C0030054:Oxygen [Element, Ion, or Isotope,Pharmacologic Substance]
   742   C0205332:Reactive [Qualitative Concept]
   742   C1704640:Matrix [Spatial Concept]
   742   C1704675:Interaction [Functional Concept]
   742   C1705920:Species [Conceptual Entity]
   742   C1706515:Matrix [Body Substance]
   742   C3146294:Generated [Activity]

Phrase: "with unsaturated fatty acids"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0015690:Fatty Acids, Unsaturated [Lipid]
   901   C0015684:Fatty Acids [Lipid]
   827   C0001128:Acids [Chemical]
   827   C0522535:Unsaturated [Quantitative Concept]
   793 E C0202406:Acid [Laboratory Procedure]

Phrase: "of the inner leaflet,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1708664:Leaflet [Manufactured Object]
   861   C3273178:Leaflet [Intellectual Product]

Phrase: "from the inner"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205102:Inner [Spatial Concept]

Phrase: "to the outer leaflets"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1708664:Leaflet [Manufactured Object]
   827   C3273178:Leaflet [Intellectual Product]

Phrase: "of the mitochondrial inner membrane"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C0230840:Mitochondrial Inner Membrane [Cell Component]
   913   C0596952:Mitochondrial membrane [Cell Component]
   827   C0025255:Membrane [Tissue]
   827   C0205102:Inner [Spatial Concept]
   827   C0596901:Membrane [Cell Component]
   827   C1706182:Membrane [Manufactured Object]
   755 E C0205287:Membranous [Qualitative Concept]

Phrase: "(44"

Phrase: ")."
Processing 00000000.tx.225: This would remove fatty acid peroxides and prevent damage of mitochondrial DNA, aconitase, and other matrix components. 

Phrase: "This"

Phrase: "would"

Phrase: "remove"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0849355:remove [Qualitative Concept]
  1000   C1883720:Remove [Activity]
  1000   C3244314:remove [Functional Concept]

Phrase: "fatty acid peroxides"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0031180:Peroxides [Inorganic Chemical]
   734   C0015684:Fatty acid [Lipid]

Phrase: "and"

Phrase: "prevent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0309872:PREVENT [Pharmacologic Substance]

Phrase: "damage of mitochondrial DNA,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   819   C0012860:DNA Damage [Cell or Molecular Dysfunction]
   819   C1096176:Mitochondrial Damage [Pathologic Function]
   770   C0010957:Damage [Injury or Poisoning]
   770   C1883709:Damage [Functional Concept]

Phrase: "aconitase,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001156:Aconitase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and"

Phrase: "other matrix components."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0449432:Components [Manufactured Object]
   827 E C1705248:Component [Conceptual Entity]
Processing 00000000.tx.226: 4) 4-hydroxynonenal (HNE), a lipid by-product of mitochondrial superoxide (SOD) production, is proposed to activate a UCP3-mediated proton leak (43). 

Phrase: "4"

Phrase: ")"

Phrase: "4-hydroxynonenal (HNE),"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0048297:4-hydroxynonenal [Organic Chemical,Pharmacologic Substance]

Phrase: "a lipid by-product of mitochondrial superoxide (SOD) production,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C1514468:product [Entity]
   744   C1704444:Product [Quantitative Concept]

Phrase: "is"

Phrase: "proposed"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1441414:PROPOSED [Idea or Concept]
  1000   C1553874:Proposed [Qualitative Concept]
  1000   C1578820:Proposed [Idea or Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "activate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515877:Activate [Functional Concept]
  1000   C1879547:Activate [Activity]

Phrase: "a UCP3-mediated proton leak"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   799   C0332234:Leak [Functional Concept]
   799   C1608322:Leak NOS [Finding]
   799   C1881366:LEAK [Phenomenon or Process]

Phrase: "(43"

Phrase: ")."
Processing 00000000.tx.227: It is proposed that this decreases mitochondrial membrane potential and hence decreases ROS production.  

Phrase: "It"

Phrase: "is"

Phrase: "proposed"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1441414:PROPOSED [Idea or Concept]
  1000   C1553874:Proposed [Qualitative Concept]
  1000   C1578820:Proposed [Idea or Concept]

Phrase: "that"

Phrase: "this decreases mitochondrial membrane potential"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   923   C1720920:Membrane Potential, Mitochondrial [Cell Function]
   861   C0025251:Membrane Potential [Cell Function]
   861   C0596952:Mitochondrial membrane [Cell Component]
   812   C0025255:Membrane [Tissue]
   812   C0026237:Mitochondrial [Cell Component]
   812   C0521451:Mitochondrial [Functional Concept]
   812   C0596901:Membrane [Cell Component]
   812   C1706182:Membrane [Manufactured Object]
   812   C3245505:Potential [Qualitative Concept]
   741 E C0205287:Membranous [Qualitative Concept]

Phrase: "and"

Phrase: "hence"

Phrase: "decreases"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0392756:Decrease [Qualitative Concept]
  1000   C0547047:Decrease [Quantitative Concept]

Phrase: "ROS production."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0033268:production [Occupational Activity]
   756   C0162772:Reactive Oxygen Species [Biologically Active Substance,Element, Ion, or Isotope]
Processing 00000000.tx.228: The second mechanism also involves mitochondrial fatty acid handling and is schematically depicted in Fig. 

Phrase: "The second mechanism also"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0441712:Mechanism [Functional Concept]
   827   C1706376:Mechanism [Manufactured Object]

Phrase: "involves"

Phrase: "mitochondrial fatty acid handling"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0018578:Handling [Behavior]
   812   C1832073:Handling [Finding]

Phrase: "and"

Phrase: "is"

Phrase: "schematically"

Phrase: "depicted in Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
Processing 00000000.tx.229: 7. 

Phrase: "7."
Processing 00000000.tx.230: Schrauwen et al. 

Phrase: "Schrauwen et al."
Processing 00000000.tx.231: (40) hypothesized that when fatty acid supply exceeds oxidation, fatty acids spontaneously enter the mitochondria independent of CPT mechanisms and accumulate as nonesterified fatty acid anions in the matrix. 

Phrase: "(40"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439509:/40 [Temporal Concept]

Phrase: ")"

Phrase: "hypothesized"

Phrase: "that"

Phrase: "when"

Phrase: "fatty acid supply"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   827   C0243163:supply [Idea or Concept]
   827   C0699914:supply [Quantitative Concept]
   827   C1314650:SUPPLY, NOT OTHERWISE SPECIFIED [Medical Device]
   827   C1561604:supply [Functional Concept]
   827   C1875802:SUPPLY [Medical Device]
   827   C1999230:Supply [Activity]
   734   C0015684:Fatty acid [Lipid]

Phrase: "exceeds"

Phrase: "oxidation,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030011:Oxidation [Molecular Function]

Phrase: "fatty acids spontaneously"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   901   C0015684:Fatty Acids [Lipid]
   827   C0001128:Acids [Chemical]
   793 E C0202406:Acid [Laboratory Procedure]

Phrase: "enter"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1522196:ENTER [Functional Concept]

Phrase: "the mitochondria independent of CPT mechanisms"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0026237:Mitochondria [Cell Component]

Phrase: "and"

Phrase: "accumulate as nonesterified fatty acid anions"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   833   C0015688:Non-esterified fatty acid [Lipid]
   816   C2316831:Fatty acid anion [Organic Chemical]
   790   C0015684:Fatty acid [Lipid]
   753   C0001128:Acid [Chemical]
   753   C0003075:Anions [Element, Ion, or Isotope]
   753   C0202406:Acid [Laboratory Procedure]

Phrase: "in the matrix."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1704640:Matrix [Spatial Concept]
  1000   C1706515:Matrix [Body Substance]
Processing 00000000.tx.232: UCP3, according to this second hypothesis, also translocates free fatty acid anions out of the matrix. 

Phrase: "UCP3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0539733:uncoupling protein-3 [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
  1000   C1421315:UNCOUPLING PROTEIN 3 [Gene or Genome]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "according to this second hypothesis,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1512571:Hypothesis [Idea or Concept]

Phrase: "also"

Phrase: "translocates"

Phrase: "free fatty acid anions out of the matrix."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   783   C2316831:Fatty acid anion [Organic Chemical]
   744   C0003075:Anions [Element, Ion, or Isotope]
Processing 00000000.tx.233: The latter hypothesis thus proposes a mechanism for efflux of potentially detrimental fatty acid anions but does not implicate UCP3 in facilitating increased fatty acid oxidation. 

Phrase: "The latter hypothesis thus"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1512571:Hypothesis [Idea or Concept]

Phrase: "proposes"

Phrase: "a mechanism for efflux of potentially detrimental fatty acid anions"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   739   C0441712:Mechanism [Functional Concept]
   739   C1706376:Mechanism [Manufactured Object]

Phrase: "but"

Phrase: "does"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "implicate"

Phrase: "UCP3 in facilitating increased fatty acid oxidation."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0539733:uncoupling protein-3 [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   790   C1421315:UNCOUPLING PROTEIN 3 [Gene or Genome]
   762   C1159301:protein oxidation [Molecular Function]
   742   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.234: The results of this study support the first hypothesized mechanism, as we observed increased fatty acid oxidation due to increased UCP3 expression. 

Phrase: "The results of this study"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   797   C0683954:results study [Finding]
   726   C1274040:Result [Functional Concept]
   726   C1546471:Result [Idea or Concept]
   726   C2825142:Result [Finding]

Phrase: "support"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0183683:Support [Medical Device]
  1000   C1521721:Support [Conceptual Entity]

Phrase: "the first hypothesized mechanism,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0441712:Mechanism [Functional Concept]
   827   C1706376:Mechanism [Manufactured Object]

Phrase: "as"

Phrase: "we"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "increased fatty acid oxidation due to increased UCP3 expression."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   775   C1158366:fatty acid oxidation [Molecular Function]
   756   C0015684:Fatty acid [Lipid]
   754   C1159301:protein oxidation [Molecular Function]
   738   C0001128:Acid [Chemical]
   738   C0030011:Oxidation [Molecular Function]
   738   C0202406:Acid [Laboratory Procedure]
Processing 00000000.tx.235: The latter was not related to any effects of the adenoviral infection process itself as there was no change in fatty acid oxidation in GFP-infected cells. 

Phrase: "The latter"

Phrase: "was"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "related to any effects of the adenoviral infection process"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   764   C0851887:adenoviral infection [Disease or Syndrome]
   742   C0001483:Adenoviral [Virus]
   742   C0009450:Infection, NOS [Disease or Syndrome]
   742   C0439849:Related [Qualitative Concept]
   742   C0445223:Related [Finding]
   742   C1184743:Process [Body Part, Organ, or Organ Component]
   742   C1280500:effects [Qualitative Concept]
   742   C1522240:Process [Phenomenon or Process]
   729   C0745283:INFECTIOUS PROCESS [Pathologic Function]
   708 E C0163712:Relate [Organic Chemical]
   708 E C2348382:Effect [Qualitative Concept]

Phrase: "itself"

Phrase: "as"

Phrase: "there"

Phrase: "was"

Phrase: "no change in fatty acid oxidation"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0442739:No change [Finding]
   790   C1548568:No change [Intellectual Product]
   783   C0152254:Fatty change [Pathologic Function]
   753   C0392747:Change [Functional Concept]
   753   C0443172:change [Quantitative Concept]
   753   C1705241:Change [Quantitative Concept]

Phrase: "in GFP-infected cells."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   804   C0007634:Cells [Cell]
   804   C3282337:Cells [Cell]
   771 E C1269647:Cell [Cell]
   771 E C1704653:Cell [Medical Device]
   771 E C1948049:Cell [Spatial Concept]
   717   C0120285:green fluorescent protein [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]
Processing 00000000.tx.236: Previous studies involving supraphysiological expression of the UCPs have been criticized for the artifactual uncoupling of oxidative phosphorylation that results (21). 

Phrase: "Previous studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "involving"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1314939:Involving [Functional Concept]

Phrase: "supraphysiological expression of the UCPs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "have"

Phrase: "been"

Phrase: "criticized for the artifactual"

Phrase: "uncoupling of oxidative phosphorylation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0030013:Oxidative Phosphorylation [Molecular Function]
   770   C0031715:Phosphorylation [Molecular Function]
   770   C0311404:Oxidative [Functional Concept]
   770   C1158886:Phosphorylation [Molecular Function]

Phrase: "that results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "(21"

Phrase: ")."
Processing 00000000.tx.237: By inducing UCP3 protein expression within the physiological range, we aimed to avoid any artifactual uncoupling. 

Phrase: "By inducing UCP3 protein expression"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   858   C1171362:protein expression [Genetic Function]
   799   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "within the physiological range,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1514721:Range [Quantitative Concept]
   861   C2348147:Range [Quantitative Concept]
   861   C3542016:Range [Intellectual Product]

Phrase: "we"

Phrase: "aimed"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   966   C1947946:Aim [Idea or Concept]
   966   C2948600:Aim [Pharmacologic Substance]
   966   C3540471:AIM [Gene or Genome]
   966   C3540472:AIM [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "avoid"

Phrase: "any artifactual"

Phrase: "uncoupling."
Processing 00000000.tx.238: As the 2.2- to 2.5-fold induction of UCP3 expression resulted in no inherent decreases in mitochondrial membrane potential (Fig. 5) or any significant increases in basal oxygen consumption (Fig. 4) of cells, it is clear that artifactual uncoupling was not an issue. 

Phrase: "As the 2.2-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0740116:+2 [Quantitative Concept]
   861   C2827735:2+ [Quantitative Concept]
   861   C2981700:2+ [Classification]

Phrase: "to 2.5-fold induction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0205263:Induction [Functional Concept]
   812   C0857127:induction [Therapeutic or Preventive Procedure]

Phrase: "of UCP3 expression"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   875   C1171362:protein expression [Genetic Function]
   812   C0185117:Expression [Therapeutic or Preventive Procedure]
   756   C0539733:uncoupling protein-3 [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   756   C1421315:UNCOUPLING PROTEIN 3 [Gene or Genome]

Phrase: "resulted in no inherent decreases"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   760   C0547047:decreases [Quantitative Concept]
   726 E C0392756:Decrease [Qualitative Concept]
   726   C1274040:Result [Functional Concept]
   726   C1546471:Result [Idea or Concept]
   726   C2825142:Result [Finding]

Phrase: "in mitochondrial membrane potential"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
  1000   C1720920:Membrane Potential, Mitochondrial [Cell Function]
   901   C0025251:Membrane Potential [Cell Function]
   901   C0596952:Mitochondrial membrane [Cell Component]
   827   C0025255:Membrane [Tissue]
   827   C0026237:Mitochondrial [Cell Component]
   827   C0521451:Mitochondrial [Functional Concept]
   827   C0596901:Membrane [Cell Component]
   827   C1706182:Membrane [Manufactured Object]
   827   C3245505:Potential [Qualitative Concept]
   755 E C0205287:Membranous [Qualitative Concept]

Phrase: "(Fig. 5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")"

Phrase: "or"

Phrase: "any significant increases in basal oxygen consumption"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0442805:increases [Functional Concept]

Phrase: "(Fig. 4"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")"

Phrase: "of cells,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "it"

Phrase: "is"

Phrase: "clear"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2963144:Clear [Qualitative Concept]

Phrase: "that artifactual"

Phrase: "uncoupling"

Phrase: "was"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "an issue."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0033213:Issue [Finding]
  1000   C1706387:Issue [Intellectual Product]
Processing 00000000.tx.239: Although there was a trend for increased oxygen consumption with increased UCP3 expression, this however did not coincide with any decrease in mitochondria membrane potential (Fig. 5). 

Phrase: "Although"

Phrase: "there"

Phrase: "was"

Phrase: "a trend for increased oxygen consumption"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1521798:trend [Temporal Concept]

Phrase: "with increased UCP3 expression,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   853   C1171362:protein expression [Genetic Function]
   804   C0185117:Expression [Therapeutic or Preventive Procedure]
   717   C0539733:uncoupling protein-3 [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   717   C1421315:UNCOUPLING PROTEIN 3 [Gene or Genome]

Phrase: "this however"

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "coincide with any decrease"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0392756:Decrease [Qualitative Concept]
   770   C0547047:Decrease [Quantitative Concept]

Phrase: "in mitochondria membrane potential"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   901   C0025251:Membrane Potential [Cell Function]
   884   C0596952:Mitochondrion membrane [Cell Component]
   827   C0025255:Membrane [Tissue]
   827   C0596901:Membrane [Cell Component]
   827   C1706182:Membrane [Manufactured Object]
   827   C3245505:Potential [Qualitative Concept]
   755 E C0205287:Membranous [Qualitative Concept]

Phrase: "(Fig. 5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.240: It is possible that with substantially increased sample sizes, a statistically significant increase might be detected. 

Phrase: "It"

Phrase: "is"

Phrase: "possible"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332149:Possible [Qualitative Concept]
  1000   C1705910:Possible [Qualitative Concept]
  1000   C2362652:Possible [Qualitative Concept]

Phrase: "that with substantially increased sample sizes,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C0242618:Sizes, Sample [Quantitative Concept]
   783   C0332509:increased sizes [Finding]
   753   C0205217:Increased [Quantitative Concept]
   753   C0370003:Sample [Substance]
   753   C0442805:Increased [Functional Concept]
   753   C0456389:SIZES [Spatial Concept]
   753   C2347026:Sample [Conceptual Entity]

Phrase: "a statistically significant increase"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0442805:Increase [Functional Concept]
   734   C0237881:statistically significant [Quantitative Concept]

Phrase: "might"

Phrase: "be"

Phrase: "detected."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0442726:Detected [Finding]
  1000   C1511790:Detected [Therapeutic or Preventive Procedure]
Processing 00000000.tx.241: If there were actually an increase in coupled oxygen consumption, then it would presumably be driven by increased ATP demands (e.g., acyl-CoA synthase activity). 

Phrase: "If"

Phrase: "there"

Phrase: "were"

Phrase: "actually"

Phrase: "an increase in coupled oxygen consumption,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0442805:Increase [Functional Concept]

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "it"

Phrase: "would"

Phrase: "presumably"

Phrase: "be"

Phrase: "driven by increased ATP demands"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0205217:Increased [Quantitative Concept]
   760   C0441516:demands [Therapeutic or Preventive Procedure]
   760   C0442805:Increased [Functional Concept]
   760   C0699784:demands [Idea or Concept]
   726   C0013126:Drive [Mental Process]

Phrase: "("

Phrase: "e.g."

Phrase: ","

Phrase: "acyl-CoA synthase activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0205177:Activity [Functional Concept]
   812   C0439167:% activity [Quantitative Concept]
   812   C0441655:Activity [Activity]
   812   C1561536:*Activity [Idea or Concept]

Phrase: ")."
Processing 00000000.tx.242: Our findings indicate that uncoupled respiration does not necessarily follow overexpression, an important advance in our understanding of this mitochondrial anion carrier protein. 

Phrase: "Our findings"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C2607943:findings [Functional Concept]
  1000   C2926606:Findings [Clinical Attribute]
  1000   C3539655:Findings [Intellectual Product]
   966 E C0037088:Finding [Sign or Symptom]
   966 E C0243095:Finding [Finding]
   966 E C2825141:Finding [Finding]

Phrase: "indicate"

Phrase: "that uncoupled respiration"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0035203:Respiration [Physiologic Function]
   861   C0282636:respiration [Cell Function]
   861   C1160636:respiration [Biologic Function]

Phrase: "does"

Phrase: "not necessarily"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1518422:Not [Functional Concept]

Phrase: "follow"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332283:follow [Temporal Concept]
  1000   C1719822:Follow [Intellectual Product]

Phrase: "overexpression,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1514559:Overexpression [Genetic Function]

Phrase: "an important advance in our understanding of this mitochondrial anion carrier protein."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   736   C0725066:Advance [Medical Device]
Processing 00000000.tx.243: There are reports that increased UCP3 expression increases glucose metabolism. 

Phrase: "There"

Phrase: "are"

Phrase: "reports"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0684224:Report [Intellectual Product]
  1000   C0700287:Report [Health Care Activity]
  1000   C3273238:Report [Intellectual Product]

Phrase: "that increased UCP3 expression"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   853   C1171362:protein expression [Genetic Function]
   804   C0185117:Expression [Therapeutic or Preventive Procedure]
   717   C0539733:uncoupling protein-3 [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   717   C1421315:UNCOUPLING PROTEIN 3 [Gene or Genome]

Phrase: "increases"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "glucose metabolism."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0596620:glucose metabolism [Molecular Function]
   861   C0025519:Metabolism [Organism Function]
   861   C0025520:metabolism [Functional Concept]
Processing 00000000.tx.244: Mice that overexpress UCP3 protein in muscle at levels 20-fold normal have improved glucose homeostasis (41) and protection against hyperglycemic-induced damage (17). 

Phrase: "Mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mice [Mammal]
  1000   C0025929:mice [Mammal]
  1000   C0026809:Mice [Mammal]

Phrase: "that"

Phrase: "overexpress"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1514559:overexpress [Genetic Function]

Phrase: "UCP3 protein in muscle"

Phrase: "at levels 20-fold normal"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0205307:Normal [Qualitative Concept]
   812   C0439166:% normal [Quantitative Concept]
   812   C2347086:% Normal [Quantitative Concept]

Phrase: "have"

Phrase: "improved glucose homeostasis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C1326961:glucose homeostasis [Physiologic Function]
   827   C0019868:Homeostasis [Biologic Function]

Phrase: "(41"

Phrase: ")"

Phrase: "and"

Phrase: "protection against hyperglycemic-induced damage"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1545588:Protection [Finding]

Phrase: "(17"

Phrase: ")."
Processing 00000000.tx.245: Further, Huppertz et al. 

Phrase: "Further,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1517331:Further [Spatial Concept]
   966 E C0205108:far [Spatial Concept]

Phrase: "Huppertz et al."
Processing 00000000.tx.246: (26) demonstrated that substantial UCP3 overexpression using adenovirus gene transfer in L6 myotubes increases GLUT4 translocation and glucose uptake. 

Phrase: "(26"

Phrase: ")"

Phrase: "demonstrated"

Phrase: "that substantial UCP3 overexpression"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   853   C1514559:Protein Overexpression [Genetic Function]
           Overexpression
   717   C0539733:uncoupling protein-3 [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   717   C1421315:UNCOUPLING PROTEIN 3 [Gene or Genome]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "adenovirus gene transfer in L6 myotubes"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C1517499:Gene Transfer [Molecular Biology Research Technique]
   753   C0017337:Gene [Gene or Genome]
   753   C0040671:Transfer [Mental Process]
   753   C1705822:Transfer [Activity]

Phrase: "increases"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "GLUT4 translocation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0040715:Translocation [Cell or Molecular Dysfunction]
   861   C2987521:Translocation [Activity]

Phrase: "and"

Phrase: "glucose uptake."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1159527:glucose uptake [Cell Function]
   861   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   861   C0243144:Uptake [Physiologic Function]
   861   C0347980:% uptake [Quantitative Concept]
Processing 00000000.tx.247: The relative levels of UCP3 expression in the latter study were much higher than those herein. 

Phrase: "The relative levels of UCP3 expression"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   750   C0428479:Protein level [Laboratory or Test Result]
   750   C0456949:Level 3 [Intellectual Product]
   750   C3244092:expression level [Idea or Concept]
   744   C0441889:Levels [Qualitative Concept]
   711 E C0456079:Level [Classification]
   711 E C1547707:Level [Geographic Area]
   711 E C2946261:Level [Pharmacologic Substance]

Phrase: "in the latter study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0557651:Study [Manufactured Object]
   861   C2603343:Study [Research Activity]

Phrase: "were"

Phrase: "much higher than those herein."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   726   C0205250:High [Qualitative Concept]
   726   C1299351:High [Qualitative Concept]
   726   C2700149:HIGH [Intellectual Product]
Processing 00000000.tx.248: Although a very pronounced band for UCP3 was detected in Western blots of infected cells, no UCP3 was detected in the uninfected control cells. 

Phrase: "Although"

Phrase: "a very pronounced band for UCP3"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   789   C0242194:Band 3 Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   767   C0230715:A band [Cell Component]
   744   C0175723:Band [Medical Device]
   744   C0439645:Band [Spatial Concept]
   744   C1521913:band [Cell Component]

Phrase: "was"

Phrase: "detected in Western blots of infected cells,"
Meta Candidates (Total=11; Excluded=4; Pruned=0; Remaining=7)
   778   C0949466:Western Blots [Laboratory Procedure]
   748   C0007634:Cells [Cell]
   748   C0439663:Infected [Functional Concept]
   748   C0442726:Detected [Finding]
   748   C1511790:Detected [Therapeutic or Preventive Procedure]
   748   C1705493:Western [Spatial Concept]
   748   C3282337:Cells [Cell]
   745 E C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
   714 E C1269647:Cell [Cell]
   714 E C1704653:Cell [Medical Device]
   714 E C1948049:Cell [Spatial Concept]

Phrase: "no UCP3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0539733:uncoupling protein-3 [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
  1000   C1421315:UNCOUPLING PROTEIN 3 [Gene or Genome]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "was"

Phrase: "detected in the uninfected control cells."
Meta Candidates (Total=12; Excluded=3; Pruned=0; Remaining=9)
   753   C0007634:Cells [Cell]
   753   C0243148:control [Qualitative Concept]
   753   C0442726:Detected [Finding]
   753   C1511790:Detected [Therapeutic or Preventive Procedure]
   753   C1550141:Control [Substance]
   753   C1882979:Control [Conceptual Entity]
   753   C2587213:Control [Functional Concept]
   753   C3274648:Control [Qualitative Concept]
   753   C3282337:Cells [Cell]
   719 E C1269647:Cell [Cell]
   719 E C1704653:Cell [Medical Device]
   719 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.249: The latter findings may reflect artifactual uncoupling (e.g., due to supraphysiologic UCP3 levels). 

Phrase: "The latter findings"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   861   C2607943:findings [Functional Concept]
   861   C2926606:Findings [Clinical Attribute]
   861   C3539655:Findings [Intellectual Product]
   827 E C0037088:Finding [Sign or Symptom]
   827 E C0243095:Finding [Finding]
   827 E C2825141:Finding [Finding]

Phrase: "may"

Phrase: "reflect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0558058:reflect [Mental Process]

Phrase: "artifactual"

Phrase: "uncoupling"

Phrase: "("

Phrase: "e.g."

Phrase: ","

Phrase: "due to supraphysiologic UCP3 levels"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   836   C0428479:Protein level [Laboratory or Test Result]
   804   C0441889:Levels [Qualitative Concept]
   771 E C0456079:Level [Classification]
   771 E C1547707:Level [Geographic Area]
   771 E C2946261:Level [Pharmacologic Substance]
   717   C0539733:uncoupling protein-3 [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   717   C1421315:UNCOUPLING PROTEIN 3 [Gene or Genome]

Phrase: ")."
Processing 00000000.tx.250: For example, the chronic treatment of the L6 cells with doses of dinitrophenol similar to those used herein (1050 mol/l) resulted in increased glucose uptake and metabolism through a phosphatidylinositol-3-kinase mechanism, similar to the effects observed for UCP3 infection. 

Phrase: "For example,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707959:Example [Conceptual Entity]

Phrase: "the chronic treatment of the L6 cells"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   748   C0039798:treatment [Functional Concept]
   748   C0087111:Treatment [Therapeutic or Preventive Procedure]
   748   C1522326:Treatment [Functional Concept]
   748   C1533734:Treatment [Therapeutic or Preventive Procedure]
   748   C1705169:Treatment [Conceptual Entity]
   748   C3538994:TREATMENT [Research Activity]

Phrase: "with doses"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0178602:Doses [Quantitative Concept]
   966 E C0869039:Dose [Quantitative Concept]
   966 E C1114758:Dose # [Clinical Attribute]
   966 E C1428722:DOS [Gene or Genome]

Phrase: "of dinitrophenol"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0012466:Dinitrophenol [Organic Chemical]

Phrase: "similar to those used herein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C2348205:Similar [Qualitative Concept]

Phrase: "(1050 mol/l)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   901   C0347982:mol/L [Quantitative Concept]

Phrase: "resulted in increased glucose uptake"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   806   C0860803:increased glucose [Finding]
   806   C1159527:glucose uptake [Cell Function]
   760   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   760   C0205217:Increased [Quantitative Concept]
   760   C0243144:Uptake [Physiologic Function]
   760   C0347980:% uptake [Quantitative Concept]
   760   C0442805:Increased [Functional Concept]
   726   C1274040:Result [Functional Concept]
   726   C1546471:Result [Idea or Concept]
   726   C2825142:Result [Finding]

Phrase: "and"

Phrase: "metabolism through a phosphatidylinositol-3-kinase mechanism,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   774   C1158430:phosphatidylinositol metabolism [Molecular Function]
   748   C0025519:Metabolism [Organism Function]
   748   C0025520:metabolism [Functional Concept]

Phrase: "similar to the effects"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C2348205:Similar [Qualitative Concept]

Phrase: "observed for UCP3 infection."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0539733:uncoupling protein-3 [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   833   C1421315:UNCOUPLING PROTEIN 3 [Gene or Genome]
   753   C0009450:Infection, NOS [Disease or Syndrome]
   753   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C1441672:Observed [Functional Concept]
Processing 00000000.tx.251: Although these authors did not assess either mitochondrial membrane potential or oxygen consumption, they did demonstrate increased lactate production in UCP3-infected cells, consistent with the possibility that mitochondria were uncoupled (i.e., cells would need to rely exclusively on glycolytic ATP production). 

Phrase: "Although"

Phrase: "these authors"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0221193:Authors [Professional or Occupational Group]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "assess"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1516048:Assess [Activity]

Phrase: "either mitochondrial membrane potential"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   923   C1720920:Membrane Potential, Mitochondrial [Cell Function]
   861   C0025251:Membrane Potential [Cell Function]
   861   C0596952:Mitochondrial membrane [Cell Component]
   812   C0025255:Membrane [Tissue]
   812   C0026237:Mitochondrial [Cell Component]
   812   C0521451:Mitochondrial [Functional Concept]
   812   C0596901:Membrane [Cell Component]
   812   C1706182:Membrane [Manufactured Object]
   812   C3245505:Potential [Qualitative Concept]
   741 E C0205287:Membranous [Qualitative Concept]

Phrase: "or"

Phrase: "oxygen consumption,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0030055:Oxygen Consumption [Clinical Attribute]
  1000   C1305742:oxygen consumption [Diagnostic Procedure]
   861   C0009830:Consumption [Activity]
   861   C0030054:Oxygen [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1947907:Consumption [Physiologic Function]

Phrase: "they"

Phrase: "did"

Phrase: "demonstrate"

Phrase: "increased lactate production in UCP3-infected cells,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0033268:production [Occupational Activity]

Phrase: "consistent with the possibility"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0332290:Consistent with [Idea or Concept]
           Consistent

Phrase: "that mitochondria"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0026237:Mitochondria [Cell Component]

Phrase: "were"

Phrase: "uncoupled"

Phrase: "(i.e., cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]
   734   C0683454:I-E [Diagnostic Procedure,Intellectual Product]

Phrase: "would"

Phrase: "need"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027552:Need [Qualitative Concept]
  1000   C0686904:need [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "rely"

Phrase: "exclusively on glycolytic ATP production"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0033268:production [Occupational Activity]

Phrase: ")."
Processing 00000000.tx.252: Our results showing dinitrophenol-activated glucose oxidation but no effect of UCP3 infection thus suggest that the effects on glucose metabolism in the latter study resulted from secondary uncoupling due to supraphysiological levels of UCP3. 

Phrase: "Our results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "showing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "dinitrophenol-activated glucose oxidation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0030011:Oxidation [Molecular Function]

Phrase: "but"

Phrase: "no effect of UCP3 infection thus"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C1301751:No effect [Qualitative Concept]
   744   C1280500:Effect [Qualitative Concept]
   744   C2348382:Effect [Qualitative Concept]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the effects on glucose metabolism"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   781   C1158774:glucose effect [Genetic Function]
   760   C1280500:effects [Qualitative Concept]
   726 E C2348382:Effect [Qualitative Concept]

Phrase: "in the latter study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0557651:Study [Manufactured Object]
   861   C2603343:Study [Research Activity]

Phrase: "resulted from secondary"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0027627:secondary [Neoplastic Process]
   790   C0175668:Secondary [Temporal Concept]
   790   C0205436:Secondary [Quantitative Concept]
   756   C1274040:Result [Functional Concept]
   756   C1546471:Result [Idea or Concept]
   756   C2825142:Result [Finding]

Phrase: "uncoupling due to supraphysiological levels of UCP3."
Meta Candidates (Total=12; Excluded=3; Pruned=0; Remaining=9)
   784   C0539733:uncoupling protein-3 [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   784   C1421315:UNCOUPLING PROTEIN 3 [Gene or Genome]
   764   C0678226:Due to [Functional Concept]
           due
   745   C0428479:Protein level [Laboratory or Test Result]
   745   C0456949:Level 3 [Intellectual Product]
   742   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0441889:Levels [Qualitative Concept]
   742   C3146286:Due [Idea or Concept]
   708 E C0456079:Level [Classification]
   708 E C1547707:Level [Geographic Area]
   708 E C2946261:Level [Pharmacologic Substance]
Processing 00000000.tx.253: A number of other investigations into UCP3 function have identified a role for the protein in the protection from ROS. 

Phrase: "A number of other investigations"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0237753:*Number [Quantitative Concept]
   760   C0449788:Number [Quantitative Concept]

Phrase: "into UCP3 function"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   875   C0815043:protein function [Amino Acid, Peptide, or Protein]
   875   C1527118:Protein Function [Molecular Function]
   812   C0031843:function [Physiologic Function]
   812   C0542341:Function [Functional Concept]
   812   C0700205:FUNCTION [Classification]
   812   C1705273:Function [Intellectual Product]
   756   C0539733:uncoupling protein-3 [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   756   C1421315:UNCOUPLING PROTEIN 3 [Gene or Genome]
   741 E C0205245:Functional [Functional Concept]
   741 E C2700217:Functional [Conceptual Entity]

Phrase: "have"

Phrase: "identified"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205396:Identified [Qualitative Concept]
  1000   C1550043:Identified [Finding]
  1000   C1551388:Identified [Functional Concept]

Phrase: "a role for the protein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0035820:Role [Social Behavior]
   760   C1705810:Role [Conceptual Entity]

Phrase: "in the protection"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1545588:Protection [Finding]

Phrase: "from ROS."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0162772:Reactive Oxygen Species [Biologically Active Substance,Element, Ion, or Isotope]
   827   C0030054:Oxygen [Element, Ion, or Isotope,Pharmacologic Substance]
   827   C0205332:Reactive [Qualitative Concept]
   827   C1705920:Species [Conceptual Entity]
Processing 00000000.tx.254: The UCP3 knockout mouse provided the first evidence of such a role (42). 

Phrase: "The UCP3 knockout mouse"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   840   C0206745:Knock-Out Mouse [Mammal]
   804   C0025914:Mouse [Mammal]
   804   C0025929:mouse [Mammal]
   804   C0026809:Mouse [Mammal]
   717   C0539733:uncoupling protein-3 [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   717   C1421315:UNCOUPLING PROTEIN 3 [Gene or Genome]

Phrase: "provided"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1999230:Provided [Activity]

Phrase: "the first evidence of such"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   806   C0332120:Evidence of [Functional Concept]
           Evidence

Phrase: "a role"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0035820:Role [Social Behavior]
  1000   C1705810:Role [Conceptual Entity]

Phrase: "(42"

Phrase: ")."
Processing 00000000.tx.255: Elegant in vitro studies conducted thereafter identified a potential role for by-products of ROS, such as the lipid peroxide 4-hydroxynonenal, as activators of UCP3 (43). 

Phrase: "Elegant in vitro studies"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   906   C0681828:in vitro study [Research Activity]
   812   C0947630:studies [Laboratory Procedure]
   779 E C0557651:Study [Manufactured Object]
   779 E C2603343:Study [Research Activity]

Phrase: "conducted"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0004927:Conduct [Individual Behavior]

Phrase: "thereafter"

Phrase: "identified"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205396:Identified [Qualitative Concept]
  1000   C1550043:Identified [Finding]
  1000   C1551388:Identified [Functional Concept]

Phrase: "a potential role for by-products of ROS,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   739   C0035820:Role [Social Behavior]
   739   C1705810:Role [Conceptual Entity]

Phrase: "such as the lipid peroxide 4-hydroxynonenal,"

Phrase: "as"

Phrase: "activators of UCP3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C0059297:activator protein 3 [Amino Acid, Peptide, or Protein]

Phrase: "(43"

Phrase: ")."
Processing 00000000.tx.256: Hydroxynonenal was shown to activate UCP3 as evidenced by mitochondrial uncoupling. 

Phrase: "Hydroxynonenal"

Phrase: "was"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "activate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515877:Activate [Functional Concept]
  1000   C1879547:Activate [Activity]

Phrase: "UCP3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0539733:uncoupling protein-3 [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
  1000   C1421315:UNCOUPLING PROTEIN 3 [Gene or Genome]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "as"

Phrase: "evidenced by mitochondrial"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0026237:Mitochondrial [Cell Component]
   790   C0521451:Mitochondrial [Functional Concept]
   756   C0332120:Evidence [Functional Concept]

Phrase: "uncoupling."
Processing 00000000.tx.257: This was interpreted as a mechanism to lower membrane potential and minimize further ROS production. 

Phrase: "This"

Phrase: "was"

Phrase: "interpreted as a mechanism to"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0441712:Mechanism [Functional Concept]
   760   C1285553:interpreted [Functional Concept]
   760   C1706376:Mechanism [Manufactured Object]

Phrase: "lower"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0441994:Lower [Spatial Concept]
  1000   C1548802:Lower [Body Location or Region]
  1000   C2003888:Lower [Activity]

Phrase: "membrane potential"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C0025251:Membrane Potential [Cell Function]
   861   C0025255:Membrane [Tissue]
   861   C0596901:Membrane [Cell Component]
   861   C1706182:Membrane [Manufactured Object]
   861   C3245505:Potential [Qualitative Concept]
   789 E C0205287:Membranous [Qualitative Concept]

Phrase: "and"

Phrase: "minimize"

Phrase: "further ROS production."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0033268:production [Occupational Activity]
   717   C0162772:Reactive Oxygen Species [Biologically Active Substance,Element, Ion, or Isotope]
Processing 00000000.tx.258: This mechanism for UCP3 activation is depicted as mechanism 4 in Fig. 

Phrase: "This mechanism for UCP3 activation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0441712:Mechanism [Functional Concept]
   748   C1706376:Mechanism [Manufactured Object]

Phrase: "is"

Phrase: "depicted as mechanism 4"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0441712:Mechanism [Functional Concept]
   770   C1706376:Mechanism [Manufactured Object]

Phrase: "in Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.259: 7. 

Phrase: "7."
Processing 00000000.tx.260: It has also been proposed that UCP3 functions to remove lipid peroxides from mitochondria and thus protect cells from potentially damaging ROS and their by-products (mechanism 3 in Fig. 7) (44). 

Phrase: "It"

Phrase: "has"

Phrase: "also"

Phrase: "been"

Phrase: "proposed"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1441414:PROPOSED [Idea or Concept]
  1000   C1553874:Proposed [Qualitative Concept]
  1000   C1578820:Proposed [Idea or Concept]

Phrase: "that UCP3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0539733:uncoupling protein-3 [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
  1000   C1421315:UNCOUPLING PROTEIN 3 [Gene or Genome]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "functions"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0031843:function [Physiologic Function]
  1000   C0542341:Function [Functional Concept]
  1000   C0700205:FUNCTION [Classification]
  1000   C1705273:Function [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "remove"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0849355:remove [Qualitative Concept]
  1000   C1883720:Remove [Activity]
  1000   C3244314:remove [Functional Concept]

Phrase: "lipid peroxides from mitochondria"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C0023776:Lipid Peroxides [Lipid]
   770   C0023779:Lipid [Lipid]
   770   C0031180:Peroxides [Inorganic Chemical]

Phrase: "and"

Phrase: "thus"

Phrase: "protect"

Phrase: "cells from potentially"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   790   C0007634:Cells [Cell]
   790   C3282337:Cells [Cell]
   756 E C1269647:Cell [Cell]
   756 E C1704653:Cell [Medical Device]
   756 E C1948049:Cell [Spatial Concept]

Phrase: "damaging"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0010957:Damage [Injury or Poisoning]
   966   C1883709:Damage [Functional Concept]

Phrase: "ROS"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0162772:Reactive Oxygen Species [Biologically Active Substance,Element, Ion, or Isotope]
   827   C0030054:Oxygen [Element, Ion, or Isotope,Pharmacologic Substance]
   827   C0205332:Reactive [Qualitative Concept]
   827   C1705920:Species [Conceptual Entity]

Phrase: "and"

Phrase: "their by-products"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0006539:BY [Geographic Area]
   861   C1514468:Products [Entity]
   827 E C1704444:Product [Quantitative Concept]

Phrase: "(mechanism 3 in Fig. 7"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0349966:Fig [Food]
   760   C0441712:Mechanism [Functional Concept]
   760   C1337208:FIG [Food]
   760   C1706376:Mechanism [Manufactured Object]

Phrase: ")"

Phrase: "(44"

Phrase: ")."
Processing 00000000.tx.261: Based on the latter two proposed mechanisms, we investigated ROS production in our treated and untreated L6 muscle cells. 

Phrase: "Based on the latter two proposed mechanisms,"
Meta Candidates (Total=11; Excluded=4; Pruned=0; Remaining=7)
   748   C0205448:Two [Quantitative Concept]
   748   C0441712:Mechanisms [Functional Concept]
   748   C1441414:PROPOSED [Idea or Concept]
   748   C1527178:Based [Functional Concept]
   748   C1553874:Proposed [Qualitative Concept]
   748   C1578820:Proposed [Idea or Concept]
   748   C1705938:Based [Idea or Concept]
   714 E C0002055:base [Inorganic Chemical]
   714 E C0178499:Base [Chemical Viewed Functionally]
   714 E C1706376:Mechanism [Manufactured Object]
   714 E C1880279:Base [Biomedical or Dental Material]

Phrase: "we"

Phrase: "investigated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292732:investigated [Functional Concept]

Phrase: "ROS production in our treated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0033268:production [Occupational Activity]

Phrase: "and"

Phrase: "untreated L6 muscle cells."
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   861   C0596981:Muscle Cells [Cell]
   812   C0007634:Cells [Cell]
   812   C0026845:Muscle [Tissue]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]
   741 E C0442025:Muscular [Spatial Concept]
Processing 00000000.tx.262: Our findings demonstrate that moderate increases in UCP3 protein and chronic dinitrophenol treatment both decrease ROS production. 

Phrase: "Our findings"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C2607943:findings [Functional Concept]
  1000   C2926606:Findings [Clinical Attribute]
  1000   C3539655:Findings [Intellectual Product]
   966 E C0037088:Finding [Sign or Symptom]
   966 E C0243095:Finding [Finding]
   966 E C2825141:Finding [Finding]

Phrase: "demonstrate"

Phrase: "that moderate increases in UCP3 protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0442805:increases [Functional Concept]

Phrase: "and"

Phrase: "chronic dinitrophenol treatment"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   827   C0039798:treatment [Functional Concept]
   827   C0087111:Treatment [Therapeutic or Preventive Procedure]
   827   C1522326:Treatment [Functional Concept]
   827   C1533734:Treatment [Therapeutic or Preventive Procedure]
   827   C1705169:Treatment [Conceptual Entity]
   827   C3538994:TREATMENT [Research Activity]

Phrase: "both"

Phrase: "decrease"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0392756:Decrease [Qualitative Concept]
  1000   C0547047:Decrease [Quantitative Concept]

Phrase: "ROS production."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0033268:production [Occupational Activity]
   756   C0162772:Reactive Oxygen Species [Biologically Active Substance,Element, Ion, or Isotope]
Processing 00000000.tx.263: However, classic evidence of mitochondrial uncoupling was evident only in the case of dinitrophenol treatment, which caused increased cellular oxygen consumption and a corresponding reduction in membrane potential. 

Phrase: "However,"

Phrase: "classic evidence of mitochondrial"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0332120:Evidence of [Functional Concept]
           Evidence

Phrase: "uncoupling"

Phrase: "was"

Phrase: "evident only in the case of dinitrophenol treatment,"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   744   C0012466:Dinitrophenol [Organic Chemical]
   744   C0039798:treatment [Functional Concept]
   744   C0087111:Treatment [Therapeutic or Preventive Procedure]
   744   C0205171:Only [Quantitative Concept]
   744   C0868928:Case [Functional Concept]
   744   C1522326:Treatment [Functional Concept]
   744   C1533734:Treatment [Therapeutic or Preventive Procedure]
   744   C1705169:Treatment [Conceptual Entity]
   744   C1706255:CASE [Medical Device]
   744   C1706256:Case [Conceptual Entity]
   744   C1720467:Only [Intellectual Product]
   744   C3538994:TREATMENT [Research Activity]
   731   C0332120:Evidence of [Functional Concept]

Phrase: "which"

Phrase: "caused"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0015127:cause [Functional Concept]
   966   C1524003:Cause [Conceptual Entity]

Phrase: "increased cellular oxygen consumption"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0030055:Oxygen Consumption [Clinical Attribute]
   861   C1305742:oxygen consumption [Diagnostic Procedure]
   812   C0009830:Consumption [Activity]
   812   C0030054:Oxygen [Element, Ion, or Isotope,Pharmacologic Substance]
   812   C1947907:Consumption [Physiologic Function]

Phrase: "and"

Phrase: "a corresponding reduction in membrane potential."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0301630:Reduction [Natural Phenomenon or Process]
   753   C0392756:Reduction [Qualitative Concept]
   753   C0441610:Reduction [Therapeutic or Preventive Procedure]
Processing 00000000.tx.264: This is consistent with earlier observations indicating that mild uncoupling, by reducing membrane potential, can diminish ROS production at complex I of the electron transport chain (25). 

Phrase: "This"

Phrase: "is"

Phrase: "consistent with earlier observations"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0332290:Consistent with [Idea or Concept]
           Consistent

Phrase: "indicating"

Phrase: "that mild"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2945599:Mild [Qualitative Concept]

Phrase: "uncoupling"

Phrase: ","

Phrase: "by reducing membrane potential,"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   901   C0025251:Membrane Potential [Cell Function]
   827   C0025255:Membrane [Tissue]
   827   C0596901:Membrane [Cell Component]
   827   C1706182:Membrane [Manufactured Object]
   827   C3245505:Potential [Qualitative Concept]
   755 E C0205287:Membranous [Qualitative Concept]

Phrase: "can"

Phrase: "diminish"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205216:diminish [Quantitative Concept]

Phrase: "ROS production at complex I of the electron transport chain"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   736   C0033268:production [Occupational Activity]

Phrase: "(25"

Phrase: ")."
Processing 00000000.tx.265: It has been hypothesized that UCPs (including UCP3) function within a negative-feedback pathway that limits mitochondrial ROS production through mild uncoupling. 

Phrase: "It"

Phrase: "has"

Phrase: "been"

Phrase: "hypothesized"

Phrase: "that UCPs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1421313:UCP [Gene or Genome]

Phrase: "("

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "UCP3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0539733:uncoupling protein-3 [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
  1000   C1421315:UNCOUPLING PROTEIN 3 [Gene or Genome]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ")"

Phrase: "function within a negative-feedback pathway"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   753   C0015744:Feedback [Phenomenon or Process]
   753   C0031843:function [Physiologic Function]
   753   C0205160:Negative [Qualitative Concept]
   753   C0542341:Function [Functional Concept]
   753   C0700205:FUNCTION [Classification]
   753   C1513916:Negative [Finding]
   753   C1704259:Pathway [Molecular Function]
   753   C1705273:Function [Intellectual Product]
   753   C1705987:Pathway [Conceptual Entity]
   753   C2825415:Negative [Conceptual Entity]
   753   C2825491:Negative [Qualitative Concept]
   753   C2911691:Feedback [Mental Process]

Phrase: "that"

Phrase: "limits"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439801:limit [Functional Concept]
  1000   C1549649:Limit [Idea or Concept]
  1000   C2349209:Limit [Conceptual Entity]

Phrase: "mitochondrial ROS production through mild"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0033268:production [Occupational Activity]

Phrase: "uncoupling."
Processing 00000000.tx.266: In vitro evidence for this hypothesis comes from the observation that superoxide-dependent activation of UCP3 causes mild uncoupling in mitochondria (45). 

Phrase: "In vitro evidence for this hypothesis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0332120:Evidence [Functional Concept]

Phrase: "comes from the observation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0302523:Observation [Research Activity]
   770   C0700325:observation [Health Care Activity]
   770   C1964257:Observation [Diagnostic Procedure]

Phrase: "that superoxide-dependent activation of UCP3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   767   C0599177:protein activation [Genetic Function]
   744   C1879547:Activation [Activity]

Phrase: "causes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0015127:cause [Functional Concept]
  1000   C1314792:Causes [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "mild"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2945599:Mild [Qualitative Concept]

Phrase: "uncoupling in mitochondria"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0026237:Mitochondria [Cell Component]

Phrase: "(45"

Phrase: ")."
Processing 00000000.tx.267: In vivo overexpression of UCP1 completely reverses hyperglycemia-induced mitochondrial ROS overproduction in aortic endothelial cells (46). 

Phrase: "In vivo overexpression of UCP1 completely"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1514559:Overexpression [Genetic Function]

Phrase: "reverses"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1555029:Reverse [Idea or Concept]

Phrase: "hyperglycemia-induced mitochondrial ROS overproduction in aortic endothelial cells"

Phrase: "(46"

Phrase: ")."
Processing 00000000.tx.268: However, we found that UCP3 overexpression was not accompanied by changes in either cellular oxygen consumption or membrane potential, despite its significant negative impact on ROS production. 

Phrase: "However,"

Phrase: "we"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "that UCP3 overexpression"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   875   C1514559:Protein Overexpression [Genetic Function]
           Overexpression
   756   C0539733:uncoupling protein-3 [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   756   C1421315:UNCOUPLING PROTEIN 3 [Gene or Genome]

Phrase: "was"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "accompanied by changes"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0392747:changes [Functional Concept]
   790   C0443172:changes [Quantitative Concept]
   756 E C1705241:Change [Quantitative Concept]

Phrase: "in either cellular oxygen consumption"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0030055:Oxygen Consumption [Clinical Attribute]
   861   C1305742:oxygen consumption [Diagnostic Procedure]
   812   C0009830:Consumption [Activity]
   812   C0030054:Oxygen [Element, Ion, or Isotope,Pharmacologic Substance]
   812   C1947907:Consumption [Physiologic Function]

Phrase: "or"

Phrase: "membrane potential,"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C0025251:Membrane Potential [Cell Function]
   861   C0025255:Membrane [Tissue]
   861   C0596901:Membrane [Cell Component]
   861   C1706182:Membrane [Manufactured Object]
   861   C3245505:Potential [Qualitative Concept]
   789 E C0205287:Membranous [Qualitative Concept]

Phrase: "despite its significant negative impact"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1825598:IMPACT [Gene or Genome]

Phrase: "on ROS production."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0033268:production [Occupational Activity]
   756   C0162772:Reactive Oxygen Species [Biologically Active Substance,Element, Ion, or Isotope]
Processing 00000000.tx.269: This implies that diminished ROS production in myotubes, although UCP3 dependent, is not mediated by uncoupling of oxidative phosphorylation. 

Phrase: "This"

Phrase: "implies"

Phrase: "that diminished ROS production in myotubes,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0033268:production [Occupational Activity]

Phrase: "although"

Phrase: "UCP3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0539733:uncoupling protein-3 [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
  1000   C1421315:UNCOUPLING PROTEIN 3 [Gene or Genome]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "dependent,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0851827:Dependent [Qualitative Concept]
  1000   C1701901:Dependent [Qualitative Concept]
  1000   C3244310:dependent [Functional Concept]

Phrase: "is"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "mediated by"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0086597:mediated [Social Behavior]
   833   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]

Phrase: "uncoupling of oxidative phosphorylation."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0030013:Oxidative Phosphorylation [Molecular Function]
   770   C0031715:Phosphorylation [Molecular Function]
   770   C0311404:Oxidative [Functional Concept]
   770   C1158886:Phosphorylation [Molecular Function]
Processing 00000000.tx.270: Mitochondrial ROS has been implicated as a central mediator of hyperglycemia-induced diabetes complications in endothelial cells (23). 

Phrase: "Mitochondrial ROS"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   923   C0162772:Reactive Oxygen Species [Biologically Active Substance,Element, Ion, or Isotope]
   812   C0030054:Oxygen [Element, Ion, or Isotope,Pharmacologic Substance]
   812   C0205332:Reactive [Qualitative Concept]
   812   C1705920:Species [Conceptual Entity]

Phrase: "has"

Phrase: "been"

Phrase: "implicated as a central mediator of hyperglycemia-induced diabetes complications"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   760   C0342257:Diabetes Complications [Pathologic Function]
   739   C0009566:Complications [Pathologic Function]
   739   C0011847:Diabetes [Disease or Syndrome]
   739   C0011849:Diabetes [Disease or Syndrome]
   739   C0020456:Hyperglycaemia [Disease or Syndrome]
   739   C0205099:Central [Spatial Concept]
   739   C0205263:Induced [Functional Concept]
   739   C1171258:complications [Pathologic Function]
   739   C1363844:Mediator [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C1879652:Central - [Laboratory Procedure]
   706 E C2362589:Complication [Idea or Concept]

Phrase: "in endothelial cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
  1000   C0225336:Endothelial Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C0014257:Endothelial [Tissue]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "(23"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.271: This, together with our observation that UCP3 mitigates ROS production in myotubes and a growing body of evidence that UCP3 overexpression improves glucose homeostasis (17,26,41), underscores the central role and potential importance of UCP3 function in the development treatment of diabetes. 

Phrase: "This,"

Phrase: "together with our observation"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0302523:Observation [Research Activity]
  1000   C0700325:observation [Health Care Activity]
  1000   C1964257:Observation [Diagnostic Procedure]
   928 E C1518527:OBSERVATIONAL [Research Activity]

Phrase: "that UCP3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0539733:uncoupling protein-3 [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
  1000   C1421315:UNCOUPLING PROTEIN 3 [Gene or Genome]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "mitigates"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C1553901:Mitigate [Idea or Concept]
   944 E C0205081:Moderate [Qualitative Concept]
   944 E C1881878:Moderate [Qualitative Concept]

Phrase: "ROS production in myotubes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0033268:production [Occupational Activity]

Phrase: "and"

Phrase: "a growing body of evidence"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0242821:body [Human]
   760   C0460148:Body [Anatomical Structure]
   760   C1268086:Body [Anatomical Structure]

Phrase: "that UCP3 overexpression"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   875   C1514559:Protein Overexpression [Genetic Function]
           Overexpression
   756   C0539733:uncoupling protein-3 [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   756   C1421315:UNCOUPLING PROTEIN 3 [Gene or Genome]

Phrase: "improves"

Phrase: "glucose homeostasis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1326961:glucose homeostasis [Physiologic Function]
   861   C0019868:Homeostasis [Biologic Function]

Phrase: "(17,"

Phrase: "26,"

Phrase: "41"

Phrase: ")"

Phrase: ","

Phrase: "underscores"

Phrase: "the central role"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0035820:Role [Social Behavior]
   861   C1705810:Role [Conceptual Entity]

Phrase: "and"

Phrase: "potential importance of UCP3 function"

Phrase: "in the development treatment"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0039798:treatment [Functional Concept]
   861   C0087111:Treatment [Therapeutic or Preventive Procedure]
   861   C1522326:Treatment [Functional Concept]
   861   C1533734:Treatment [Therapeutic or Preventive Procedure]
   861   C1705169:Treatment [Conceptual Entity]
   861   C3538994:TREATMENT [Research Activity]

Phrase: "of diabetes."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011847:Diabetes [Disease or Syndrome]
  1000   C0011849:Diabetes [Disease or Syndrome]
Processing 00000000.tx.272: In conclusion, our results demonstrate that moderate physiological induction of UCP3 protein expression in muscle cells results in increased fatty acid oxidation in the absence of uncoupling. 

Phrase: "In conclusion,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707478:Conclusion [Idea or Concept]

Phrase: "our results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "demonstrate"

Phrase: "that moderate physiological induction of UCP3 protein expression"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   739   C0205263:Induction [Functional Concept]
   739   C0857127:induction [Therapeutic or Preventive Procedure]

Phrase: "in muscle cells"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
  1000   C0596981:Muscle Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C0026845:Muscle [Tissue]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
   789 E C0442025:Muscular [Spatial Concept]

Phrase: "results in increased fatty acid oxidation"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   833   C1158366:fatty acid oxidation [Molecular Function]
   790   C0015684:Fatty acid [Lipid]
   753   C0001128:Acid [Chemical]
   753   C0030011:Oxidation [Molecular Function]
   753   C0202406:Acid [Laboratory Procedure]
   753   C0205217:Increased [Quantitative Concept]
   753   C0442805:Increased [Functional Concept]
   753   C1274040:Result [Functional Concept]
   753   C1546471:Result [Idea or Concept]
   753   C2825142:Result [Finding]

Phrase: "in the absence"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332197:absence [Quantitative Concept]
  1000   C1689985:Absence [Anatomical Abnormality]
   928 E C2699517:ABSENT [Finding]

Phrase: "of uncoupling."
Processing 00000000.tx.273: The results are consistent with the clinical findings of Argyropoulos et al. 

Phrase: "The results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "are"

Phrase: "consistent with the clinical findings of Argyropoulos et al."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   764   C0332290:Consistent with [Idea or Concept]
           Consistent
   709   C0332529:Consistency finding [Qualitative Concept]
Processing 00000000.tx.274: (47) who demonstrated decreased fat oxidation by indirect calorimetry in a population of Gullah-speaking African Americans with an exon six-splice donor single nucleotide polymorphism in the UCP3 gene. 

Phrase: "(47"

Phrase: ")"

Phrase: "who"

Phrase: "demonstrated"

Phrase: "decreased fat oxidation by indirect calorimetry"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0030011:Oxidation [Molecular Function]

Phrase: "in a population"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032659:Population [Quantitative Concept]
  1000   C1257890:Population [Population Group]

Phrase: "of Gullah-"

Phrase: "speaking"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0234856:Speaking [Daily or Recreational Activity]
   966 E C0600116:speak [Finding]
   966 E C1547187:Speak [Idea or Concept]

Phrase: "African Americans with an exon six-splice donor single nucleotide polymorphism"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   756   C0085756:African Americans [Population Group]
   738   C0027567:African [Population Group]
   738   C0596070:americans [Population Group]

Phrase: "in the UCP3 gene."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   875   C0751455:protein gene [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0017337:Gene [Gene or Genome]
   756   C0539733:uncoupling protein-3 [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   756   C1421315:UNCOUPLING PROTEIN 3 [Gene or Genome]
Processing 00000000.tx.275: The latter single nucleotide polymorphism was not, however, associated with decreased fat oxidation in the Maywood African-American population (48), in whom the degree of genetic admixture was greater than that in the Gullah-speaking population. 

Phrase: "The latter single nucleotide polymorphism"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   923   C0752046:Single Nucleotide Polymorphism [Nucleotide Sequence]
   812   C0028630:Nucleotide [Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0032529:Polymorphism [Genetic Function]
   812   C0037179:Single [Population Group]
   812   C0087136:single [Finding]
   812   C0205171:Single [Quantitative Concept]
   812   C1882417:Polymorphism [Qualitative Concept]

Phrase: "was"

Phrase: "not,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "however,"

Phrase: "associated with decreased fat oxidation"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   806   C0332281:Associated with [Qualitative Concept]
           Associated
   760   C0030011:Oxidation [Molecular Function]
   760   C0205216:Decreased [Quantitative Concept]
   760   C0392756:Decreased [Qualitative Concept]
   760   C0424612:FAT [Organism Attribute]
   760   C0442797:decreased [Qualitative Concept]
   726 E C0547047:Decrease [Quantitative Concept]
   726 E C0750490:Associate [Idea or Concept]
   726 E C1706221:Associate [Professional or Occupational Group]

Phrase: "in the Maywood African-American population"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0032659:Population [Quantitative Concept]
   812   C1257890:Population [Population Group]

Phrase: "(48"

Phrase: ")"

Phrase: ","

Phrase: "in whom"

Phrase: "the degree of genetic admixture"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0441889:Degree [Qualitative Concept]
   760   C0449286:Degree [Quantitative Concept]
   760   C0542560:Degree [Intellectual Product]
   760   C1561545:degree [Quantitative Concept]
   760   C2348088:Degree [Quantitative Concept]

Phrase: "was"

Phrase: "greater than that"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   882   C0439093:Greater Than [Quantitative Concept]
   790   C0443228:greater [Quantitative Concept]
   790   C1704243:Greater [Quantitative Concept]
   756 E C0549177:Great [Quantitative Concept]

Phrase: "in the Gullah-speaking population."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0032659:Population [Quantitative Concept]
   827   C1257890:Population [Population Group]
Processing 00000000.tx.276: Decreased fat oxidation has also been documented through indirect calorimetry in UCP3/ mice (20). 

Phrase: "Decreased fat oxidation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0030011:Oxidation [Molecular Function]

Phrase: "has"

Phrase: "also"

Phrase: "been"

Phrase: "documented through indirect calorimetry"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   833   C0006781:Calorimetry, Indirect [Laboratory Procedure]
   770   C0006779:Calorimetry [Laboratory Procedure]
   770   C0439852:Indirect [Qualitative Concept]
   770   C1301725:Documented [Health Care Activity]
   770   C1609436:documented [Idea or Concept]
   737 E C1301746:document [Intellectual Product]
   737 E C1547673:Document [Intellectual Product]

Phrase: "in UCP3/ mice"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   812   C0025914:Mice [Mammal]
   812   C0025929:mice [Mammal]
   812   C0026809:Mice [Mammal]
   756   C0539733:uncoupling protein-3 [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   756   C1421315:UNCOUPLING PROTEIN 3 [Gene or Genome]

Phrase: "(20"

Phrase: ")."
Processing 00000000.tx.277: In recent studies of skeletal muscle of UCP3tg mice with a twofold increase in UCP3 expression (49), there was an increased capacity for fat oxidation (e.g., increased carnitine palmitoyltransferase I and -hydroxyacyl-CoA dehydrogenase activities) in the absence of significant increases in thermogenesis. 

Phrase: "In recent studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "of skeletal muscle"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C0242692:Muscle, Skeletal [Tissue]
  1000   C1280260:Skeletal muscle [Body Part, Organ, or Organ Component]
   861   C0026845:Muscle [Tissue]
   861   C0037253:skeletal [Body System]
   861   C0521324:Skeletal [Spatial Concept]
   789 E C0442025:Muscular [Spatial Concept]

Phrase: "of UCP3tg mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0025914:Mice [Mammal]
   861   C0025929:mice [Mammal]
   861   C0026809:Mice [Mammal]

Phrase: "with a twofold increase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0442805:Increase [Functional Concept]

Phrase: "in UCP3 expression"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   875   C1171362:protein expression [Genetic Function]
   812   C0185117:Expression [Therapeutic or Preventive Procedure]
   756   C0539733:uncoupling protein-3 [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   756   C1421315:UNCOUPLING PROTEIN 3 [Gene or Genome]

Phrase: "(49"

Phrase: ")"

Phrase: ","

Phrase: "there"

Phrase: "was"

Phrase: "an increased capacity for fat oxidation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1516240:Capacity [Quantitative Concept]

Phrase: "("

Phrase: "e.g."

Phrase: ","

Phrase: "increased carnitine palmitoyltransferase I"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   923   C0007262:Carnitine palmitoyltransferase 1 [Amino Acid, Peptide, or Protein,Enzyme]
           Carnitine Palmitoyltransferase
   923   C0085966:Carnitine Palmitoyltransferase I [Amino Acid, Peptide, or Protein,Enzyme]
   923   C2258044:carnitine palmitoyltransferase I [Molecular Function]
   812   C0007258:Carnitine [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   812   C0021966:I- [Inorganic Chemical]
   812   C0087163:Carnitine [Organic Chemical,Pharmacologic Substance,Vitamin]
   812   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   812   C0729572:Palmitoyltransferase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and -"

Phrase: "hydroxyacyl-CoA dehydrogenase activities"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   923   C1415458:hydroxyacyl-CoA dehydrogenase [Gene or Genome]
   812   C0030016:Dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0441655:Activities [Activity]
   779 E C0205177:Activity [Functional Concept]
   779 E C0439167:% activity [Quantitative Concept]
   779 E C1561536:*Activity [Idea or Concept]

Phrase: ")"

Phrase: "in the absence"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332197:absence [Quantitative Concept]
  1000   C1689985:Absence [Anatomical Abnormality]
   928 E C2699517:ABSENT [Finding]

Phrase: "of significant increases"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0442805:increases [Functional Concept]

Phrase: "in thermogenesis."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0018841:Thermogenesis [Organism Function]
Processing 00000000.tx.278: Thus, our current findings support and extend the latter and provide a potential mechanism for the detrimental effects of decreased UCP3 expression in muscle with regard to the development of lipotoxicity and insulin resistance in muscle.  

Phrase: "Thus,"

Phrase: "our current findings"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   861   C2607943:findings [Functional Concept]
   861   C2926606:Findings [Clinical Attribute]
   861   C3539655:Findings [Intellectual Product]
   827 E C0037088:Finding [Sign or Symptom]
   827 E C0243095:Finding [Finding]
   827 E C2825141:Finding [Finding]

Phrase: "support"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0183683:Support [Medical Device]
  1000   C1521721:Support [Conceptual Entity]

Phrase: "and"

Phrase: "extend"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0231448:Extend [Functional Concept]
  1000   C0439792:extend [Spatial Concept]

Phrase: "the latter"

Phrase: "and"

Phrase: "provide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1999230:Provide [Activity]

Phrase: "a potential mechanism for the detrimental effects of decreased UCP3 expression"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   735   C0441712:Mechanism [Functional Concept]
   735   C1706376:Mechanism [Manufactured Object]

Phrase: "in muscle"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0026845:Muscle [Tissue]
   928 E C0442025:Muscular [Spatial Concept]

Phrase: "with regard to the development"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0243107:development [Physiologic Function]
  1000   C0678723:Development [Organism Function]
  1000   C1527148:Development [Functional Concept]
   928 E C0458003:Developmental [Qualitative Concept]

Phrase: "of lipotoxicity"

Phrase: "and"

Phrase: "insulin resistance in muscle."
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   833   C0021655:Insulin Resistance [Pathologic Function]
   833   C2700570:INSULIN RESISTANCE [Gene or Genome]
   770   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C0237834:Resistance [Mental Process]
   770   C1514892:Resistance [Physiologic Function]
   770   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C1579433:Insulin [Pharmacologic Substance]
   715 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
Processing 00000000.tx.279: ACKNOWLEDGMENTS  This study was funded by the Canadian Institute for Health Research Grants MOP 57810 (M.E.H) and MOP 12898 (M.B.W. and M.E.H.) and National Institutes of Health Grant NCRR P41 RR001395 (P.J.S.S.). 

Phrase: "ACKNOWLEDGMENTS"

Phrase: "This study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "was"

Phrase: "funded by the Canadian"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0016820:funded [Quantitative Concept]
   770   C0238884:CANADIAN [Finding]

Phrase: "Institute for Health Research Grants MOP 57810"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   778   C0260206:Research Grants [Research Activity]
   774   C0035172:Research Institute [Organization]
   748   C0018173:Grants [Quantitative Concept]
   748   C0018684:Health [Idea or Concept]
   748   C0021622:institute [Organization]
   748   C0035168:research [Research Activity]
   748   C0242481:Research [Research Activity]
   748   C1272753:Institute [Idea or Concept]
   714 E C1548284:Grant [Idea or Concept]

Phrase: "("

Phrase: "M."

Phrase: "E."

Phrase: "H)"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "MOP 12898"

Phrase: "(M.B.W."

Phrase: "and"

Phrase: "M."

Phrase: "E."

Phrase: "H.)"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "National Institutes of Health Grant NCRR P41 RR001395"

Phrase: "(P.J.S."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   913   C0234833:P s [Organ or Tissue Function]
   913   C0722388:P & S [Organic Chemical,Pharmacologic Substance]

Phrase: "S."

Phrase: ")."
Processing 00000000.tx.280: The authors thank Dr. 

Phrase: "The authors"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0221193:Authors [Professional or Occupational Group]

Phrase: "thank"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2986676:THANK [Gene or Genome]

Phrase: "Dr."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0031831:DR [Professional or Occupational Group]
  1000   C1707664:DR [Biomedical or Dental Material]
  1000   C2348314:Dr. [Conceptual Entity]
  1000   C3540849:DR [Idea or Concept]
Processing 00000000.tx.281: Amira Klip (Sick Childrens Hospital, Toronto) for donation of L6 muscle cells, Christopher Nolan and Dr. 

Phrase: "Amira Klip"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1426024:KLIP [Gene or Genome]

Phrase: "(Sick Childrens Hospital,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0019994:Hospital, NOS [Health Care Related Organization,Manufactured Object]
   827   C1510665:Hospital [Qualitative Concept]
   743 E C1609061:Hospitals [Intellectual Product]

Phrase: "Toronto"

Phrase: ")"

Phrase: "for donation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0680854:donation [Quantitative Concept]

Phrase: "of L6 muscle cells,"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   901   C0596981:Muscle Cells [Cell]
   827   C0007634:Cells [Cell]
   827   C0026845:Muscle [Tissue]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]
   755 E C0442025:Muscular [Spatial Concept]

Phrase: "Christopher Nolan"

Phrase: "and"

Phrase: "Dr."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0031831:DR [Professional or Occupational Group]
  1000   C1707664:DR [Biomedical or Dental Material]
  1000   C2348314:Dr. [Conceptual Entity]
  1000   C3540849:DR [Idea or Concept]
Processing 00000000.tx.282: Marc Prentki (McGill University, Montreal) for expert advice on glucose and fatty acid oxidation assay protocols, Dr. 

Phrase: "Marc Prentki"

Phrase: "(McGill University,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0041740:University [Manufactured Object,Organization]

Phrase: "Montreal"

Phrase: ")"

Phrase: "for expert advice"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0150600:Advice [Health Care Activity]

Phrase: "on glucose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "and"

Phrase: "fatty acid oxidation assay protocols,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   804   C0442711:Protocols [Intellectual Product]
   771 E C1507394:Protocol [Intellectual Product]
   771 E C1522729:Protocol [Intellectual Product]
   771 E C2348563:Protocol [Intellectual Product]
   717   C1158366:fatty acid oxidation [Molecular Function]

Phrase: "Dr."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0031831:DR [Professional or Occupational Group]
  1000   C1707664:DR [Biomedical or Dental Material]
  1000   C2348314:Dr. [Conceptual Entity]
  1000   C3540849:DR [Idea or Concept]
Processing 00000000.tx.283: William Sivitz (Department of Internal Medicine, University of Iowa) for the provision of recombinant adenoviruses, and Julie Beaulieu, Septimiu Bucurescu, Rick Sanger, and Kasia Hammar for skilled assistance with oxygen microelectrode work. 

Phrase: "William Sivitz"

Phrase: "(Department of Internal Medicine,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1704729:Department [Organization]

Phrase: "University of Iowa"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0022037:Iowa [Geographic Area]
   827   C0041740:University [Manufactured Object,Organization]
   827   C1555231:Iowa [Population Group]

Phrase: ")"

Phrase: "for the provision"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   928   C1549071:Provisional [Idea or Concept]

Phrase: "of recombinant adenoviruses,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0001483:Adenoviruses [Virus]
   861   C1514798:recombinant [Organism]
   827 E C0001486:Adenovirus [Disease or Syndrome]
   827 E C1552907:adenovirus, NOS [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "and"

Phrase: "Julie Beaulieu,"

Phrase: "Septimiu Bucurescu,"

Phrase: "Rick Sanger,"

Phrase: "and"

Phrase: "Kasia Hammar for skilled assistance"

Phrase: "with oxygen microelectrode work."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0043227:Work [Occupational Activity]
   734   C0597155:oxygen microelectrode [Medical Device]
Processing 00000000.tx.284: Address correspondence and reprint requests to Mary-Ellen Harper, PhD, Faculty of Medicine, University of Ottawa, 451 Smyth Rd., Ottawa, ON, Canada K1H 8M5. 

Phrase: "Address correspondence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0282413:Correspondence [Intellectual Product]

Phrase: "and"

Phrase: "reprint"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3273171:Reprint [Intellectual Product]

Phrase: "requests to Mary-Ellen Harper,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0686900:request [Functional Concept]
   760   C1272683:Request [Functional Concept]
   760   C1522634:Request [Intellectual Product]

Phrase: "PhD,"

Phrase: "Faculty of Medicine,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0015535:Faculty [Professional or Occupational Group]

Phrase: "University of Ottawa,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0041740:University [Manufactured Object,Organization]
   827   C1551454:Ottawa [Population Group]

Phrase: "451 Smyth Rd.,"

Phrase: "Ottawa,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1551454:Ottawa [Population Group]

Phrase: "ON,"

Phrase: "Canada K1H 8M5."
Processing 00000000.tx.285: E-mail: mharper{at}uottawa.ca Received for publication December 21, 2004 and accepted in revised form May 2, 2005 CPT, carnitine palmitoyl transferase; 

Phrase: "E-mail"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0013849:E-Mail [Intellectual Product]
  1000   C1705961:E-mail [Intellectual Product]
   861   C0024492:Mail [Manufactured Object]
   861   C1538057:MAIL [Gene or Genome]
   861   C1547565:Mail [Idea or Concept]

Phrase: ":"

Phrase: "mharper{at}uottawa.ca"

Phrase: "Received for publication December 21,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0034036:Publication [Intellectual Product,Manufactured Object]
   760   C0034037:Publication [Occupational Activity]
   760   C1514756:Received [Qualitative Concept]
   760   C1704324:Publication [Intellectual Product]

Phrase: "2004"

Phrase: "and"

Phrase: "accepted in revised form May 2,"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   753   C0348078:Form [Qualitative Concept]
   753   C0376315:Form [Manufactured Object]
   753   C1272684:Accepted [Qualitative Concept]
   753   C1522492:Form [Functional Concept]
   753   C1527075:Revised [Therapeutic or Preventive Procedure]
   753   C1548435:Accepted [Idea or Concept]
   719 E C1548601:Accept [Idea or Concept]

Phrase: "2005 CPT,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   923   C0007262:Carnitine Palmitoyltransferase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0729572:Palmitoyltransferase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0007258:Carnitine [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   812   C0040676:Transferase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0087163:Carnitine [Organic Chemical,Pharmacologic Substance,Vitamin]

Phrase: "carnitine palmitoyl transferase"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0007262:Carnitine Palmitoyltransferase [Amino Acid, Peptide, or Protein,Enzyme]
   901   C0729572:Palmitoyltransferase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0007258:Carnitine [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   827   C0040676:Transferase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0087163:Carnitine [Organic Chemical,Pharmacologic Substance,Vitamin]

Phrase: ";"
Processing 00000000.tx.286: CoASH, uncombined CoA; 

Phrase: "CoASH,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0009140:CoASH [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "uncombined CoA"

Phrase: ";"
Processing 00000000.tx.287: DCFDA, 5-(and 6)-carboxy-2',7'-dichlorohydofluorescein diacetate; 

Phrase: "DCFDA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0057672:DCFDA [Organic Chemical]

Phrase: "5-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "("

Phrase: "and"

Phrase: "6"

Phrase: ")-"

Phrase: "carboxy-2',"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0596260:Carboxy [Organic Chemical]

Phrase: "7'-dichlorohydofluorescein diacetate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0369114:Diacetate [Organic Chemical]

Phrase: ";"
Processing 00000000.tx.288: GFP, green fluorescent protein; 

Phrase: "GFP,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0120285:green fluorescent protein [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0303920:Fluorescent [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   827   C0332583:Green [Qualitative Concept]

Phrase: "green fluorescent protein"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0120285:green fluorescent protein [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0303920:Fluorescent [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   827   C0332583:Green [Qualitative Concept]

Phrase: ";"
Processing 00000000.tx.289: MTE1, mitochondrial thioesterase-1; 

Phrase: "MTE1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0026237:Mitochondrial [Cell Component]
   827   C0521451:Mitochondrial [Functional Concept]

Phrase: "mitochondrial thioesterase-1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0026237:Mitochondrial [Cell Component]
   827   C0521451:Mitochondrial [Functional Concept]

Phrase: ";"
Processing 00000000.tx.290: ROS, reactive oxygen species; 

Phrase: "ROS,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0162772:Reactive Oxygen Species [Biologically Active Substance,Element, Ion, or Isotope]
   827   C0030054:Oxygen [Element, Ion, or Isotope,Pharmacologic Substance]
   827   C0205332:Reactive [Qualitative Concept]
   827   C1705920:Species [Conceptual Entity]

Phrase: "reactive oxygen species"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0162772:Reactive Oxygen Species [Biologically Active Substance,Element, Ion, or Isotope]
   827   C0030054:Oxygen [Element, Ion, or Isotope,Pharmacologic Substance]
   827   C0205332:Reactive [Qualitative Concept]
   827   C1705920:Species [Conceptual Entity]

Phrase: ";"
Processing 00000000.tx.291: TMRE, tetramethylrhodamine ethyl ester; 

Phrase: "TMRE,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0672030:tetramethyl rhodamine ethyl ester [Organic Chemical,Pharmacologic Substance]
   827   C0014898:Ester [Organic Chemical]

Phrase: "tetramethylrhodamine ethyl ester"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0672030:tetramethyl rhodamine ethyl ester [Organic Chemical,Pharmacologic Substance]
   827   C0014898:Ester [Organic Chemical]

Phrase: ";"
Processing 00000000.tx.292: UCP, uncoupling protein  REFERENCES TOP ABSTRACT RESEARCH DESIGN AND METHODS RESULTS DISCUSSION REFERENCES  Mootha VK, Lindgren CM, Eriksson KF, Subramanian A, Sihag S, Lehar J, Puigserver P, Carlsson E, Ridderstrale M, Laurila E: PGC-1-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. 

Phrase: "UCP,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "uncoupling protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "TOP ABSTRACT RESEARCH DESIGN"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0035171:Research Design [Research Activity]
   812   C0035168:research [Research Activity]
   812   C0242481:Research [Research Activity]
   812   C1707689:Design [Activity]
   812   C2983265:DESIGN [Intellectual Product]

Phrase: "AND"

Phrase: "METHODS RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Mootha VK,"

Phrase: "Lindgren CM,"

Phrase: "Eriksson KF,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1427198:KF [Gene or Genome]

Phrase: "Subramanian A,"

Phrase: "Sihag S,"

Phrase: "Lehar J,"

Phrase: "Puigserver P,"

Phrase: "Carlsson E,"

Phrase: "Ridderstrale M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Laurila E"

Phrase: ":"

Phrase: "PGC-1-responsive genes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   886   C1418503:PGC gene [Gene or Genome]
   812   C0017337:Genes [Gene or Genome]

Phrase: "involved in oxidative phosphorylation"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0030013:Oxidative Phosphorylation [Molecular Function]
   770   C0031715:Phosphorylation [Molecular Function]
   770   C0311404:Oxidative [Functional Concept]
   770   C1158886:Phosphorylation [Molecular Function]
   770   C1314939:Involved [Functional Concept]

Phrase: "are"

Phrase: "coordinately"

Phrase: "downregulated in human diabetes."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0011847:Diabetes [Disease or Syndrome]
   770   C0011849:Diabetes [Disease or Syndrome]
   770   C0086418:Human [Human]
Processing 00000000.tx.293: Nat Genet34 :267 273,2003[Medline] Patti ME, Butte AJ, Crunkhorn S, Cusi K, Berria R, Kashyap S, Miyazaki Y, Kohane I, Costello M, Saccone R: Coordinated reduction of genes of oxidative metabolism in humans with insulin resistance and diabetes: potential role of PGC1 and NRF1. 

Phrase: "Nat Genet34"

Phrase: ":"

Phrase: "267 273,"

Phrase: "2003"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Patti"

Phrase: "ME,"

Phrase: "Butte AJ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0230613:AJ [Cell Component]

Phrase: "Crunkhorn S,"

Phrase: "Cusi K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Berria R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Kashyap S,"

Phrase: "Miyazaki Y,"

Phrase: "Kohane I,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Costello M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Saccone R"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: ":"

Phrase: "Coordinated reduction of genes of oxidative metabolism"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0301630:Reduction [Natural Phenomenon or Process]
   748   C0392756:Reduction [Qualitative Concept]
   748   C0441610:Reduction [Therapeutic or Preventive Procedure]

Phrase: "in humans"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086418:Humans [Human]

Phrase: "with insulin resistance"
Meta Candidates (Total=12; Excluded=5; Pruned=0; Remaining=7)
  1000   C0021655:Insulin Resistance [Pathologic Function]
  1000   C2700570:INSULIN RESISTANCE [Gene or Genome]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0237834:Resistance [Mental Process]
   861   C1514892:Resistance [Physiologic Function]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   789 E C0332325:Resistant [Functional Concept]
   789 E C1550464:resistent [Idea or Concept]
   789 E C2827757:RESISTANT [Laboratory or Test Result]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "diabetes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011847:Diabetes [Disease or Syndrome]
  1000   C0011849:Diabetes [Disease or Syndrome]

Phrase: ":"

Phrase: "potential role of PGC1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0035820:Role [Social Behavior]
   770   C1705810:Role [Conceptual Entity]

Phrase: "and"

Phrase: "NRF1."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1417700:NRF1 [Gene or Genome]
  1000   C1417846:NRF1 [Gene or Genome]
Processing 00000000.tx.294: Proc Natl Acad Sci U S A100 :8466 8471,2003[Abstract/Free FullText] Schrauwen P, Hesselink MK, Blaak EE, Borghouts LB, Schaart G, Saris WH, Keizer HA: Uncoupling protein 3 content is decreased in skeletal muscle of patients with type 2 diabetes. 

Phrase: "Proc Natl Acad Sci U S A100"

Phrase: ":"

Phrase: "8466 8471,"

Phrase: "2003"

Phrase: "[Abstract/Free FullText"

Phrase: "] Schrauwen P,"

Phrase: "Hesselink MK,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3539059:MK [Idea or Concept]

Phrase: "Blaak EE,"

Phrase: "Borghouts LB,"

Phrase: "Schaart G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "Saris WH,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2349143:Wh [Quantitative Concept]

Phrase: "Keizer HA"

Phrase: ":"

Phrase: "Uncoupling protein 3 content"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0423896:Content [Mental Process]
   812   C0456205:Content [Conceptual Entity]
   756   C0539733:uncoupling protein-3 [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   756   C1421315:UNCOUPLING PROTEIN 3 [Gene or Genome]

Phrase: "is"

Phrase: "decreased in skeletal muscle of patients"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   790   C0242692:Muscle, Skeletal [Tissue]
   790   C1280260:Skeletal muscle [Body Part, Organ, or Organ Component]
   753   C0026845:Muscle [Tissue]
   753   C0030705:Patients [Patient or Disabled Group]
   753   C0037253:skeletal [Body System]
   753   C0205216:Decreased [Quantitative Concept]
   753   C0392756:Decreased [Qualitative Concept]
   753   C0442797:decreased [Qualitative Concept]
   753   C0521324:Skeletal [Spatial Concept]
   719 E C0547047:Decrease [Quantitative Concept]

Phrase: "with type 2 diabetes."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0011860:Type 2 Diabetes [Disease or Syndrome]
   913   C1320657:type diabetes [Finding]
   901   C0441730:Type 2 [Classification]
   827   C0011847:Diabetes [Disease or Syndrome]
   827   C0011849:Diabetes [Disease or Syndrome]
   827   C0332307:Type [Qualitative Concept]
   827   C1547052:*Type [Quantitative Concept]
Processing 00000000.tx.295: Diabetes50 :2870 2873,2001[Abstract/Free FullText] Kozak LP, Harper ME: Mitochondrial uncoupling proteins in energy expenditure. 

Phrase: "Diabetes50"

Phrase: ":"

Phrase: "2870 2873,"

Phrase: "2001"

Phrase: "[Abstract/Free FullText"

Phrase: "] Kozak LP,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0037943:LP [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   861   C0228341:LP [Body Part, Organ, or Organ Component]
   861   C2239920:LP [Gene or Genome]

Phrase: "Harper"

Phrase: "ME"

Phrase: ":"

Phrase: "Mitochondrial uncoupling proteins in energy expenditure."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   816   C0066604:mitochondrial uncoupling protein [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   783   C0949610:Mitochondrial Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.296: Annu Rev Nutr20 :339 363,2000[Medline] Nedergaard J, Golozoubova V, Matthais A, Asadi A, Jacobsson A, Cannon B: UCP1: the only protein able to mediate adaptive non-shivering thermogenesis and metabolic inefficiency. 

Phrase: "Annu Rev Nutr20"

Phrase: ":"

Phrase: "339 363,"

Phrase: "2000"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Nedergaard J,"

Phrase: "Golozoubova V,"

Phrase: "Matthais A,"

Phrase: "Asadi A,"

Phrase: "Jacobsson A,"

Phrase: "Cannon B"

Phrase: ":"

Phrase: "UCP1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1421313:UCP1 [Gene or Genome]

Phrase: ":"

Phrase: "the only protein able to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "mediate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086597:Mediate [Social Behavior]

Phrase: "adaptive non-shivering thermogenesis"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   812   C0018841:Thermogenesis [Organism Function]
   812   C0036973:Shivering [Finding]
   812   C1518422:Non [Functional Concept]
   741 E C0040822:Trembled [Sign or Symptom]
   741 E C0234369:Trembles [Sign or Symptom]

Phrase: "and"

Phrase: "metabolic inefficiency."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0231184:Inefficiency [Finding]
   789 E C0231185:Inefficient [Functional Concept]
Processing 00000000.tx.297: Biochim Biophys Acta1504 :82 106,2001[Medline] Harper ME, Himms-Hagen J: Mitochondrial efficiency: lessons learned from transgenic mice. 

Phrase: "Biochim Biophys Acta1504"

Phrase: ":"

Phrase: "82 106,"

Phrase: "2001"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Harper"

Phrase: "ME,"

Phrase: "Himms-Hagen J"

Phrase: ":"

Phrase: "Mitochondrial efficiency"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0013682:Efficiency [Quantitative Concept]
   789 E C0442799:Efficient [Qualitative Concept]

Phrase: ":"

Phrase: "lessons"

Phrase: "learned from transgenic mice."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   833   C0025936:Mice, Transgenic [Mammal]
   770   C0003069:Transgenic [Animal]
   770   C0023185:learned [Mental Process]
   770   C0025914:Mice [Mammal]
   770   C0025929:mice [Mammal]
   770   C0026809:Mice [Mammal]
Processing 00000000.tx.298: Biochim Biophys Acta1504 :159 172,2001[Medline] Enerbck S, Jacobsson A, Simpson EM, Guerra C, Yamashita H, Harper ME, Kozak LP: Mice lacking mitochondrial uncoupling protein are cold-sensitive but not obese. 

Phrase: "Biochim Biophys Acta1504"

Phrase: ":"

Phrase: "159 172,"

Phrase: "2001"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Enerbck S,"

Phrase: "Jacobsson A,"

Phrase: "Simpson EM,"

Phrase: "Guerra C,"

Phrase: "Yamashita H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Harper"

Phrase: "ME,"

Phrase: "Kozak LP"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0037943:LP [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   861   C0228341:LP [Body Part, Organ, or Organ Component]
   861   C2239920:LP [Gene or Genome]

Phrase: ":"

Phrase: "Mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mice [Mammal]
  1000   C0025929:mice [Mammal]
  1000   C0026809:Mice [Mammal]

Phrase: "lacking"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332268:Lacking [Qualitative Concept]

Phrase: "mitochondrial uncoupling protein"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0066604:mitochondrial uncoupling protein [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   913   C0949610:Mitochondrial Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "are"

Phrase: "cold-sensitive"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0009269:cold sensitive [Sign or Symptom]
   861   C0332324:Sensitive [Functional Concept]
   861   C1550474:sensitive [Idea or Concept]

Phrase: "but"

Phrase: "not obese."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0028754:Obese [Disease or Syndrome]
Processing 00000000.tx.299: Nature387 :90 94,1997[Medline] Liu X, Rossmeisl M, McClaine J, Riachi M, Harper ME, Kozak LP: Paradoxical resistance to diet-induced obesity in UCP1-deficient mice. 

Phrase: "Nature387"

Phrase: ":"

Phrase: "90 94,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439083:>90 [Quantitative Concept]
   861   C0439087:<90 [Quantitative Concept]

Phrase: "1997"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Liu X,"

Phrase: "Rossmeisl M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "McClaine J,"

Phrase: "Riachi M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Harper"

Phrase: "ME,"

Phrase: "Kozak LP"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0037943:LP [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   861   C0228341:LP [Body Part, Organ, or Organ Component]
   861   C2239920:LP [Gene or Genome]

Phrase: ":"

Phrase: "Paradoxical resistance to diet-induced obesity"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   754   C0332325:Resistant to [Functional Concept]
   753   C0237834:Resistance [Mental Process]
   753   C1514892:Resistance [Physiologic Function]

Phrase: "in UCP1-deficient mice."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]
Processing 00000000.tx.300: J Clin Invest111 :399 407,2003[Abstract/Free FullText] Fleury C, Neverova M, Collins S, Raimbault S, Champigny O, Levi-Meyrueis C, Bouillaud F, Seldin MF, Surwit RS, Ricquier D: Uncoupling protein-2: a novel gene linked to obesity and hyperinsulinemia. 

Phrase: "J Clin Invest111"

Phrase: ":"

Phrase: "399 407,"

Phrase: "2003"

Phrase: "[Abstract/Free FullText"

Phrase: "] Fleury C,"

Phrase: "Neverova M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Collins S,"

Phrase: "Raimbault S,"

Phrase: "Champigny O,"

Phrase: "Levi-Meyrueis C,"

Phrase: "Bouillaud F,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "Seldin MF,"

Phrase: "Surwit RS,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3539879:RS [Idea or Concept]

Phrase: "Ricquier D"

Phrase: ":"

Phrase: "Uncoupling protein-2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0536847:uncoupling protein-2 [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
  1000   C1421314:UNCOUPLING PROTEIN 2 [Gene or Genome]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ":"

Phrase: "a novel gene"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017337:Gene [Gene or Genome]

Phrase: "linked to obesity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0028754:Obesity [Disease or Syndrome]
   790   C1963185:Obesity [Finding]
   756   C1517892:Link [Intellectual Product]
   756   C1704666:Link [Intellectual Product]

Phrase: "and"

Phrase: "hyperinsulinemia."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0020459:Hyperinsulinaemia [Disease or Syndrome]
Processing 00000000.tx.301: Nat Genet15 :269 272,1997[Medline] Gimeno RE, Dembski M, Weng X, Deng N, Shyjan AW, Gimeno CJ, Iris F, Ellis SJ, Woolf EA, Tartaglia LA: Cloning and characterization of an uncoupling protein homolog: a potential molecular mediator of human thermogenesis. 

Phrase: "Nat Genet15"

Phrase: ":"

Phrase: "269 272,"

Phrase: "1997"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Gimeno RE,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2986904:RE [Idea or Concept]

Phrase: "Dembski M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Weng X,"

Phrase: "Deng N,"

Phrase: "Shyjan AW,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0282379:AW [Geographic Area]
   861   C0332281:AW [Qualitative Concept]

Phrase: "Gimeno CJ,"

Phrase: "Iris F,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "Ellis SJ,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1515101:SJ [Geographic Area]
   861   C2986905:SJ [Idea or Concept]

Phrase: "Woolf EA,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0014963:EA [Organic Chemical,Pharmacologic Substance]
   861   C1457900:EA [Quantitative Concept]

Phrase: "Tartaglia LA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0023031:La [Element, Ion, or Isotope]

Phrase: ":"

Phrase: "Cloning"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0009015:Cloning [Research Activity]

Phrase: "and"

Phrase: "characterization of an uncoupling protein homolog"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1880022:Characterization [Activity]

Phrase: ":"

Phrase: "a potential molecular mediator of human thermogenesis."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1363844:Mediator [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.302: Diabetes46 :900 906,1997[Abstract] Boss O, Samec S, Paoloni-Giacobino A, Rosier C, Dulloo A, Seydoux J, Muzzin P, Giacobino JP: Uncoupling protein-3: a new member of the mitochondrial carrier family with tissue-specific expression. 

Phrase: "Diabetes46"

Phrase: ":"

Phrase: "900 906,"

Phrase: "1997"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Boss O,"

Phrase: "Samec S,"

Phrase: "Paoloni-Giacobino A,"

Phrase: "Rosier C,"

Phrase: "Dulloo A,"

Phrase: "Seydoux J,"

Phrase: "Muzzin P,"

Phrase: "Giacobino JP"

Phrase: ":"

Phrase: "Uncoupling protein-3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0539733:uncoupling protein-3 [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
  1000   C1421315:UNCOUPLING PROTEIN 3 [Gene or Genome]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ":"

Phrase: "a new member of the mitochondrial carrier family"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   767   C0086282:Family member [Family Group]
   767   C1611821:Family Member [Intellectual Product]
   744   C0680022:member [Population Group]
   744   C2698041:Member [Professional or Occupational Group]

Phrase: "with tissue-specific expression."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0185117:Expression [Therapeutic or Preventive Procedure]
   734   C1955394:Tissue specific [Body Substance]
Processing 00000000.tx.303: FEBS Lett408 :39 42,1997[Medline] Vidal-Puig A, Solanes G, Grujic D, Flier JS, Lowell BB: UCP3: an uncoupling protein homologue expressed preferentially and abundantly in skeletal muscle and brown adipose tissue. 

Phrase: "FEBS Lett408"

Phrase: ":"

Phrase: "39 42,"

Phrase: "1997"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Vidal-Puig A,"

Phrase: "Solanes G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "Grujic D,"

Phrase: "Flier JS,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1552154:Js [Body Part, Organ, or Organ Component]

Phrase: "Lowell BB"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0004739:BB [Geographic Area]
   861   C0332297:BB [Spatial Concept]

Phrase: ":"

Phrase: "UCP3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0539733:uncoupling protein-3 [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
  1000   C1421315:UNCOUPLING PROTEIN 3 [Gene or Genome]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ":"

Phrase: "an uncoupling protein homologue"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1334043:Homologue [Gene or Genome]

Phrase: "expressed"

Phrase: "preferentially"

Phrase: "and"

Phrase: "abundantly in skeletal muscle"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0242692:Muscle, Skeletal [Tissue]
   833   C1280260:Skeletal muscle [Body Part, Organ, or Organ Component]
   770   C0026845:Muscle [Tissue]
   770   C0037253:skeletal [Body System]
   770   C0521324:Skeletal [Spatial Concept]

Phrase: "and"

Phrase: "brown adipose tissue."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0006298:Adipose Tissue, Brown [Tissue]
   901   C0001527:Adipose tissue [Tissue]
   827   C0040300:Tissue [Tissue]
   827   C0678579:Brown [Natural Phenomenon or Process]
   827   C1547928:Tissue [Intellectual Product]
   755   C0028754:Adiposity [Disease or Syndrome]
   755   C1563743:adiposity [Organism Attribute]
Processing 00000000.tx.304: Biochem Biophys Res Commun235 :79 82,1997[Medline] Pecqueur C, Alves-Guerra M-C, Gelly C, Lvi-Meyrueis C, Couplan E, Collins S, Ricquier D, Bouillaud F, Miroux B: Uncoupling protein 2, in vivo distribution, induction upon oxidative stress, and evidence for translational regulation. 

Phrase: "Biochem Biophys Res Commun235"

Phrase: ":"

Phrase: "79 82,"

Phrase: "1997"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Pecqueur C,"

Phrase: "Alves-Guerra M-C,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   812   C0441923:M+ [Intellectual Product]

Phrase: "Gelly C,"

Phrase: "Lvi-Meyrueis C,"

Phrase: "Couplan E,"

Phrase: "Collins S,"

Phrase: "Ricquier D,"

Phrase: "Bouillaud F,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "Miroux B"

Phrase: ":"

Phrase: "Uncoupling protein 2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0536847:uncoupling protein-2 [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
  1000   C1421314:UNCOUPLING PROTEIN 2 [Gene or Genome]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "in vivo distribution,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0520511:distribution [Idea or Concept]
   827   C1704711:Distribution [Functional Concept]
   734   C1515655:In Vivo [Spatial Concept]

Phrase: "induction upon oxidative stress,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   881   C1518761:Oxidative Stress Induction [Cell or Molecular Dysfunction]
   770   C0205263:Induction [Functional Concept]
   770   C0857127:induction [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "evidence for translational regulation."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0332120:Evidence [Functional Concept]
Processing 00000000.tx.305: J Biol Chem276 :8705 8712,2001[Abstract/Free FullText] Arsenijevic D, Onuma H, Pecqueur C, Raimbault S, Manning BS, Miroux B, Couplan E, Alves-Guerra MC, Goubern M, Surwit R: Disruption of the uncoupling protein-2 gene in mice reveals a role in immunity and reactive oxygen species production. 

Phrase: "J Biol Chem276"

Phrase: ":"

Phrase: "8705 8712,"

Phrase: "2001"

Phrase: "[Abstract/Free FullText"

Phrase: "] Arsenijevic D,"

Phrase: "Onuma H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Pecqueur C,"

Phrase: "Raimbault S,"

Phrase: "Manning"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0024554:MAN [Finding]
   966   C0025266:Man [Population Group]
   966   C0086418:Man [Human]

Phrase: "BS,"

Phrase: "Miroux B,"

Phrase: "Couplan E,"

Phrase: "Alves-Guerra MC,"

Phrase: "Goubern M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Surwit R"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: ":"

Phrase: "Disruption of the uncoupling protein-2 gene"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0332453:Disruption [Functional Concept]

Phrase: "in mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mice [Mammal]
  1000   C0025929:mice [Mammal]
  1000   C0026809:Mice [Mammal]

Phrase: "reveals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:reveal [Qualitative Concept]

Phrase: "a role in immunity"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0035820:Role [Social Behavior]
   770   C1705810:Role [Conceptual Entity]

Phrase: "and"

Phrase: "reactive oxygen species production."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0033268:production [Occupational Activity]
   756   C0162772:Reactive Oxygen Species [Biologically Active Substance,Element, Ion, or Isotope]
Processing 00000000.tx.306: Nat Genet26 :435 439,2000[Medline] Harper ME, Antoniou A, Villalobos-Menuey E, Russo A, Trauger R, Vendemelio M, George A, Bartholomew R, Carlo D, Shaikh A: Characterization of a novel metabolic strategy used by drug-resistant tumor cells. 

Phrase: "Nat Genet26"

Phrase: ":"

Phrase: "435 439,"

Phrase: "2000"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Harper"

Phrase: "ME,"

Phrase: "Antoniou A,"

Phrase: "Villalobos-Menuey E,"

Phrase: "Russo A,"

Phrase: "Trauger R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Vendemelio M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "George A,"

Phrase: "Bartholomew R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Carlo D,"

Phrase: "Shaikh A"

Phrase: ":"

Phrase: "Characterization of a novel metabolic strategy"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1880022:Characterization [Activity]

Phrase: "used by drug-resistant tumor cells."
Meta Candidates (Total=21; Excluded=8; Pruned=0; Remaining=13)
   790   C0431085:Tumor cells [Cell]
   790   C1273517:Used by [Finding]
           used
   783   C0449889:Drug used [Functional Concept]
   767 E C0242510:drug use [Mental or Behavioral Dysfunction]
   756 E C0597032:Tumor Cell [Cell]
   753   C0007634:Cells [Cell]
   753   C0013227:Drug [Pharmacologic Substance]
   753   C0027651:Tumor [Neoplastic Process]
   753   C0332325:Resistant [Functional Concept]
   753   C1254351:Drug [Pharmacologic Substance]
   753   C1578706:Tumor [Intellectual Product]
   753   C2827757:RESISTANT [Laboratory or Test Result]
   753   C3273930:Tumor [Finding]
   753   C3282337:Cells [Cell]
   719 E C0042153:use [Functional Concept]
   719 E C0457083:Use [Functional Concept]
   719 E C1269647:Cell [Cell]
   719 E C1704653:Cell [Medical Device]
   719 E C1947944:Use [Intellectual Product]
   719 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.307: FASEB J16 :1550 1557,2002[Abstract/Free FullText] Chan CB, Saleh MC, Koshkin V, Wheeler MB: Uncoupling protein 2 and islet function. 

Phrase: "FASEB J16"

Phrase: ":"

Phrase: "1550 1557,"

Phrase: "2002"

Phrase: "[Abstract/Free FullText"

Phrase: "] Chan CB,"

Phrase: "Saleh MC,"

Phrase: "Koshkin V,"

Phrase: "Wheeler MB"

Phrase: ":"

Phrase: "Uncoupling protein 2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0536847:uncoupling protein-2 [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
  1000   C1421314:UNCOUPLING PROTEIN 2 [Gene or Genome]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "islet function."
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   861   C0031843:function [Physiologic Function]
   861   C0542341:Function [Functional Concept]
   861   C0700205:FUNCTION [Classification]
   861   C1705273:Function [Intellectual Product]
   789 E C0205245:Functional [Functional Concept]
   789 E C2700217:Functional [Conceptual Entity]
Processing 00000000.tx.308: Diabetes53 :S136 S142,2004[Abstract/Free FullText] Vincent AM, Olzmann JA, Brownlee M, Sivitz WI, Russell JW: Uncoupling proteins prevent glucose-induced neuronal oxidative stress and programmed cell death. 

Phrase: "Diabetes53"

Phrase: ":"

Phrase: "S136 S142,"

Phrase: "2004"

Phrase: "[Abstract/Free FullText"

Phrase: "] Vincent"

Phrase: "AM"

Phrase: ","

Phrase: "Olzmann JA,"

Phrase: "Brownlee M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Sivitz WI,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0043193:WI [Geographic Area]

Phrase: "Russell JW"

Phrase: ":"

Phrase: "Uncoupling proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "prevent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0309872:PREVENT [Pharmacologic Substance]

Phrase: "glucose-induced neuronal oxidative stress"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   840   C0242606:Oxidative Stress [Cell or Molecular Dysfunction]
   804   C0038435:Stress [Finding]
   804   C0311404:Oxidative [Functional Concept]
   733 E C0231297:Stressful [Functional Concept]

Phrase: "and"

Phrase: "programmed cell death."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0162638:Programmed Cell Death [Cell Function]
   901   C0007587:Cell Death [Cell Function]
   827   C0007634:Cell [Cell]
   827   C0011065:Death [Organism Function]
   827   C1269647:Cell [Cell]
   827   C1306577:Death, NOS [Finding]
   827   C1704653:Cell [Medical Device]
   827   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.309: Diabetes53 :726 734,2004[Abstract/Free FullText] Argyropoulos G, Harper ME: Uncoupling proteins and thermoregulation. 

Phrase: "Diabetes53"

Phrase: ":"

Phrase: "726 734,"

Phrase: "2004"

Phrase: "[Abstract/Free FullText"

Phrase: "] Argyropoulos G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "Harper"

Phrase: "ME"

Phrase: ":"

Phrase: "Uncoupling proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "thermoregulation."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0005905:Thermoregulation [Organism Function]
  1000   C0262758:thermoregulation [Therapeutic or Preventive Procedure]
Processing 00000000.tx.310: J Appl Physiol92 :2187 2198,2002[Abstract/Free FullText] Cadenas S, Buckingham JA, Samec S, Seydoux J, Din N, Dulloo AG, Brand MD: UCP2 and UCP3 rise in starved rat skeletal muscle but mitochondrial proton conductance is unchanged. 

Phrase: "J Appl Physiol92"

Phrase: ":"

Phrase: "2187 2198,"

Phrase: "2002"

Phrase: "[Abstract/Free FullText"

Phrase: "] Cadenas S,"

Phrase: "Buckingham JA,"

Phrase: "Samec S,"

Phrase: "Seydoux J,"

Phrase: "Din N,"

Phrase: "Dulloo AG,"

Phrase: "Brand MD"

Phrase: ":"

Phrase: "UCP2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1421314:UCP2 [Gene or Genome]

Phrase: "and"

Phrase: "UCP3 rise in starved rat skeletal muscle"

Phrase: "but"

Phrase: "mitochondrial proton conductance"

Phrase: "is"

Phrase: "unchanged."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0442739:Unchanged [Finding]
  1000   C2346711:Unchanged [Qualitative Concept]
Processing 00000000.tx.311: FEBS Lett462 :257 260,1999[Medline] Bezaire V, Hofmann W, Kramer JK, Kozak LP, Harper ME: Effects of fasting on muscle mitochondrial energetics and fatty acid metabolism in Ucp3/ and wild-type mice. 

Phrase: "FEBS Lett462"

Phrase: ":"

Phrase: "257 260,"

Phrase: "1999"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Bezaire V,"

Phrase: "Hofmann W,"

Phrase: "Kramer JK,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1420098:JK [Gene or Genome]

Phrase: "Kozak LP,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0037943:LP [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   861   C0228341:LP [Body Part, Organ, or Organ Component]
   861   C2239920:LP [Gene or Genome]

Phrase: "Harper"

Phrase: "ME"

Phrase: ":"

Phrase: "Effects of fasting"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C1280500:effects [Qualitative Concept]
   756 E C2348382:Effect [Qualitative Concept]

Phrase: "on muscle mitochondrial energetics"

Phrase: "and"

Phrase: "fatty acid metabolism in Ucp3/"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   862   C0596563:Fatty Acid Metabolism [Molecular Function]
   760   C0025519:Metabolism [Organism Function]
   760   C0025520:metabolism [Functional Concept]

Phrase: "and"

Phrase: "wild-type mice."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   966   C1520150:Wild Type Mouse [Mammal]
   901   C1883559:Wild Type [Organism Attribute]
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]
   827   C0332307:Type [Qualitative Concept]
   827   C0445392:Wild [Intellectual Product]
   827   C1547052:*Type [Quantitative Concept]
Processing 00000000.tx.312: Am J Physiol Endocrinol Metab281 :E975 E982,2001[Abstract/Free FullText] Stuart JA, Cadenas S, Jekabsons MB, Roussel D, Brand MD: Mitochondrial proton leak and the uncoupling protein 1 homologues. 

Phrase: "Am"

Phrase: "J Physiol Endocrinol Metab281"

Phrase: ":"

Phrase: "E975 E982,"

Phrase: "2001"

Phrase: "[Abstract/Free FullText"

Phrase: "] Stuart JA,"

Phrase: "Cadenas S,"

Phrase: "Jekabsons MB,"

Phrase: "Roussel D,"

Phrase: "Brand MD"

Phrase: ":"

Phrase: "Mitochondrial proton leak"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0332234:Leak [Functional Concept]
   827   C1608322:Leak NOS [Finding]
   827   C1881366:LEAK [Phenomenon or Process]

Phrase: "and"

Phrase: "the uncoupling protein 1 homologues."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   779   C1334043:Homologue [Gene or Genome]
   756   C0107264:uncoupling protein 1 [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   756   C1421313:UNCOUPLING PROTEIN 1 [Gene or Genome]
Processing 00000000.tx.313: Biochim Biophys Acta1504 :144 158,2001[Medline] Stuart JA, Harper JA, Brindle KM, Jekabsons MB, Brand MD: Physiological levels of mammalian uncoupling protein 2 do not uncouple yeast mitochondria. 

Phrase: "Biochim Biophys Acta1504"

Phrase: ":"

Phrase: "144 158,"

Phrase: "2001"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Stuart JA,"

Phrase: "Harper JA,"

Phrase: "Brindle KM,"

Phrase: "Jekabsons MB,"

Phrase: "Brand MD"

Phrase: ":"

Phrase: "Physiological levels of mammalian uncoupling protein 2"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   757   C0428479:Protein level [Laboratory or Test Result]
   757   C0456948:Level 2 [Intellectual Product]
   748   C0205463:Physiological [Functional Concept]
   748   C0441889:Levels [Qualitative Concept]
   714 E C0456079:Level [Classification]
   714 E C1547707:Level [Geographic Area]
   714 E C2946261:Level [Pharmacologic Substance]

Phrase: "do"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "uncouple"

Phrase: "yeast mitochondria."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0026237:Mitochondria [Cell Component]
Processing 00000000.tx.314: J Biol Chem276 :18633 18639,2001[Abstract/Free FullText] Du X-L, Edelstein D, Rossetti L, Fantus IG, Goldberg H, Ziyadeh F, Wu J, Brownlee M: Hyperglycemia-induced mitochondrial superoxide overproduction activates the hexosamine pathway and induces plasminogen activator inhibitor-1 expression by increasing Sp1 glycosylation. 

Phrase: "J Biol Chem276"

Phrase: ":"

Phrase: "18633 18639,"

Phrase: "2001"

Phrase: "[Abstract/Free FullText"

Phrase: "] Du X-L,"

Phrase: "Edelstein D,"

Phrase: "Rossetti L,"

Phrase: "Fantus IG,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0021027:Ig [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   861   C0305052:IG [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   861   C0360506:IG [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   861   C3541296:IG [Idea or Concept]

Phrase: "Goldberg H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Ziyadeh F,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "Wu J,"

Phrase: "Brownlee M"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: ":"

Phrase: "Hyperglycemia-induced mitochondrial superoxide overproduction"

Phrase: "activates"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515877:Activate [Functional Concept]
  1000   C1879547:Activate [Activity]

Phrase: "the hexosamine pathway"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1704259:Pathway [Molecular Function]
   861   C1705987:Pathway [Conceptual Entity]

Phrase: "and"

Phrase: "induces"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "plasminogen activator inhibitor-1 expression by increasing Sp1 glycosylation."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0185117:Expression [Therapeutic or Preventive Procedure]
Processing 00000000.tx.315: Proc Natl Acad Sci U S A97 :12222 12226,2000[Abstract/Free FullText] Brownlee M: Biochemistry and molecular cell biology of diabetic complications. 

Phrase: "Proc Natl Acad Sci U S A97"

Phrase: ":"

Phrase: "12222 12226,"

Phrase: "2000"

Phrase: "[Abstract/Free FullText"

Phrase: "] Brownlee M"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: ":"

Phrase: "Biochemistry"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0005477:Biochemistry [Occupation or Discipline]

Phrase: "and"

Phrase: "molecular cell biology of diabetic complications."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0010819:Cell Biology [Biomedical Occupation or Discipline]
   783   C0026376:Molecular Biology [Biomedical Occupation or Discipline]
   753   C0005532:Biology [Biomedical Occupation or Discipline]
Processing 00000000.tx.316: Nature414 :813 820,2001[Medline] Miwa S, St-Pierre J, Partridge L, Brand MD: Superoxide and hydrogen peroxide production by Drosophila mitochondria. 

Phrase: "Nature414"

Phrase: ":"

Phrase: "813 820,"

Phrase: "2001"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Miwa S,"

Phrase: "St-Pierre J,"

Phrase: "Partridge L,"

Phrase: "Brand MD"

Phrase: ":"

Phrase: "Superoxide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0038836:Superoxide [Element, Ion, or Isotope]

Phrase: "and"

Phrase: "hydrogen peroxide production by Drosophila mitochondria."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0033268:production [Occupational Activity]
Processing 00000000.tx.317: Free Radic Biol Med35 :938 948,2003[Medline] Huppertz C, Fischer BM, Kim YB, Kotani K, Vidal-Puig A, Slieker LJ, Sloop KW, Lowell BB, Kahn BB: Uncoupling protein 3 (UCP3) stimulates glucose uptake in muscle cells through a phosphoinositide 3-kinase-dependent mechanism. 

Phrase: "Free Radic Biol Med35"

Phrase: ":"

Phrase: "938 948,"

Phrase: "2003"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Huppertz C,"

Phrase: "Fischer BM,"

Phrase: "Kim YB,"

Phrase: "Kotani K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Vidal-Puig A,"

Phrase: "Slieker LJ,"

Phrase: "Sloop KW,"

Phrase: "Lowell BB,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0004739:BB [Geographic Area]
   861   C0332297:BB [Spatial Concept]

Phrase: "Kahn BB"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0004739:BB [Geographic Area]
   861   C0332297:BB [Spatial Concept]

Phrase: ":"

Phrase: "Uncoupling protein 3 (UCP3)"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0539733:uncoupling protein-3 [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
  1000   C1421315:UNCOUPLING PROTEIN 3 [Gene or Genome]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "stimulates"

Phrase: "glucose uptake in muscle cells"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C1159527:glucose uptake [Cell Function]
   760   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   760   C0243144:Uptake [Physiologic Function]
   760   C0347980:% uptake [Quantitative Concept]

Phrase: "through a phosphoinositide 3-kinase-dependent mechanism."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0441712:Mechanism [Functional Concept]
   804   C1706376:Mechanism [Manufactured Object]
Processing 00000000.tx.318: J Biol Chem276 :12520 12529,2001[Abstract/Free FullText] Roduit R, Nolan C, Alarcon C, Moore P, Barbeau A, Delghingaro-Augusto V, Przybykowski E, Morin J, Masse F, Massie B: A role for the malonyl-CoA/long-chain acyl-CoA pathway of lipid signaling in the regulation of insulin secretion in response to both fuel and nonfuel stimuli. 

Phrase: "J Biol Chem276"

Phrase: ":"

Phrase: "12520 12529,"

Phrase: "2001"

Phrase: "[Abstract/Free FullText"

Phrase: "] Roduit R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Nolan C,"

Phrase: "Alarcon C,"

Phrase: "Moore P,"

Phrase: "Barbeau A,"

Phrase: "Delghingaro-Augusto V,"

Phrase: "Przybykowski E,"

Phrase: "Morin J,"

Phrase: "Masse F,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "Massie B"

Phrase: ":"

Phrase: "A role"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0035820:Role [Social Behavior]
  1000   C1705810:Role [Conceptual Entity]

Phrase: "for the malonyl-CoA/long-chain acyl-CoA pathway"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   795   C1704259:Pathway [Molecular Function]
   795   C1705987:Pathway [Conceptual Entity]
   710   C0001374:Long-Chain Acyl CoA [Biologically Active Substance,Lipid,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "of lipid signaling"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0037083:Signaling [Cell Function]
   861   C3537152:signaling [Biologic Function]

Phrase: "in the regulation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0851285:Regulation [Governmental or Regulatory Activity]
  1000   C1327622:Regulation [Biologic Function]

Phrase: "of insulin secretion"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C1256369:insulin secretion [Cell Function]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0036536:secretion [Biologic Function]
   861   C0036537:Secretion [Body Substance]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "in response"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0871261:Response [Organism Attribute]
  1000   C1704632:Response [Finding]
  1000   C1706817:Response [Intellectual Product]
  1000   C2911692:Response [Mental Process]

Phrase: "to both fuel"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0556991:Fuel [Manufactured Object]

Phrase: "and"

Phrase: "nonfuel stimuli."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0234402:Stimuli [Phenomenon or Process]
Processing 00000000.tx.319: Diabetes53 :1007 1019,2004[Abstract/Free FullText] Land SC, Porterfield DM, Sanger RH, Smith PJS: The self-referencing oxygen-selective microelectrode: detection of transmembrane oxygen flux from single cells. 

Phrase: "Diabetes53"

Phrase: ":"

Phrase: "1007 1019,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450318:1019 [Intellectual Product]

Phrase: "2004"

Phrase: "[Abstract/Free FullText"

Phrase: "] Land SC,"

Phrase: "Porterfield DM,"

Phrase: "Sanger RH,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0035493:Rh [Element, Ion, or Isotope]
   861   C2699077:Rh- [Classification]
   861   C2699078:Rh+ [Classification]

Phrase: "Smith PJS"

Phrase: ":"

Phrase: "The self-referencing oxygen-selective microelectrode"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   853   C0597155:oxygen microelectrode [Medical Device]
   804   C0025973:Microelectrode [Medical Device]

Phrase: ":"

Phrase: "detection of transmembrane oxygen flux"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   844   C2256387:detection of oxygen [Cell Function]
   760   C1511790:Detection [Therapeutic or Preventive Procedure]

Phrase: "from single cells."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.320: J Exp Biol202 :211 218,1999[Abstract/Free FullText] Porterfield DM, Corkey RF, Sanger RH, Tornheim K, Smith PJ, Corkey BE: Oxygen consumption oscillates in single clonal pancreatic -cells (HIT). 

Phrase: "J Exp Biol202"

Phrase: ":"

Phrase: "211 218,"

Phrase: "1999"

Phrase: "[Abstract/Free FullText"

Phrase: "] Porterfield DM,"

Phrase: "Corkey RF,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0035448:RF [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0201660:RF [Laboratory Procedure]
   861   C0748398:RF [Finding]

Phrase: "Sanger RH,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0035493:Rh [Element, Ion, or Isotope]
   861   C2699077:Rh- [Classification]
   861   C2699078:Rh+ [Classification]

Phrase: "Tornheim K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Smith PJ,"

Phrase: "Corkey"

Phrase: "BE"

Phrase: ":"

Phrase: "Oxygen consumption"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0030055:Oxygen Consumption [Clinical Attribute]
  1000   C1305742:oxygen consumption [Diagnostic Procedure]
   861   C0009830:Consumption [Activity]
   861   C0030054:Oxygen [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1947907:Consumption [Physiologic Function]

Phrase: "oscillates in single clonal pancreatic -cells"
Meta Candidates (Total=12; Excluded=3; Pruned=0; Remaining=9)
   753   C0007634:Cells [Cell]
   753   C0030274:Pancreatic [Body Part, Organ, or Organ Component]
   753   C0037179:Single [Population Group]
   753   C0087136:single [Finding]
   753   C0205171:Single [Quantitative Concept]
   753   C1522642:Clonal [Tissue]
   753   C1704387:Clonal [Qualitative Concept]
   753   C3282337:Cells [Cell]
   748   C0009013:Clone Cells [Cell]
   719 E C1269647:Cell [Cell]
   719 E C1704653:Cell [Medical Device]
   719 E C1948049:Cell [Spatial Concept]

Phrase: "(HIT"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0272285:HIT [Disease or Syndrome]
  1000   C0332159:hit [Functional Concept]
  1000   C1708373:Hit [Functional Concept]

Phrase: ")."
Processing 00000000.tx.321: Diabetes49 :1511 1516,2000[Abstract] Jung SK, Gorski W, Aspinwall CW, Kauri LM, Kennedy RT: Oxygen microsensor and its application to single cells and mouse pancreatic islets. 

Phrase: "Diabetes49"

Phrase: ":"

Phrase: "1511 1516,"

Phrase: "2000"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Jung SK,"

Phrase: "Gorski W,"

Phrase: "Aspinwall CW,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0454665:CW [Geographic Area]

Phrase: "Kauri LM,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1261082:LM [Body Part, Organ, or Organ Component]
   861   C1551056:lm [Quantitative Concept]
   861   C2981682:LM [Quantitative Concept]

Phrase: "Kennedy RT"

Phrase: ":"

Phrase: "Oxygen microsensor"

Phrase: "and"

Phrase: "its application to single cells"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0185125:Application [Health Care Activity]
   760   C1947919:Application [Intellectual Product]
   760   C2347934:Application [Intellectual Product]
   760   C3539080:APPLICATION [Quantitative Concept]

Phrase: "and"

Phrase: "mouse pancreatic islets."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   913   C1522528:Mouse Islets [Tissue]
   901   C0022131:Pancreatic Islets [Body Part, Organ, or Organ Component]
   827   C0030274:Pancreatic [Body Part, Organ, or Organ Component]
Processing 00000000.tx.322: Anal Chem71 :3642 3649,1999[Medline] Jaburek M, Varecha M, Gimeno RE, Dembski M, Jezek P, Zhang M, Burn P, Tartaglia LA, Garlid KD: Transport function and regulation of mitochondrial uncoupling proteins 2 and 3. 

Phrase: "Anal Chem71"

Phrase: ":"

Phrase: "3642 3649,"

Phrase: "1999"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Jaburek M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Varecha M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Gimeno RE,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2986904:RE [Idea or Concept]

Phrase: "Dembski M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Jezek P,"

Phrase: "Zhang M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Burn P,"

Phrase: "Tartaglia LA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0023031:La [Element, Ion, or Isotope]

Phrase: "Garlid KD"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0026691:KD [Disease or Syndrome]
   861   C1705240:KD [Gene or Genome]
   861   C1839259:KD [Disease or Syndrome]

Phrase: ":"

Phrase: "Transport function"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   861   C0031843:function [Physiologic Function]
   861   C0542341:Function [Functional Concept]
   861   C0700205:FUNCTION [Classification]
   861   C1705273:Function [Intellectual Product]
   789 E C0205245:Functional [Functional Concept]
   789 E C2700217:Functional [Conceptual Entity]

Phrase: "and"

Phrase: "regulation of mitochondrial uncoupling proteins 2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0851285:Regulation [Governmental or Regulatory Activity]
   753   C1327622:Regulation [Biologic Function]
   704   C0536847:mitochondrial uncoupling protein 2 [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "and"

Phrase: "3."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]
Processing 00000000.tx.323: J Biol Chem274 :26003 26007,1999[Abstract/Free FullText] Acin A, Rodriguez M, Rique H, Canet E, Boutin JA, Galizzi JP: Cloning and characterization of the 5' flanking region of the human uncoupling protein 3 (UCP3) gene. 

Phrase: "J Biol Chem274"

Phrase: ":"

Phrase: "26003 26007,"

Phrase: "1999"

Phrase: "[Abstract/Free FullText"

Phrase: "] Acin A,"

Phrase: "Rodriguez M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Rique H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Canet E,"

Phrase: "Boutin JA,"

Phrase: "Galizzi JP"

Phrase: ":"

Phrase: "Cloning"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0009015:Cloning [Research Activity]

Phrase: "and"

Phrase: "characterization of the 5' flanking region of the human uncoupling protein 3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   736   C1880022:Characterization [Activity]

Phrase: "(UCP3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0539733:uncoupling protein-3 [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
  1000   C1421315:UNCOUPLING PROTEIN 3 [Gene or Genome]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ")"

Phrase: "gene."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017337:Gene [Gene or Genome]
Processing 00000000.tx.324: Biochem Biophys Res Commun258 :278 283,1999[Medline] Weigle DS, Selfridge LE, Schwartz MW, Seeley RJ, Cummings DE, Havel PJ, Kuijper JL, BeltrandelRio H: Elevated free fatty acids induce uncoupling protein 3 expression in muscle: a potential explanation for the effect of fasting. 

Phrase: "Biochem Biophys Res Commun258"

Phrase: ":"

Phrase: "278 283,"

Phrase: "1999"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Weigle DS,"

Phrase: "Selfridge LE,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439090:LE [Idea or Concept]
   861   C1423767:LE [Gene or Genome]

Phrase: "Schwartz MW,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0024548:MW [Geographic Area]
   861   C0026385:mw [Quantitative Concept]
   861   C0556966:mW [Quantitative Concept]

Phrase: "Seeley RJ,"

Phrase: "Cummings DE,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0011198:DE [Geographic Area]
   861   C0017480:DE [Geographic Area]
   861   C3541240:DE [Idea or Concept]

Phrase: "Havel PJ,"

Phrase: "Kuijper JL,"

Phrase: "BeltrandelRio H"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: ":"

Phrase: "Elevated free fatty acids"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   923   C0015688:Free Fatty Acids [Lipid]
   890 E C2698488:Free Fatty Acid [Laboratory Procedure]
   861   C0015684:Fatty Acids [Lipid]
   812   C0001128:Acids [Chemical]
   812   C0332296:free [Functional Concept]
   812   C1880497:Free [Qualitative Concept]
   812   C1996904:Free [Qualitative Concept]
   779 E C0202406:Acid [Laboratory Procedure]

Phrase: "induce"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "uncoupling protein 3 expression in muscle"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   783   C1171362:expression protein [Genetic Function]
   753   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: ":"

Phrase: "a potential explanation for the effect of fasting."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0681841:Explanation [Intellectual Product]
Processing 00000000.tx.325: Diabetes47 :298 302,1998[Abstract] Boss O, Hagen T, Lowell BB: Uncoupling proteins 2 and 3: potential regulators of mitochondrial energy metabolism. 

Phrase: "Diabetes47"

Phrase: ":"

Phrase: "298 302,"

Phrase: "1998"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Boss O,"

Phrase: "Hagen T,"

Phrase: "Lowell BB"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0004739:BB [Geographic Area]
   861   C0332297:BB [Spatial Concept]

Phrase: ":"

Phrase: "Uncoupling proteins 2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   983   C0536847:uncoupling protein-2 [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   983   C1421314:UNCOUPLING PROTEIN 2 [Gene or Genome]
   827   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: ":"

Phrase: "potential regulators of mitochondrial energy metabolism."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   753   C0182953:regulators [Medical Device]
   719 E C1704734:Regulator [Medical Device]
   719 E C1704735:Regulator [Conceptual Entity]
Processing 00000000.tx.326: Diabetes49 :143 156,2000[Abstract] Himms-Hagen J, Harper ME: Physiological role of UCP3 may be export of fatty acids from mitochondria when fatty acid oxidation predominates: an hypothesis. 

Phrase: "Diabetes49"

Phrase: ":"

Phrase: "143 156,"

Phrase: "2000"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Himms-Hagen J,"

Phrase: "Harper"

Phrase: "ME"

Phrase: ":"

Phrase: "Physiological role of UCP3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0035820:Role [Social Behavior]
   753   C1705810:Role [Conceptual Entity]

Phrase: "may"

Phrase: "be"

Phrase: "export of fatty acids"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   833   C0015684:Fatty Acids [Lipid]
   770   C0001128:Acids [Chemical]
   770   C0699789:Export [Phenomenon or Process]
   737 E C0202406:Acid [Laboratory Procedure]

Phrase: "from mitochondria"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0026237:Mitochondria [Cell Component]

Phrase: "when"

Phrase: "fatty acid oxidation"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1158366:fatty acid oxidation [Molecular Function]
   901   C0015684:Fatty acid [Lipid]
   827   C0001128:Acid [Chemical]
   827   C0030011:Oxidation [Molecular Function]
   827   C0202406:Acid [Laboratory Procedure]

Phrase: "predominates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332251:Predominate [Qualitative Concept]

Phrase: ":"

Phrase: "an hypothesis."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1512571:Hypothesis [Idea or Concept]
Processing 00000000.tx.327: Exp Biol Med226 :78 84,2001[Abstract/Free FullText] Eaton S: Current Views of Fatty Acid Oxidation and Ketogenesis : From Organelles to Point Mutations. 

Phrase: "Exp Biol Med226"

Phrase: ":"

Phrase: "78 84,"

Phrase: "2001"

Phrase: "[Abstract/Free FullText"

Phrase: "] Eaton S"

Phrase: ":"

Phrase: "Current Views of Fatty Acid Oxidation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0449911:Views [Spatial Concept]

Phrase: "and"

Phrase: "Ketogenesis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0599816:ketogenesis [Molecular Function]

Phrase: ":"

Phrase: "From Organelles to Point Mutations."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   861   C0162735:Point Mutations [Cell or Molecular Dysfunction]
   812   C0026882:Mutations [Genetic Function]
   812   C1552961:Point [Quantitative Concept]
   812   C2347617:point [Quantitative Concept]
   779 E C1705285:Mutation [Cell or Molecular Dysfunction]
Processing 00000000.tx.328: New York, Kluwer Academic/Plenum Publishers,1999 Hunt MC, Nousiainen SE, Huttunen MK, Orii KE, Svensson LT, Alexson SE: Peroxisome proliferator-induced long chain acyl-CoA thioesterases comprise a highly conserved novel multi-gene family involved in lipid metabolism. 

Phrase: "New York,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027976:New York [Geographic Area]
   861   C0205314:New [Temporal Concept]

Phrase: "Kluwer Academic/Plenum Publishers,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   779   C1709767:Publisher [Occupation or Discipline]

Phrase: "1999 Hunt MC,"

Phrase: "Nousiainen SE,"

Phrase: "Huttunen MK,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3539059:MK [Idea or Concept]

Phrase: "Orii KE,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0022558:KE [Geographic Area]

Phrase: "Svensson LT,"

Phrase: "Alexson SE"

Phrase: ":"

Phrase: "Peroxisome proliferator-induced long chain acyl-CoA thioesterases"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   907   C1825828:PEROXISOMAL LONG-CHAIN ACYL-CoA THIOESTERASE [Gene or Genome]

Phrase: "comprise"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2700400:Comprise [Activity]

Phrase: "a highly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205250:Highly [Qualitative Concept]

Phrase: "conserved"

Phrase: "novel multi-gene family"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C1517488:Gene Family [Gene or Genome]
   812   C0015576:Family [Family Group]
   812   C1704727:Family [Conceptual Entity]
   741 E C0241888:Familial [Functional Concept]

Phrase: "involved in lipid metabolism."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   833   C0598783:Lipid Metabolism [Molecular Function]
   833   C1517898:Lipid Metabolism [Molecular Function]
   770   C0023779:Lipid [Lipid]
   770   C0025519:Metabolism [Organism Function]
   770   C0025520:metabolism [Functional Concept]
   770   C1314939:Involved [Functional Concept]
Processing 00000000.tx.329: J Biol Chem274 :34317 34326,1999[Abstract/Free FullText] Moore GB, Himms-Hagen J, Harper ME, Clapham JC: Overexpression of UCP-3 in skeletal muscle of mice results in increased expression of mitochondrial thioesterase mRNA. 

Phrase: "J Biol Chem274"

Phrase: ":"

Phrase: "34317 34326,"

Phrase: "1999"

Phrase: "[Abstract/Free FullText"

Phrase: "] Moore GB,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0041700:GB [Geographic Area]
   861   C1551090:Gb [Quantitative Concept]

Phrase: "Himms-Hagen J,"

Phrase: "Harper"

Phrase: "ME,"

Phrase: "Clapham JC"

Phrase: ":"

Phrase: "Overexpression of UCP-3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   797   C1514559:Protein Overexpression [Genetic Function]
           Overexpression

Phrase: "in skeletal muscle"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C0242692:Muscle, Skeletal [Tissue]
  1000   C1280260:Skeletal muscle [Body Part, Organ, or Organ Component]
   861   C0026845:Muscle [Tissue]
   861   C0037253:skeletal [Body System]
   861   C0521324:Skeletal [Spatial Concept]
   789 E C0442025:Muscular [Spatial Concept]

Phrase: "of mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mice [Mammal]
  1000   C0025929:mice [Mammal]
  1000   C0026809:Mice [Mammal]

Phrase: "results in increased expression of mitochondrial thioesterase mRNA."
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   767   C0066598:mRNA, mitochondrial [Nucleic Acid, Nucleoside, or Nucleotide]
   767   C1515670:mRNA Expression [Genetic Function]
   744   C0026237:Mitochondrial [Cell Component]
   744   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   744   C0185117:Expression [Therapeutic or Preventive Procedure]
   744   C0205217:Increased [Quantitative Concept]
   744   C0442805:Increased [Functional Concept]
   744   C0521451:Mitochondrial [Functional Concept]
   744   C1274040:Result [Functional Concept]
   744   C1546471:Result [Idea or Concept]
   744   C2825142:Result [Finding]
Processing 00000000.tx.330: Biochem Biophys Res Commun283 :785 790,2001[Medline] Stavinoha MA, RaySpellicy JW, Essop MF, Graveleau C, Abel ED, Hart-Sailors ML, Mersmann HJ, Bray MS, Young ME: Evidence for mitochondrial thioesterase 1 as a peroxisome proliferator-activated receptor--regulated gene in cardiac and skeletal muscle. 

Phrase: "Biochem Biophys Res Commun283"

Phrase: ":"

Phrase: "785 790,"

Phrase: "2001"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Stavinoha MA,"

Phrase: "RaySpellicy JW,"

Phrase: "Essop MF,"

Phrase: "Graveleau C,"

Phrase: "Abel ED,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3538926:ED [Idea or Concept]

Phrase: "Hart-Sailors ML,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0439526:/mL [Quantitative Concept]

Phrase: "Mersmann HJ,"

Phrase: "Bray MS,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039676:MS [Amino Acid, Peptide, or Protein,Enzyme]
   861   C2349943:Ms. [Conceptual Entity]
   861   C3539704:MS [Gene or Genome]

Phrase: "Young"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332239:Young [Temporal Concept]

Phrase: "ME"

Phrase: ":"

Phrase: "Evidence for mitochondrial thioesterase 1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0332120:Evidence [Functional Concept]

Phrase: "as a peroxisome proliferator-activated receptor"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
  1000   C0166418:peroxisome proliferator activated receptor [Amino Acid, Peptide, or Protein,Receptor]
  1000   C1418776:PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR [Gene or Genome]
   861   C0600434:peroxisome proliferator [Hazardous or Poisonous Substance]
   812   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   812   C0752063:Peroxysome [Cell Component]
   812   C1879547:Activated [Activity]
   812   C2984308:Peroxisome [Functional Concept]
   779 E C1515877:Activate [Functional Concept]
   741 E C3546463:peroxisomal [Cell Component]

Phrase: "--"

Phrase: "regulated gene in cardiac"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0017337:Gene [Gene or Genome]

Phrase: "and"

Phrase: "skeletal muscle."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C0242692:Muscle, Skeletal [Tissue]
  1000   C1280260:Skeletal muscle [Body Part, Organ, or Organ Component]
   861   C0026845:Muscle [Tissue]
   861   C0037253:skeletal [Body System]
   861   C0521324:Skeletal [Spatial Concept]
   789 E C0442025:Muscular [Spatial Concept]
Processing 00000000.tx.331: Am J Physiol Endocrinol Metab287 :E878 E887,2004[Abstract/Free FullText] Schrauwen P, Saris WH, Hesselink MK: An alternative function for human uncoupling protein 3: protection of mitochondria against accumulation of nonesterified fatty acids. 

Phrase: "Am"

Phrase: "J Physiol Endocrinol Metab287"

Phrase: ":"

Phrase: "E878 E887,"

Phrase: "2004"

Phrase: "[Abstract/Free FullText"

Phrase: "] Schrauwen P,"

Phrase: "Saris WH,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2349143:Wh [Quantitative Concept]

Phrase: "Hesselink MK"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3539059:MK [Idea or Concept]

Phrase: ":"

Phrase: "An alternative function for human uncoupling protein 3"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   767   C0815043:function protein [Amino Acid, Peptide, or Protein]
   767   C1527118:Protein Function [Molecular Function]
   744   C0031843:function [Physiologic Function]
   744   C0542341:Function [Functional Concept]
   744   C0700205:FUNCTION [Classification]
   744   C1705273:Function [Intellectual Product]

Phrase: ":"

Phrase: "protection of mitochondria"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1545588:Protection [Finding]

Phrase: "against accumulation"

Phrase: "of nonesterified fatty acids."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0015688:Nonesterified Fatty Acids [Lipid]
   901   C0015684:Fatty Acids [Lipid]
   827   C0001128:Acids [Chemical]
   793 E C0202406:Acid [Laboratory Procedure]
Processing 00000000.tx.332: FASEB J15 :2497 2502,2001[Abstract/Free FullText] Clapham JC, Arch JR, Chapman H, Haynes A, Lister C, Moore GB, Piercy V, Carter SA, Lehner I, Smith SA: Mice overexpressing human uncoupling protein-3 in skeletal muscle are hyperphagic and lean. 

Phrase: "FASEB J15"

Phrase: ":"

Phrase: "2497 2502,"

Phrase: "2001"

Phrase: "[Abstract/Free FullText"

Phrase: "] Clapham JC,"

Phrase: "Arch JR,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1708595:Jr [Idea or Concept]
   861   C3280986:JR [Disease or Syndrome]

Phrase: "Chapman H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Haynes A,"

Phrase: "Lister C,"

Phrase: "Moore GB,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0041700:GB [Geographic Area]
   861   C1551090:Gb [Quantitative Concept]

Phrase: "Piercy V,"

Phrase: "Carter SA,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0036243:SA [Geographic Area]
   861   C1539696:SA [Gene or Genome]
   861   C1825840:SA [Gene or Genome]
   861   C3539736:Sa [Spatial Concept]

Phrase: "Lehner I,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Smith SA"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0036243:SA [Geographic Area]
   861   C1539696:SA [Gene or Genome]
   861   C1825840:SA [Gene or Genome]
   861   C3539736:Sa [Spatial Concept]

Phrase: ":"

Phrase: "Mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mice [Mammal]
  1000   C0025929:mice [Mammal]
  1000   C0026809:Mice [Mammal]

Phrase: "overexpressing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1514559:overexpress [Genetic Function]

Phrase: "human uncoupling protein-3 in skeletal muscle"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   814   C0539733:uncoupling protein-3 [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   814   C1421315:UNCOUPLING PROTEIN 3 [Gene or Genome]
   774   C0026832:Muscle Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   774   C1142652:human protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "are"

Phrase: "hyperphagic"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   928   C0020505:Hyperphagia [Mental or Behavioral Dysfunction]

Phrase: "and"

Phrase: "lean."
Processing 00000000.tx.333: Nature406 :415 418,2000[Medline] Vidal-Puig AJ, Grujic D, Zhang CY, Hagen T, Boss O, Ido Y, Szczepanik A, Wade J, Mootha V, Cortright R: Energy metabolism in uncoupling protein 3 gene knockout mice. 

Phrase: "Nature406"

Phrase: ":"

Phrase: "415 418,"

Phrase: "2000"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Vidal-Puig AJ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0230613:AJ [Cell Component]

Phrase: "Grujic D,"

Phrase: "Zhang CY,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0010622:CY [Geographic Area]
   861   C0332298:CY [Functional Concept]

Phrase: "Hagen T,"

Phrase: "Boss O,"

Phrase: "Ido Y,"

Phrase: "Szczepanik A,"

Phrase: "Wade"

Phrase: "J,"

Phrase: "Mootha V,"

Phrase: "Cortright R"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: ":"

Phrase: "Energy metabolism in uncoupling protein 3 gene knockout mice."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   764   C0014272:Energy Metabolism [Physiologic Function]
   762   C0597299:Protein Metabolism [Molecular Function]
   742   C0025519:Metabolism [Organism Function]
   742   C0025520:metabolism [Functional Concept]
   742   C0424589:Energy [Finding]
   742   C0542479:Energy [Natural Phenomenon or Process]
   742   C1442080:Energy [Quantitative Concept]
Processing 00000000.tx.334: J Biol Chem275 :16258 16266,2000[Abstract/Free FullText] Echtay KS, Esteves TC, Pakay JL, Jekabsons MB, Lambert AJ, Portero-Otin M, Pamplona R, Vidal-Puig AJ, Wang S, Roebuck SJ: A signalling role for 4-hydroxy-2-nonenal in regulation of mitochondrial uncoupling. 

Phrase: "J Biol Chem275"

Phrase: ":"

Phrase: "16258 16266,"

Phrase: "2000"

Phrase: "[Abstract/Free FullText"

Phrase: "] Echtay KS,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3541894:ks [Quantitative Concept]

Phrase: "Esteves TC,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0041405:TC [Geographic Area]
   861   C1824670:TC [Gene or Genome]
   861   C3272447:TC [Gene or Genome]

Phrase: "Pakay JL,"

Phrase: "Jekabsons MB,"

Phrase: "Lambert AJ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0230613:AJ [Cell Component]

Phrase: "Portero-Otin M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0441923:M+ [Intellectual Product]

Phrase: "Pamplona R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Vidal-Puig AJ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0230613:AJ [Cell Component]

Phrase: "Wang S,"

Phrase: "Roebuck SJ"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1515101:SJ [Geographic Area]
   861   C2986905:SJ [Idea or Concept]

Phrase: ":"

Phrase: "A signalling role for 4-hydroxy-2-nonenal"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0035820:Role [Social Behavior]
   744   C1705810:Role [Conceptual Entity]

Phrase: "in regulation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0851285:Regulation [Governmental or Regulatory Activity]
  1000   C1327622:Regulation [Biologic Function]

Phrase: "of mitochondrial"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0026237:Mitochondrial [Cell Component]
  1000   C0521451:Mitochondrial [Functional Concept]

Phrase: "uncoupling."
Processing 00000000.tx.335: EMBO J22 :4103 4110,2003[Abstract/Free FullText] Goglia F, Skulachev VP: A function for novel uncoupling proteins: antioxidant defense of mitochondrial matrix by translocating fatty acid peroxides from the inner to the outer membrane leaflet. 

Phrase: "EMBO J22"

Phrase: ":"

Phrase: "4103 4110,"

Phrase: "2003"

Phrase: "[Abstract/Free FullText"

Phrase: "] Goglia F,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "Skulachev VP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1883540:{VP} [Quantitative Concept]

Phrase: ":"

Phrase: "A function for novel uncoupling proteins"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   783   C0815043:function proteins [Amino Acid, Peptide, or Protein]
   767 E C1527118:Protein Function [Molecular Function]
   753   C0031843:function [Physiologic Function]
   753   C0542341:Function [Functional Concept]
   753   C0700205:FUNCTION [Classification]
   753   C1705273:Function [Intellectual Product]

Phrase: ":"

Phrase: "antioxidant defense of mitochondrial matrix"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0003402:Antioxidant [Pharmacologic Substance]
   760   C1880266:Defense [Conceptual Entity]

Phrase: "by translocating fatty acid peroxides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0031180:Peroxides [Inorganic Chemical]

Phrase: "from the inner"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205102:Inner [Spatial Concept]

Phrase: "to the outer membrane leaflet."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1708664:Leaflet [Manufactured Object]
   827   C3273178:Leaflet [Intellectual Product]
   734   C1167331:outer membrane [Cell Component]
Processing 00000000.tx.336: FASEB J17 :1585 1591,2003[Abstract/Free FullText] Echtay KS, Roussel D, St-Pierre J, Jekabsons MB, Cadenas S, Stuart JA, Harper JA, Roebuck SJ, Morrison A, Pickering S: Superoxide activates mitochondrial uncoupling proteins. 

Phrase: "FASEB J17"

Phrase: ":"

Phrase: "1585 1591,"

Phrase: "2003"

Phrase: "[Abstract/Free FullText"

Phrase: "] Echtay KS,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3541894:ks [Quantitative Concept]

Phrase: "Roussel D,"

Phrase: "St-Pierre J,"

Phrase: "Jekabsons MB,"

Phrase: "Cadenas S,"

Phrase: "Stuart JA,"

Phrase: "Harper JA,"

Phrase: "Roebuck SJ,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1515101:SJ [Geographic Area]
   861   C2986905:SJ [Idea or Concept]

Phrase: "Morrison A,"

Phrase: "Pickering S"

Phrase: ":"

Phrase: "Superoxide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0038836:Superoxide [Element, Ion, or Isotope]

Phrase: "activates"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515877:Activate [Functional Concept]
  1000   C1879547:Activate [Activity]

Phrase: "mitochondrial uncoupling proteins."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   983   C0066604:mitochondrial uncoupling protein [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   913   C0949610:Mitochondrial Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.337: Nature415 :96 99,2002[Medline] Nishikawa T, Edelstein D, Du XL, Yamagishi S, Matsumura T, Kaneda Y, Yorek MA, Beebe D, Oates PJ, Hammes HP: Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage. 

Phrase: "Nature415"

Phrase: ":"

Phrase: "96 99,"

Phrase: "2002"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Nishikawa T,"

Phrase: "Edelstein D,"

Phrase: "Du XL,"

Phrase: "Yamagishi S,"

Phrase: "Matsumura T,"

Phrase: "Kaneda Y,"

Phrase: "Yorek MA,"

Phrase: "Beebe D,"

Phrase: "Oates PJ,"

Phrase: "Hammes HP"

Phrase: ":"

Phrase: "Normalizing mitochondrial superoxide production"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0033268:production [Occupational Activity]

Phrase: "blocks"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0028778:Block [Pathologic Function]
  1000   C0332206:Block [Functional Concept]
  1000   C1533157:Block [Substance]
  1000   C1706084:Block [Geographic Area]
  1000   C2828370:Block [Quantitative Concept]

Phrase: "three pathways of hyperglycaemic damage."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1704259:Pathways [Molecular Function]
   760   C1705987:Pathways [Conceptual Entity]
Processing 00000000.tx.338: Nature404 :787 790,2000[Medline] Argyropoulos G, Brown AM, Willi SM, Zhu J, He Y, Reitman M, Gevao SM, Spruill I, Garvey WT: Effects of mutations in the human uncoupling protein 3 gene on the respiratory quotient and fat oxidation in severe obesity and type 2 diabetes. 

Phrase: "Nature404"

Phrase: ":"

Phrase: "787 790,"

Phrase: "2000"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Argyropoulos G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "Brown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0678579:Brown [Natural Phenomenon or Process]

Phrase: "AM"

Phrase: ","

Phrase: "Willi SM,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036154:SM [Geographic Area]

Phrase: "Zhu J,"

Phrase: "He Y,"

Phrase: "Reitman M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Gevao SM,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036154:SM [Geographic Area]

Phrase: "Spruill I,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Garvey WT"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2700323:WT [Fish]

Phrase: ":"

Phrase: "Effects of mutations"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C1280500:effects [Qualitative Concept]
   756 E C2348382:Effect [Qualitative Concept]

Phrase: "in the human uncoupling protein 3 gene"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   897   C0314604:Human gene [Gene or Genome]
   853   C0751455:protein gene [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0017337:Gene [Gene or Genome]
   717   C0539733:uncoupling protein-3 [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   717   C1421315:UNCOUPLING PROTEIN 3 [Gene or Genome]

Phrase: "on the respiratory quotient"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0429702:Respiratory quotient [Laboratory or Test Result]
   861   C0521346:respiratory [Functional Concept]
   861   C1546767:Respiratory [Intellectual Product]
   861   C2347741:Quotient [Quantitative Concept]

Phrase: "and"

Phrase: "fat oxidation in severe obesity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0030011:Oxidation [Molecular Function]

Phrase: "and"

Phrase: "type 2 diabetes."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0011860:Type 2 Diabetes [Disease or Syndrome]
   913   C1320657:type diabetes [Finding]
   901   C0441730:Type 2 [Classification]
   827   C0011847:Diabetes [Disease or Syndrome]
   827   C0011849:Diabetes [Disease or Syndrome]
   827   C0332307:Type [Qualitative Concept]
   827   C1547052:*Type [Quantitative Concept]
Processing 00000000.tx.339: J Clin Invest102 :1345 1351,1998[Abstract/Free FullText] Chung WK, Luke A, Cooper RS, Rotini C, Vidal-Puig A, Rosenbaum M, Chua M, Solanes G, Zheng M, Zhao L: Genetic and physiologic analysis of the role of uncoupling protein 3 in human energy homeostasis. 

Phrase: "J Clin Invest102"

Phrase: ":"

Phrase: "1345 1351,"

Phrase: "1998"

Phrase: "[Abstract/Free FullText"

Phrase: "] Chung WK,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0332174:/wk [Temporal Concept]
   861   C0439230:wk [Temporal Concept]

Phrase: "Luke A,"

Phrase: "Cooper RS,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3539879:RS [Idea or Concept]

Phrase: "Rotini C,"

Phrase: "Vidal-Puig A,"

Phrase: "Rosenbaum M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Chua M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Solanes G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "Zheng M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Zhao L"

Phrase: ":"

Phrase: "Genetic"
Meta Candidates (Total=16; Excluded=14; Pruned=0; Remaining=2)
  1000   C0017296:GENETIC [Therapeutic or Preventive Procedure]
  1000   C0314603:Genetic [Functional Concept]
   944 E C0005615:Birth [Organism Function]
   944 E C0035150:Reproduction [Organism Function]
   944 E C0079946:origin [Classification]
   944 E C0439659:Origin [Temporal Concept]
   944 E C1550512:origin [Intellectual Product]
   944 E C1550722:birth [Idea or Concept]
   944 E C3245487:birth [Intellectual Product]
   916 E C0454729:Natal [Geographic Area]
   916 E C0559522:Genital [Body System]
   916 E C1546649:Genital [Intellectual Product]
   916 E C1550642:Genital [Body Substance]
   907 E C0205313:Original [Idea or Concept]
   907 E C2347409:Original [Occupational Activity]
   888 E C0598240:originality [Mental Process]

Phrase: "and"

Phrase: "physiologic analysis of the role of uncoupling protein 3"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   762   C1514534:Protein Analysis [Molecular Biology Research Technique]
   742   C0002778:Analysis [Laboratory Procedure]
   742   C0936012:Analysis [Research Activity]
   742   C1524024:analysis [Functional Concept]

Phrase: "in human energy homeostasis."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C3157043:energy homeostasis [Biologic Function]
   827   C0019868:Homeostasis [Biologic Function]
Processing 00000000.tx.340: Diabetes48 :1890 1895,1999[Abstract] Bezaire V, Spriet LL, Campbell S, Sabet N, Gerrits M, Bonen A, Harper M-E: Constitutive UCP3 overexpression at physiological levels increases mouse skeletal muscle capacity for fatty acid transport and oxidation. 

Phrase: "Diabetes48"

Phrase: ":"

Phrase: "1890 1895,"

Phrase: "1999"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Bezaire V,"

Phrase: "Spriet LL,"

Phrase: "Campbell S,"

Phrase: "Sabet N,"

Phrase: "Gerrits M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Bonen A,"

Phrase: "Harper"

Phrase: "M-"

Phrase: "E"

Phrase: ":"

Phrase: "Constitutive UCP3 overexpression at physiological levels"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   767   C1514559:Protein Overexpression [Genetic Function]
           Overexpression

Phrase: "increases"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "mouse skeletal muscle capacity for fatty acid transport"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1516240:Capacity [Quantitative Concept]

Phrase: "and"

Phrase: "oxidation."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030011:Oxidation [Molecular Function]
Processing 00000000.tx.341: FASEB J19 :977 979,2005[Abstract/Free FullText]

Phrase: "FASEB J19"

Phrase: ":"

Phrase: "977 979,"

Phrase: "2005"

Phrase: "[Abstract/Free FullText"

Phrase: "]"

